Sentence,class,file
http://www.crohnsforum.com/showthread.php?t= 59447 .,Non-OADS,/arxiv_data1/oa_pdf/ec/a6/40800_2016_Article_29.PMC5005790.pdf
http://db.cbg-meb.nl/IB-teksten/h10647.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ec/a6/40800_2016_Article_29.PMC5005790.pdf
"219 http://jpis.orgThis August I had the opportunity to discuss scientific publication policy with my colleagues  in the Asia Pacific region and World Health Organization (WHO) at the annual convention of  the Asia Pacific Association of Medical Journal Editors (APAME) held in Bangkok, Thailand.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/jpis-46-219.PMC5005809.pdf
"2016 Aug;46(4):219 http://doi.org/10.5051/jpis.2016.46.4.219 pISSN 2093-2278·eISSN 2093-2286 Editorial Received:  Aug 29, 2016 Accepted:  Aug 29, 2016 Correspondence to Tae-Il Kim (Editor-in-Chief) Department of Periodontology, Seoul National  University School of Dentistry, 101 Daehak-ro,  Jongno-gu, Seoul 03080, Korea.",Non-OADS,/arxiv_data1/oa_pdf/23/9e/jpis-46-219.PMC5005809.pdf
"ORCID Tae-Il Kim http://orcid.org/0000-0003-4087-8021Tae-Il Kim Department of Periodontology, Seoul National University School of Dentistry, Seoul, KoreaAdvancing toward quality,  collaboration, and public access",Non-OADS,/arxiv_data1/oa_pdf/23/9e/jpis-46-219.PMC5005809.pdf
"220 http://jpis.orgABSTRACT Purpose:  The aim of this study was to present new a model that allows the study of the  bone healing process, with an emphasis on the biological behavior of different graft-to- host interfaces.",Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
"2016 Aug;46(4):220-233 http://doi.org/10.5051/jpis.2016.46.4.220 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  Feb 29, 2016 Accepted:  Jun 29, 2016 *Correspondence to Simone Lumetti Department of Biomedical, Biotechnological,  and Translational Sciences (S.Bi.Bi.T), Dental  Medicine Unit, University of Parma, Via  Gramsci 14, Parma 43126, Italy.",Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
"ORCID Giulia Ghiacci http://orcid.org/0000-0003-2902-2214 Gallia Graiani http://orcid.org/0000-0003-1926-7568 Francesca Ravanetti http://orcid.org/0000-0001-8729-3237 Simone Lumetti http://orcid.org/0000-0002-0826-927XGiulia Ghiacci,1,2 Gallia Graiani,1 Francesca Ravanetti,3 Simone Lumetti,1,*   Edoardo Manfredi,1 Carlo Galli,1,4 Antonio Cacchioli,3 Guido Maria Macaluso,1,4  Roberto Sala2 1 Department of Biomedical, Biotechnological, and Translational Sciences (S.Bi.Bi.T), University of Parma  Dental Medicine Unit, Parma, Italy 2 Department of Biomedical, Biotechnological, and Translational Sciences (S.Bi.Bi.T), University of Parma  General Pathology Unit, Parma, Italy 3Department of Veterinary Science, University of Parma, Parma, Italy 4 Institute of Materials for Electronics and Magnetism (IMEM), Italian National Research Council (CNR),  Parco Area delle Scienze, Parma, Italy“Over-inlay” block graft and  differential morphometry: a novel  block graft model to study bone  regeneration and host-to-graft  interfaces in rats",Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
221 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.220“Over-inlay” block graft and differential morphometry Edoardo Manfredi http://orcid.org/0000-0003-2718-9934 Carlo Galli http://orcid.org/0000-0001-7476-7181 Antonio Cacchioli http://orcid.org/0000-0003-4421-6842 Guido Maria Macaluso http://orcid.org/0000-0003-2203-3092 Roberto Sala http://orcid.org/0000-0003-0414-3220 Conflict of Interest No potential conflict of interest relevant to this  article was reported.,Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
"A first-layer  suture was applied in order to fix the periosteum, then a secondary layer of subcutaneous  suture was applied to allow primary intention wound healing (Vycril 5-0, Ethicon,  222 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.220“Over-inlay” block graft and differential morphometry",Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
"Microphotographs of tissue from different ROIs were captured by an optical microscope  (Nikon Eclipse 90i, Nikon, Tokyo, Japan) connected to a digital camera and morphometric  223 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.220“Over-inlay” block graft and differential morphometry A B Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
The nuclear counterstaining was performed with  224 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.220“Over-inlay” block graft and differential morphometry CB PA CA BA BAP DBBM DBBM TB CBA C/two.LP/zero.LP/zero.LP µm /two.LP/zero.LP/zero.LP µmB D Figure 2.,OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
This indicates that a suture without tension can be achieved in this model when the  225 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.220“Over-inlay” block graft and differential morphometry,Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
226 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.220“Over-inlay” block graft and differential morphometry /one.LP month NBNB DBBM DBBM DBBMDBBM DBBM DBBM DBBMDBBMNB NBFTFT FT FT FT FTFT FT FT FTFT★ ★★ ★★★ FTBA PA CA/three.LP months  /one.LP/zero.LP/zero.LP µm /one.LP/zero.LP/zero.LP µm /one.LP/zero.LP/zero.LP µm /one.LP/zero.LP/zero.LP µm /one.LP/zero.LP/zero.LP µm /one.LP/zero.LP/zero.LP µm Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
227 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.220“Over-inlay” block graft and differential morphometry 01 month % % %3 months 20 40 60 80 100 01 month3 months 20 40 60 80 100 01 month3 months 20 40 60 80 100A B CBA PA CA FT NB DBBM Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
"The use of such a simplified model was aimed at  facilitating data collection at different graft-to-host interfaces and the interpretation of the  results; indeed, the “over” component served to define a periosteal area (PA) and aided the  investigation of the relative contribution of the periosteum to graft integration, while the  228 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.220“Over-inlay” block graft and differential morphometry",Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
229 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.220“Over-inlay” block graft and differential morphometry Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
Previous authors  who used block grafts for inlay procedures in graft calvarial critical-size defects have reported  new bone at the graft borders adjacent to the host bone marrow [ 37] and underneath the  230 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.220“Over-inlay” block graft and differential morphometry,Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
PUBMED  | CROSSREF 231 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.220“Over-inlay” block graft and differential morphometry,Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
PUBMED  | CROSSREF 232 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.220“Over-inlay” block graft and differential morphometry,Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
PUBMED  | CROSSREF 233 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.220“Over-inlay” block graft and differential morphometry,Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jpis-46-220.PMC5005810.pdf
234 http://jpis.orgABSTRACT Purpose:  Immediate loading of dental implants has been proved to be feasible in partially  edentulous jaws.,Non-OADS,/arxiv_data1/oa_pdf/9a/d4/jpis-46-234.PMC5005811.pdf
"2016 Aug;46(4):234-243 http://doi.org/10.5051/jpis.2016.46.4.234 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  May 11, 2016 Accepted:  Jul 1, 2016 *Correspondence to Anders Henningsen Department of Oral and Maxillofacial  Surgery, University Medical Center Hamburg- Eppendorf, Martinistrasse 52, Hamburg 20246,  Germany.",Non-OADS,/arxiv_data1/oa_pdf/9a/d4/jpis-46-234.PMC5005811.pdf
"ORCID Anders Henningsen http://orcid.org/0000-0002-1365-7058 Ralf Smeets http://orcid.org/0000-0002-0207-5474 Aria Wahidi http://orcid.org/0000-0003-3365-3799 Lan Kluwe http://orcid.org/0000-0001-9919-4551 Frank Kornmann http://orcid.org/0000-0002-8364-2791 Max Heiland http://orcid.org/0000-0002-4987-2913 Till Gerlach http://orcid.org/0000-0003-4674-7057 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Anders Henningsen,1,2,* Ralf Smeets,1 Aria Wahidi,1 Lan Kluwe,1 Frank Kornmann,3  Max Heiland,1 Till Gerlach3 1 Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg,  Germany 2Department of Oral and Maxillofacial Surgery, German Armed Forces Hospital, Hamburg, Germany 3Private Practice for Dentistry and Oral Surgery, Oppenheim, GermanyThe feasibility of immediately loading  dental implants in edentulous jaws",Non-OADS,/arxiv_data1/oa_pdf/9a/d4/jpis-46-234.PMC5005811.pdf
Implants  235 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.234Immediate loading of implants in edentulous jaws,Non-OADS,/arxiv_data1/oa_pdf/9a/d4/jpis-46-234.PMC5005811.pdf
The distance from implant shoulder (IS) to the first  bone contact point along the implant (DIB) was measured mesially and distally and the mean  236 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.234Immediate loading of implants in edentulous jaws,Non-OADS,/arxiv_data1/oa_pdf/9a/d4/jpis-46-234.PMC5005811.pdf
"In selected cases, bone grafting and  237 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.234Immediate loading of implants in edentulous jaws CBLDIB IS Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/9a/d4/jpis-46-234.PMC5005811.pdf
238 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.234Immediate loading of implants in edentulous jaws Table 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/d4/jpis-46-234.PMC5005811.pdf
239 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.234Immediate loading of implants in edentulous jaws Table 3.,Non-OADS,/arxiv_data1/oa_pdf/9a/d4/jpis-46-234.PMC5005811.pdf
"Other parameters, such as site and size of the implants, did not have a detectable  240 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.234Immediate loading of implants in edentulous jaws Table 4.",Non-OADS,/arxiv_data1/oa_pdf/9a/d4/jpis-46-234.PMC5005811.pdf
PUBMED 241 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.234Immediate loading of implants in edentulous jaws,Non-OADS,/arxiv_data1/oa_pdf/9a/d4/jpis-46-234.PMC5005811.pdf
PUBMED  | CROSSREF 242 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.234Immediate loading of implants in edentulous jaws,Non-OADS,/arxiv_data1/oa_pdf/9a/d4/jpis-46-234.PMC5005811.pdf
PUBMED  | CROSSREF 243 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.234Immediate loading of implants in edentulous jaws,Non-OADS,/arxiv_data1/oa_pdf/9a/d4/jpis-46-234.PMC5005811.pdf
244 http://jpis.orgABSTRACT Purpose:  The aim of this study was to characterize the healing in the grafted calvarial defects  of rats after adjunctive hyperbaric oxygen therapy.,Non-OADS,/arxiv_data1/oa_pdf/6c/31/jpis-46-244.PMC5005812.pdf
"2016 Aug;46(4):244-253 http://doi.org/10.5051/jpis.2016.46.4.244 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  Apr 14, 2016 Accepted:  Jul 3, 2016 *Correspondence to Sungtae Kim Department of Periodontology, Dental  Research Institute, Seoul National University  School of Dentistry, 101 Daehak-ro, Jongno-gu,  Seoul 03080, Korea.",Non-OADS,/arxiv_data1/oa_pdf/6c/31/jpis-46-244.PMC5005812.pdf
"ORCID Hyeyoon Chang http://orcid.org/0000-0002-3376-4934 Seo-Eun Oh http://orcid.org/0000-0003-3308-3423 Seunghan Oh http://orcid.org/0000-0002-0592-7257 Kyung-Seok Hu http://orcid.org/0000-0002-9048-3805 Sungtae Kim http://orcid.org/0000-0001-6361-4104Hyeyoon Chang,1,† Seo-Eun Oh,1,2,† Seunghan Oh,3 Kyung-Seok Hu,2 Sungtae Kim1,* 1 Department of Periodontology, Dental Research Institute, Seoul National University School of Dentistry,  Seoul, Korea 2 Division of Anatomy and Developmental Biology, Department of Oral Biology, Human Identification  Research Center, BK21 PLUS Project, Yonsei University College of Dentistry, Seoul, Korea 3Department of Oral and Maxillofacial Surgery, Wonkwang University College of Dentistry, Iksan, KoreaFour-week histologic evaluation  of grafted calvarial defects with  adjunctive hyperbaric oxygen therapy  in rats",Non-OADS,/arxiv_data1/oa_pdf/6c/31/jpis-46-244.PMC5005812.pdf
245 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.244Hyperbaric oxygen therapy on calvarial defects,Non-OADS,/arxiv_data1/oa_pdf/6c/31/jpis-46-244.PMC5005812.pdf
"The histometric  measurements included the areas of new bone and soft tissue, which were obtained using the  246 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.244Hyperbaric oxygen therapy on calvarial defects Table 1.",Non-OADS,/arxiv_data1/oa_pdf/6c/31/jpis-46-244.PMC5005812.pdf
Increased new  bone formation around bone substitute particles was evident in the HBO groups ( Figure 3C  247 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.244Hyperbaric oxygen therapy on calvarial defects A B Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/6c/31/jpis-46-244.PMC5005812.pdf
248 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.244Hyperbaric oxygen therapy on calvarial defects C B AM MM M MM MMM MM DMDM DMNB NBNBNB E F DM M MMMM MM M DM DMNB NBNBDMNB Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/6c/31/jpis-46-244.PMC5005812.pdf
249 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.244Hyperbaric oxygen therapy on calvarial defects E F DC B AMM M MM M MM MMM MM MMM MM MMM NB NB NB NBNBNB NB NB NBNB BMBMBMBM BMBM Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/6c/31/jpis-46-244.PMC5005812.pdf
250 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.244Hyperbaric oxygen therapy on calvarial defects B A  C Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/6c/31/jpis-46-244.PMC5005812.pdf
"However, there is an ideal and specific ratio of BMP-2:VEGF for new bone formation  251 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.244Hyperbaric oxygen therapy on calvarial defects Table 2.",Non-OADS,/arxiv_data1/oa_pdf/6c/31/jpis-46-244.PMC5005812.pdf
PUBMED  | CROSSREF 252 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.244Hyperbaric oxygen therapy on calvarial defects,Non-OADS,/arxiv_data1/oa_pdf/6c/31/jpis-46-244.PMC5005812.pdf
PUBMED 253 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.244Hyperbaric oxygen therapy on calvarial defects,Non-OADS,/arxiv_data1/oa_pdf/6c/31/jpis-46-244.PMC5005812.pdf
254 http://jpis.orgABSTRACT Purpose:  The aim of this study was to determine the influence of anatomical conditions on  primary stability in the models simulating posterior maxilla.,Non-OADS,/arxiv_data1/oa_pdf/1a/83/jpis-46-254.PMC5005813.pdf
"2016 Aug;46(4):254-265 http://doi.org/10.5051/jpis.2016.46.4.254 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  Apr 24, 2016 Accepted:  Jul 5, 2016 *Correspondence to Seung-Yun Shin Department of Periodontology, Kyung  Hee University School of Dentistry, 26  Kyungheedae-ro, Dongdaemun-gu, Seoul  02447, Korea.",Non-OADS,/arxiv_data1/oa_pdf/1a/83/jpis-46-254.PMC5005813.pdf
"ORCID Ho-Chyul Han http://orcid.org/0000-0001-9746-583X Hyun-Chang Lim http://orcid.org/0000-0001-7695-1708 Ji-Youn Hong http://orcid.org/0000-0003-1040-7077 Su-Jin Ahn http://orcid.org/0000-0003-2128-1561 Ji-Young Han http://orcid.org/0000-0002-2364-8366 Seung-Il Shin http://orcid.org/0000-0001-8762-6169 Jong-Hyuk Chung http://orcid.org/0000-0002-2678-1525Ho-Chyul Han,1,2,† Hyun-Chang Lim,1,2,† Ji-Youn Hong,1,2 Su-Jin Ahn,3 Ji-Young Han,4  Seung-Il Shin,1,2 Jong-Hyuk Chung,1,2 Yeek Herr,1,2 Seung-Yun Shin1,2,*   1 Department of Periodontology, Kyung Hee University School of Dentistry, Seoul, Korea 2       Department of Periodontology, Periodontal-Implant Clinical Research Institute, Kyung Hee University  Dental Hospital, Seoul, Korea 3 Department of Biomaterials & Prosthodontics, Institute of Oral Biology, Kyung Hee University School of  Dentistry, Seoul, Korea 4Department of Dentistry & Periodontology, Hanyang University College of Medicine, Seoul, KoreaPrimary implant stability in a bone  model simulating clinical situations for  the posterior maxilla: an in vitro study",Non-OADS,/arxiv_data1/oa_pdf/1a/83/jpis-46-254.PMC5005813.pdf
Yeek Herr http://orcid.org/0000-0001-9243-7119 Seung-Yun Shin http://orcid.org/0000-0001-6980-7556 Funding This work was supported by a grant from  Kyung Hee University in 2014 (KHU-20140681).,Non-OADS,/arxiv_data1/oa_pdf/1a/83/jpis-46-254.PMC5005813.pdf
The density of the block simulating maxillary  255 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.254Anatomical situations affecting primary stability,Non-OADS,/arxiv_data1/oa_pdf/1a/83/jpis-46-254.PMC5005813.pdf
256 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.254Anatomical situations affecting primary stability E G F H /three.LP mm/five.LP mm/eight.LP mm/one.LP/two.LP mm A B C D /three.LP mm/five.LP mm/eight.LP mm/one.LP/two.LP mm Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/1a/83/jpis-46-254.PMC5005813.pdf
257 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.254Anatomical situations affecting primary stability,Non-OADS,/arxiv_data1/oa_pdf/1a/83/jpis-46-254.PMC5005813.pdf
258 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.254Anatomical situations affecting primary stability Table 1.,Non-OADS,/arxiv_data1/oa_pdf/1a/83/jpis-46-254.PMC5005813.pdf
259 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.254Anatomical situations affecting primary stability Table 4.,Non-OADS,/arxiv_data1/oa_pdf/1a/83/jpis-46-254.PMC5005813.pdf
"Cadaveric  260 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.254Anatomical situations affecting primary stability a,d) a)a,b,d) a,b,c)a,b,d) 3 mm 5 mm Residual bone heightISQ 8 mm 12 mm405060708090Monocortical Bicortical d) a,b)d) a)a,b,d) a,b,c)a,b,d)PTV 20-2-4-6-8-10 Residual bone height3 mm 5 mm 8 mm 12 mm4d) a,b) d) a)a,b,d) a,c)b,c,d) 3 mm 5 mm Residual bone heightIT 8 mm 12 mm20406080100120 120 b) d) a) a,b,c)d) 3 mm 5 mm Residual bone heightRT 8 mm 12 mm20406080100 a)A B D C Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/1a/83/jpis-46-254.PMC5005813.pdf
"Bicortical fixation was proposed for increasing primary stability [ 23,24], which was  clearly demonstrated in the present study; all subgroups in the bicortical groups showed  261 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.254Anatomical situations affecting primary stability PTV IT (Ncm) ISQ ISQ20-2-4-6-8-10 4 02080100120 0 0204080 6010020 0406080100120 A B D C 020406080100 RT (Ncm) F E4 2 -2 -4 -6 -8 -10 40 20 60 80 100 120 140 0 4 2 -2 -4 -6 -8 -10 40 50 60 70 80 902040608010040 50 60 70 80 9040 50 60 70 80 90IT (Ncm) IT (Ncm)RT (Ncm) RT (Ncm)Pearson’s r=/hyphen.cap/zero.LP./nine.LP/seven.LP P</zero.LP./zero.LP/zero.LP/one.LPa) Pearson’s r=/hyphen.cap/zero.LP./six.LP/one.LP P</zero.LP./zero.LP/zero.LP/one.LPa) Pearson’s r=/zero.LP./one.LP/two.LP P=/zero.LP./two.LP/eight.LPPearson’s r=/zero.LP./five.LP/eight.LP P</zero.LP./zero.LP/zero.LP/one.LPa) Pearson’s r=/zero.LP./six.LP/zero.LP P</zero.LP./zero.LP/zero.LP/one.LPa)   Pearson’s r=/hyphen.cap/zero.LP./one.LP/four.LP P=/zero.LP./two.LP/three.LP ISQ PTVPTV4060 Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/1a/83/jpis-46-254.PMC5005813.pdf
Mono- and bicortical fixation was clinically  262 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.254Anatomical situations affecting primary stability,Non-OADS,/arxiv_data1/oa_pdf/1a/83/jpis-46-254.PMC5005813.pdf
PUBMED  | CROSSREF 263 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.254Anatomical situations affecting primary stability,Non-OADS,/arxiv_data1/oa_pdf/1a/83/jpis-46-254.PMC5005813.pdf
PUBMED 264 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.254Anatomical situations affecting primary stability,Non-OADS,/arxiv_data1/oa_pdf/1a/83/jpis-46-254.PMC5005813.pdf
PUBMED  | CROSSREF 265 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.254Anatomical situations affecting primary stability,Non-OADS,/arxiv_data1/oa_pdf/1a/83/jpis-46-254.PMC5005813.pdf
266 http://jpis.orgABSTRACT Purpose:  The aim of the present study was to retrospectively investigate the influence of  potential risk indicators on the development of peri-implant disease.,Non-OADS,/arxiv_data1/oa_pdf/87/65/jpis-46-266.PMC5005814.pdf
"2016 Aug;46(4):266-276 http://doi.org/10.5051/jpis.2016.46.4.266 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  Apr 25, 2016 Accepted:  Jul 6, 2016 *Correspondence to Pier Paolo Poli Implant Center for Edentulism and Jawbone  Atrophies, Maxillofacial Surgery and  Odontostomatology Unit, Fondazione IRCCS  Cà Granda, Ospedale Maggiore Policlinico, Via  della Commenda 10, Milan 20122, Italy.",Non-OADS,/arxiv_data1/oa_pdf/87/65/jpis-46-266.PMC5005814.pdf
"ORCID Pier Paolo Poli http://orcid.org/0000-0003-3739-1490 Mario Beretta http://orcid.org/0000-0002-2223-2553 Giovanni Battista Grossi http://orcid.org/0000-0003-3367-0679 Carlo Maiorana http://orcid.org/0000-0001-8748-9483 Conflict of Interest No potential conflict of interest relevant to this  article was reported.Pier Paolo Poli,* Mario Beretta, Giovanni Battista Grossi, Carlo Maiorana Implant Center for Edentulism and Jawbone Atrophies, Maxillofacial Surgery and Odontostomatology Unit,  IRCCS Cà Granda Foundation Maggiore Policlinico Hospital, University of Milan, Milan, ItalyRisk indicators related to peri- implant disease: an observational  retrospective cohort study",Non-OADS,/arxiv_data1/oa_pdf/87/65/jpis-46-266.PMC5005814.pdf
The present cross-sectional study  was carried out in accordance with the Declaration of Helsinki of ethical human research  267 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.266Analysis of the risk indicators for peri-implant disease,Non-OADS,/arxiv_data1/oa_pdf/87/65/jpis-46-266.PMC5005814.pdf
268 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.266Analysis of the risk indicators for peri-implant disease,Non-OADS,/arxiv_data1/oa_pdf/87/65/jpis-46-266.PMC5005814.pdf
269 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.266Analysis of the risk indicators for peri-implant disease,Non-OADS,/arxiv_data1/oa_pdf/87/65/jpis-46-266.PMC5005814.pdf
270 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.266Analysis of the risk indicators for peri-implant disease Table 1.,Non-OADS,/arxiv_data1/oa_pdf/87/65/jpis-46-266.PMC5005814.pdf
271 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.266Analysis of the risk indicators for peri-implant disease,Non-OADS,/arxiv_data1/oa_pdf/87/65/jpis-46-266.PMC5005814.pdf
Our  statistical analyses indicated that a thin biotype was associated with higher percentages of  272 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.266Analysis of the risk indicators for peri-implant disease,Non-OADS,/arxiv_data1/oa_pdf/87/65/jpis-46-266.PMC5005814.pdf
Other studies failed to demonstrate a similar association between augmentation  273 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.266Analysis of the risk indicators for peri-implant disease,Non-OADS,/arxiv_data1/oa_pdf/87/65/jpis-46-266.PMC5005814.pdf
PUBMED  | CROSSREF 274 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.266Analysis of the risk indicators for peri-implant disease,Non-OADS,/arxiv_data1/oa_pdf/87/65/jpis-46-266.PMC5005814.pdf
PUBMED 275 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.266Analysis of the risk indicators for peri-implant disease,Non-OADS,/arxiv_data1/oa_pdf/87/65/jpis-46-266.PMC5005814.pdf
PUBMED  | CROSSREF 276 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.266Analysis of the risk indicators for peri-implant disease,Non-OADS,/arxiv_data1/oa_pdf/87/65/jpis-46-266.PMC5005814.pdf
277 http://jpis.orgABSTRACT Purpose:  The purpose of this study was to evaluate the clinical efficacy of enhancing  deficient interdental papilla with hyaluronic acid gel injection by assessing the radiographic  anatomical factors affecting the reconstruction of the interdental papilla.,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/jpis-46-277.PMC5005815.pdf
"2016 Aug;46(4):277-287 http://doi.org/10.5051/jpis.2016.46.4.277 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  Apr 25, 2016 Accepted:  Jul 5, 2016 *Correspondence to Byung-Ock Kim Department of Periodontology, Chosun  University School of Dentistry, 309 Pilmun- daero, Dong-gu, Gwangju 61452, Korea.",Non-OADS,/arxiv_data1/oa_pdf/8f/f8/jpis-46-277.PMC5005815.pdf
"ORCID Won-Pyo Lee http://orcid.org/0000-0003-1911-3454 Yo-Seob Seo http://orcid.org/0000-0003-1804-5648 Hee-Jung Kim http://orcid.org/0000-0002-2015-1530 Sang-Joun Yu http://orcid.org/0000-0001-8818-549X Byung-Ock Kim http://orcid.org/0000-0001-8952-617X Conflict of Interest No potential conflict of interest relevant to this  article was reported.Won-Pyo Lee,1 Yo-Seob Seo,2 Hee-Jung Kim,3 Sang-Joun Yu,1 Byung-Ock Kim1,* 1Department of Periodontology, Chosun University School of Dentistry, Gwangju, Korea 2Department of Oral and Maxillofacial Radiology, Chosun University School of Dentistry, Gwangju, Korea 3Department of Prosthodontics, Chosun University School of Dentistry, Gwangju, KoreaThe association between radiographic  embrasure morphology and  interdental papilla reconstruction  using injectable hyaluronic acid gel",Non-OADS,/arxiv_data1/oa_pdf/8f/f8/jpis-46-277.PMC5005815.pdf
278 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.277Papilla reconstruction by hyaluronic acid gel injection,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/jpis-46-277.PMC5005815.pdf
279 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.277Papilla reconstruction by hyaluronic acid gel injection Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/jpis-46-277.PMC5005815.pdf
"In addition, after fitting the periapical radiographic standardization device onto the patient’s  upper anterior area, periapical radiographic images were acquired from each interdental  280 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.277Papilla reconstruction by hyaluronic acid gel injection Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/8f/f8/jpis-46-277.PMC5005815.pdf
281 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.277Papilla reconstruction by hyaluronic acid gel injection IDR BC CP-BC CP Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/jpis-46-277.PMC5005815.pdf
282 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.277Papilla reconstruction by hyaluronic acid gel injection B A Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/jpis-46-277.PMC5005815.pdf
"Moreover, CIPR occurred at 36 sites, which is a  283 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.277Papilla reconstruction by hyaluronic acid gel injection B ABaseline CP-BC (mm)0.0 0.5 1.0 1.5 2.0 2.5 3.01.02.03.0 Baseline IDR (mm)0.0 4.0 5.0 6.0 7.0 9.01.02.03.0 8.0a)r=/zero.LP./eight.LP/seven.LP/two.LP a)r=/zero.LP./eight.LP/three.LP/nine.LP a)r=/zero.LP./seven.LP/four.LP/five.LP Figure 6.",OADS,/arxiv_data1/oa_pdf/8f/f8/jpis-46-277.PMC5005815.pdf
284 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.277Papilla reconstruction by hyaluronic acid gel injection Table 1.,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/jpis-46-277.PMC5005815.pdf
[5] have also reported that there was virtually no interdental papillary deficiency at a CP-BC  285 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.277Papilla reconstruction by hyaluronic acid gel injection Table 2.,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/jpis-46-277.PMC5005815.pdf
PUBMED  | CROSSREF 286 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.277Papilla reconstruction by hyaluronic acid gel injection,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/jpis-46-277.PMC5005815.pdf
287 http://jpis.org http://doi.org/10.5051/jpis.2016.46.4.277Papilla reconstruction by hyaluronic acid gel injection,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/jpis-46-277.PMC5005815.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 683 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/c1/dyv118.PMC5005937.pdf
"For information on how to collaborate with the ProF-SC cohort in making further use of the data and resources, and also with the BCFR, please see [http://www.bcfamilyr-egistry.org/].",Non-OADS,/arxiv_data1/oa_pdf/b3/c1/dyv118.PMC5005937.pdf
"•For collaboration with the ProF-SC cohort, see [http://www.bcfamilyregistry.org/] and [www.kcon- fab.org].690 International Journal of Epidemiology , 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/b3/c1/dyv118.PMC5005937.pdf
"728 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/84/dyv364.PMC5005944.pdf
"http://www.euro.who.int/document/ E91021.pdf (24 March 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/44/7b/dyw052.PMC5005946.pdf
"http://www3.epa.gov/ ttnchie1/ap42/ (24 March 2015, date last accessed).",OADS,/arxiv_data1/oa_pdf/44/7b/dyw052.PMC5005946.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/45/65/10.1177_2325967116662653.PMC5006135.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/ea/28/10.1177_2058460116662300.PMC5006143.pdf
"[online] [Last accessed, 15 Oct 2007] Availa - ble from URL: http://www.who.int/mental_health/prevention/ suicide/suicideprevent/en .",Non-OADS,/arxiv_data1/oa_pdf/b4/28/pyw015.PMC5006192.pdf
Available from URL: http://www.cdc.gov/nchs/data/ nvsr/nvsr53/nvsr53_05acc.pdf .,OADS,/arxiv_data1/oa_pdf/b4/28/pyw015.PMC5006192.pdf
Available at http://www.unodc.org/docu- ments/wdr2014/World_Drug_Report_2014_web.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f4/a5/pyw021.PMC5006194.pdf
"Given  the observed differences between HC and BD in voxel composi - tion, we also performed a more detailed segmentation analysis  of the brain tissue contributing to the spectrum by overlaying  the 1H-MRS voxel on to structural maps segmented by FreeSurfer  software ( https://surfer.nmr.mgh.harvard.edu ).",OADS,/arxiv_data1/oa_pdf/d2/a8/pyw032.PMC5006200.pdf
Avail - able at: http://www.ismrm.org/15/program_files/WedTP0  2.htm .,Non-OADS,/arxiv_data1/oa_pdf/d2/a8/pyw032.PMC5006200.pdf
"However, the situation has improvedwith the emergence of public available software, such asthe multiobjective evolutionary algorithm (MOEA) Frame-work (http://www.moeaframework.org/).",Non-OADS,/arxiv_data1/oa_pdf/1a/5d/PSP4-4-69.PMC5006244.pdf
"•Set up the right Java running environment (e.g., for Win-dows XP operating systems, Cygwin can be downloadedfrom https://www.cgwin.com).",OADS,/arxiv_data1/oa_pdf/1a/5d/PSP4-4-69.PMC5006244.pdf
•Download the executable MOEA Framework 2.0 version(http://www.moeaframework.org/).,OADS,/arxiv_data1/oa_pdf/1a/5d/PSP4-4-69.PMC5006244.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)Sensitivity Analysis of Systems Pharmacology Model Zhang et al.,OADS,/arxiv_data1/oa_pdf/1a/5d/PSP4-4-69.PMC5006244.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/1e/ircmj-18-06-34314.PMC5006310.pdf
Available from: http://www.hse.gov.uk/statistics/causdis/ stress /.,OADS,/arxiv_data1/oa_pdf/40/1e/ircmj-18-06-34314.PMC5006310.pdf
Available  from: http://www.who.int/tobacco/mpower/2009/en/.,Non-OADS,/arxiv_data1/oa_pdf/1f/07/LI-33-496.PMC5006328.pdf
Available from: http://www.who.int/tobacco/global_ report/2009/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/1f/07/LI-33-496.PMC5006328.pdf
Available from: http://www.labour.nic.in/ss/ INFORMALSECTORININDIA-ApproachesforSocialSecurity.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1f/07/LI-33-496.PMC5006328.pdf
Available from: http://www.whoindia.org/EN/ Section20/Section25_1861.html.,Non-OADS,/arxiv_data1/oa_pdf/1f/07/LI-33-496.PMC5006328.pdf
Available  from: http://www.tbcindia.nic.in/pdfs/Training.manual.M.tuberculosis.,Non-OADS,/arxiv_data1/oa_pdf/4f/b4/LI-33-507.PMC5006330.pdf
Available from: http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/4f/b4/LI-33-507.PMC5006330.pdf
Interested applicants are requested to visit ICS website http://www.indianchestsociety.in  for more  information.,Non-OADS,/arxiv_data1/oa_pdf/cc/22/LI-33-528.PMC5006334.pdf
Available from: http://www.who.int/water_sanitation_health/ dwq/arsenicum4.pdf.,Non-OADS,/arxiv_data1/oa_pdf/dd/13/LI-33-546.PMC5006339.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/28/ircmj-18-06-34971.PMC5006439.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: PonsFunctional connectivityResting-state MRIMeditationAffective processing 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/b4/main.PMC5006446.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.06.018 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/b4/main.PMC5006446.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/b4/main.PMC5006446.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: PMPCIVFANXA5 M2LMWHLive birth 1.,Non-OADS,/arxiv_data1/oa_pdf/3b/57/main.PMC5006578.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.06.024 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/57/main.PMC5006578.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/57/main.PMC5006578.pdf
"http://dx.doi.org/10.1056/NEJMp1500523 (February 26, 2015).",OADS,/arxiv_data1/oa_pdf/3b/57/main.PMC5006578.pdf
(2) http://dx.doi.org/10.1002/14651858.CD002859.pub2 (Art.,Non-OADS,/arxiv_data1/oa_pdf/3b/57/main.PMC5006578.pdf
"In Vitro 1, 101. http://dx.doi.org/10.4172/j ﬁv.",OADS,/arxiv_data1/oa_pdf/3b/57/main.PMC5006578.pdf
"Rep. 2,827. http://dx.doi.org/10.1038/srep00827 (Epub 2012 Nov 9).",Non-OADS,/arxiv_data1/oa_pdf/3b/57/main.PMC5006578.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Humanized mice Leukemia LymphopeniaMixed-lineage leukemia fusion geneRecipient leukocyte infusion 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/24/main.PMC5006579.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.06.0282352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/24/main.PMC5006579.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/24/main.PMC5006579.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Integration host factor (IHF) Histone like protein (HU)Nontypeable Haemophilus in ﬂuenzae Pseudomonas aeruginosaOtitis mediaRespiratory tract infection 1.,Non-OADS,/arxiv_data1/oa_pdf/f2/94/main.PMC5006588.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.06.022 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/94/main.PMC5006588.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/94/main.PMC5006588.pdf
http://dx.doi.org/10.1007/s10096-016-2640-x .,Non-OADS,/arxiv_data1/oa_pdf/f2/94/main.PMC5006588.pdf
http://dx.doi.org/10.1007/s00405-015-3650-5 .,Non-OADS,/arxiv_data1/oa_pdf/f2/94/main.PMC5006588.pdf
17. http://dx.doi.org/10.3390/ijms17050617 .,Non-OADS,/arxiv_data1/oa_pdf/f2/94/main.PMC5006588.pdf
3. http://dx.doi.org/ 10.1128/microbiolspec.MB-0004-2014 .,Non-OADS,/arxiv_data1/oa_pdf/f2/94/main.PMC5006588.pdf
"Exp., pii: 2481. doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/f2/94/main.PMC5006588.pdf
http://dx.doi.org/10.1128/ microbiolspec.UTI-0015-2012 .,Non-OADS,/arxiv_data1/oa_pdf/f2/94/main.PMC5006588.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MicrocephalyNeurogenesisNeuroblastomaTerminally differentiatedUndifferentiatedZika virus 1.,Non-OADS,/arxiv_data1/oa_pdf/2a/29/main.PMC5006602.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.06.026 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/29/main.PMC5006602.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/29/main.PMC5006602.pdf
Available from:) http://ecdc.europa.eu/ en/publications/Publications/zika-virus-americas-association-with-microcephaly- rapid-risk-assessment.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2a/29/main.PMC5006602.pdf
http://dx.doi.org/10.1016/ j.jped.2016.02.009 (S0021-7557(16)30001-8.,OADS,/arxiv_data1/oa_pdf/2a/29/main.PMC5006602.pdf
http://dx.doi.org/10.3201/eid2207.151990 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/2a/29/main.PMC5006602.pdf
"Cell Stem Cell 18, 1 –4.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2a/29/main.PMC5006602.pdf
http://dx.doi.org/10.2807/1560-7917.ES.2016.21.8.30148 .,Non-OADS,/arxiv_data1/oa_pdf/2a/29/main.PMC5006602.pdf
http://dx.doi.org/10.1371/journal.pntd.0002348 (Aug 1.,Non-OADS,/arxiv_data1/oa_pdf/2a/29/main.PMC5006602.pdf
"63, 32 –35.http://dx.doi.org/10.1016/j.jcv.2014.12.",OADS,/arxiv_data1/oa_pdf/2a/29/main.PMC5006602.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Melanoma CDT2 DTLCullinUbiquitylationMLN4924PevonedistatBRAFNRAS 1.,Non-OADS,/arxiv_data1/oa_pdf/b0/34/main.PMC5006603.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.06.023 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/34/main.PMC5006603.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/34/main.PMC5006603.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Sickle cell diseaseVaso-occlusive crisis Acute chest syndrome ScoreProspective study 1.,Non-OADS,/arxiv_data1/oa_pdf/c4/59/main.PMC5006640.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.06.038 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/59/main.PMC5006640.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/59/main.PMC5006640.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/eb/main.PMC5006642.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.06.045 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/eb/main.PMC5006642.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/eb/main.PMC5006642.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: HIV-1EnvelopeTrimerCoreceptorsMolecular mimicryPeptides Inhibitors Immune evasion 1.,Non-OADS,/arxiv_data1/oa_pdf/59/6e/main.PMC5006643.pdf
"2Present addresses: Rosetta Design Group LLC, 47 Maple Street, Burlington, VT 05401. http://dx.doi.org/10.1016/j.ebiom.2016.06.0372352-3964/Published by Elsevier B.V.",Non-OADS,/arxiv_data1/oa_pdf/59/6e/main.PMC5006643.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/6e/main.PMC5006643.pdf
"The raw CD data were analyzed by Dichroweb and using the Contin-LL algorithm ( http://dichroweb.cryst.bbk.ac.uk/html/ home.shtml ), and reference set 3 for secondary structure prediction.",OADS,/arxiv_data1/oa_pdf/59/6e/main.PMC5006643.pdf
"The peptide was constructed as a random coil, and explicitly solvated with TIP3P water molecules and Na+and Cl−coun- terions using the VMD program ( http://www.ks.uiuc.edu/Research/ vmd/ ).",OADS,/arxiv_data1/oa_pdf/59/6e/main.PMC5006643.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Bone PPARγ Insulin sensitizersOsteoblastOsteoclastOsteocyteAdipocytePost-translational modi ﬁcations 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/35/main.PMC5006645.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.06.040 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/35/main.PMC5006645.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/35/main.PMC5006645.pdf
A multicenter report from UK reports that up to 71% of cases (68 cases examined) developed GVHD and halfEBioMedicine 10 (2016) 11 –12 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.06.028 .,Non-OADS,/arxiv_data1/oa_pdf/78/da/main.PMC5006657.pdf
This ability to manipulate the cytokine stimulation and to selectively populate the engraftment of immune cells entertains the possibility of designing http://dx.doi.org/10.1016/j.ebiom.2016.07.003 2352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/78/da/main.PMC5006657.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/da/main.PMC5006657.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Whiplash associated disorders Positron emission tomographyNon-painful electrical stimulationNeuropsychological questionnaires 1.,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.008 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
"1316, 29 –52.http://dx.doi.org/10.1111/nyas.12360 .",Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1016/j.ejpain.2004.11.001 .,OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4123-07.2008 .,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1212/WNL.51.2.345 .,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1097/BRS.,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/ 10.1371/journal.pone.0004542 .,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1097/BRS.,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
"24, 77 –87.http://dx.doi.org/10.1007/s11065-014-9246-9 .",Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1016/j.neuroimage.2014.03.029 .,OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1007/s11307-005-7001-6 .,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
"21, 93 – 100. http://dx.doi.org/10.1007/s00586-011-1920-5 .",Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/ 10.1016/j.neulet.2004.02.047 .,OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
"Pain 149, 64 –70.http://dx.doi.org/10.1016/j.pain.2010.01.008 .Linnman, C., Moulton, E.A., Barmettler, G., Becerra, L., Borsook, D., 2012.",Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1016/0306-3623(94)00292-U .,OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1016/S1053-8119(03)00169-1 .,OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1016/S0361- 9230(00)00442-1 .,OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
"1300, 79 –96.http://dx.doi.org/10.1016/j.brainres.2009.08.088 .",OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1002/art.27497 .,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1212/WNL.,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/ 10.1007/s002590000381 .,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
"Lancet 384, 1346. http://dx.doi.org/10.1016/S0140-6736(14)61814-6 .",OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/ 10.1016/j.pain.2006.01.014 .,OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1080/16501970410030742 (quiz 210).,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1016/j.math.2012.07.009 .,OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1007/ s00586-005-0040-5 .,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
947 –963http://dx.doi.org/10.1007/978-3-642-54307-4 .,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.2519/jospt.,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
Headache 2. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1097/BRS.,Non-OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
http://dx.doi.org/10.1111/j.1600-0447.1983.tb09716.x .257 D. Vállez García et al.,OADS,/arxiv_data1/oa_pdf/3e/24/main.PMC5006659.pdf
Matrix metalloproteinase-10 regulates stemness ofEBioMedicine 10 (2016) 17 –18 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.06.048 .,Non-OADS,/arxiv_data1/oa_pdf/aa/6c/main.PMC5006660.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.0092352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/aa/6c/main.PMC5006660.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/6c/main.PMC5006660.pdf
Standardization and validation of cfDNA assays are important issues realized by the current EU/IMI consortium CAN- CER-ID ( www.cancer-id.eu ).EBioMedicine 10 (2016) 15 –16 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.06.032 .,Non-OADS,/arxiv_data1/oa_pdf/8f/98/main.PMC5006662.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.006 2352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/8f/98/main.PMC5006662.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/98/main.PMC5006662.pdf
"Conversely, if an activating mutation is present, thisEBioMedicine 10 (2016) 3 –4 http://dx.doi.org/10.1016/j.ebiom.2016.07.005 2352-3964/© 2016 Published by Elsevier B.V.",Non-OADS,/arxiv_data1/oa_pdf/39/ea/main.PMC5006663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/ea/main.PMC5006663.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Leber's hereditary optic neuropathy Gene therapy Best-corrected visual acuity Leber's hereditary optic neuropathy (LHON) is one of the most com- mon causes of blindness in young adults.,Non-OADS,/arxiv_data1/oa_pdf/e7/e4/main.PMC5006665.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.0022352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/e4/main.PMC5006665.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/e4/main.PMC5006665.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: StatinInsulin secretion Glucose uptake Glucose homeostasisIsletBeta cellAdipose tissueMuscleOGTTTransmission electron microscopy Ca 2+measurements 1.,Non-OADS,/arxiv_data1/oa_pdf/7f/90/main.PMC5006666.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.0072352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/90/main.PMC5006666.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/90/main.PMC5006666.pdf
http://dx.doi.org/10.1371/journal.pone.0151592 eCollection 2016.,Non-OADS,/arxiv_data1/oa_pdf/7f/90/main.PMC5006666.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ec/9b/ndt-12-2095.PMC5006669.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2095–2104Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2095OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11254 2 improvement in social and cognitive functioning  associated with paliperidone extended-release  treatment in patients with schizophrenia:  a 24-week, single arm, open-label study chuan shi,1–4 shu Qiao Yao,5  Yi Feng Xu,6 Jian guo shi,7  Xiu Feng Xu,8 cong Pei  Zhang,9 hua Jin,10 Xin Yu1–4 1clinical research center, Peking  University sixth hospital, 2clinical  research center, Peking University  institute of Mental health, 3Key  laboratory of Mental health, Ministry  of health (Peking University),   4National clinical research center  for Mental Disorders (Peking  University sixth hospital), Beijing,   5clinical center of Psychology, The  second Xiangya hospital, central  south University, changsha, hunan  Province, 6Department of Psychiatry,   institute of Mental health, shanghai  Jiao T ong University, shanghai,   7Department of Psychiatry, Xi’an  Mental health center, Xian, shanxi  Province, 8Department of Psychiatry,   The First affiliated hospital of  Kunming Medical school, Kunming,   Yunnan Province, 9Department  of Psychiatry, The First haerbin  Psychiatric hospital, haerbin,   heilongjiang Province, People’s  republic of china; 10Department of  Psychiatry, University of california  at san Diego, la Jolla, san Diego,   ca, UsaPurpose:  This single-arm, open-label study aimed to explore the effects of extended-release  paliperidone on social and cognitive function in patients with schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/ec/9b/ndt-12-2095.PMC5006669.pdf
"Furthermore, a system - atic review of eleven comparative studies revealed that paliperidone ER resulted  in significantly greater improvements in functionality as assessed by the Personal correspondence: Xin Yu clinical research center, Peking  University sixth hospital, 51 hua Yuan  Bei road, haidian District, Beijing,  100191, People’s republic of china Tel +86 10 139 1022 9255 Fax +86 10 6238 4009 email yuxin@bjmu.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Shi et al Running head recto: Paliperidone treatment for schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S112542",Non-OADS,/arxiv_data1/oa_pdf/ec/9b/ndt-12-2095.PMC5006669.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ec/9b/ndt-12-2095.PMC5006669.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/9b/ndt-12-2095.PMC5006669.pdf
"An extensive body of scienti ﬁc evidence supports the fact that clevidipine is a superior drug for treatment of acute hypertension, providing a rapid blood pressure adjustment in the surgical and critical care setting, as demonstrated by the ECLIPSE Trials (2008) ( Aronson et al., 2008 ).EBioMedicine 10 (2016) 23 –24 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.06.027 .",Non-OADS,/arxiv_data1/oa_pdf/ae/89/main.PMC5006690.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.014 2352-3964/© 2016 The Ohio State University Wexner Medical Center.,Non-OADS,/arxiv_data1/oa_pdf/ae/89/main.PMC5006690.pdf
This is an open access article under the CC BY-NC-ND lice nse ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/89/main.PMC5006690.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ae/89/main.PMC5006690.pdf
"http://dx.doi.org/10.1213/01.ane.0000281443.13712.b9 (918 –25, January 01).",Non-OADS,/arxiv_data1/oa_pdf/ae/89/main.PMC5006690.pdf
http://dx.doi.org/10.1007/s12630-014-0131-z (May 01).,Non-OADS,/arxiv_data1/oa_pdf/ae/89/main.PMC5006690.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: BCGBoostingMeasles vaccineNonspeci ﬁc effects of vaccines Oral polio vaccineRevaccination 1.,Non-OADS,/arxiv_data1/oa_pdf/18/0c/main.PMC5006692.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.016 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/18/0c/main.PMC5006692.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/0c/main.PMC5006692.pdf
http://dx.doi.org/10.1126/ scitranslmed.3003586 .,Non-OADS,/arxiv_data1/oa_pdf/18/0c/main.PMC5006692.pdf
"( http://www.who.int/ immunization/sage/meetings/2014/april - accessed June 1, 2014).",Non-OADS,/arxiv_data1/oa_pdf/18/0c/main.PMC5006692.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/50/main.PMC5006693.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.0182352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/94/50/main.PMC5006693.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/50/main.PMC5006693.pdf
Published by Elsevier B.V. Thi s is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Anti-angiogenic treatmentBreast cancer Resistance DCE-MRIRadiogenomics 1.,Non-OADS,/arxiv_data1/oa_pdf/ee/6e/main.PMC5006694.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.0172352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/6e/main.PMC5006694.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/6e/main.PMC5006694.pdf
"Furthermore, all scripts and codes used for the analysis have been submitted to the GitHub public directory: https:// github.com/nph/MRI.Side effects reporting followed CTCAEv3.0 (http://ctep.cancer.gov ).",Non-OADS,/arxiv_data1/oa_pdf/ee/6e/main.PMC5006694.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Neutrophil extracellular traps (NETs)LactoferrinChromatinOxygen radicals 1.,Non-OADS,/arxiv_data1/oa_pdf/43/07/main.PMC5006695.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.0122352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/43/07/main.PMC5006695.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/07/main.PMC5006695.pdf
InEBioMedicine 10 (2016) 13 –14 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.07.017 .,OADS,/arxiv_data1/oa_pdf/ca/23/main.PMC5006723.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.038 2352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/ca/23/main.PMC5006723.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ca/23/main.PMC5006723.pdf
"It has been previously suggested that receptors for ﬂaviviruses as DC-SIGN, TIM-1, TIM-4, Tyro3 or AXL could also be responsible for ZIKV entryEBioMedicine 10 (2016) 7 –8 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.06.026 .",Non-OADS,/arxiv_data1/oa_pdf/48/c7/main.PMC5006724.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.026 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/c7/main.PMC5006724.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/c7/main.PMC5006724.pdf
"However, it is of note that after correctionEBioMedicine 10 (2016) 9 –10 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.07.011 .",Non-OADS,/arxiv_data1/oa_pdf/84/f1/main.PMC5006725.pdf
The duration and severity of in ﬂammation are also crucial for http://dx.doi.org/10.1016/j.ebiom.2016.07.029 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/84/f1/main.PMC5006725.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/f1/main.PMC5006725.pdf
"Further, theEBioMedicine 10 (2016) 21 –22 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.06.018 .",OADS,/arxiv_data1/oa_pdf/ef/d7/main.PMC5006726.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.037 2352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/ef/d7/main.PMC5006726.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/d7/main.PMC5006726.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MyopiaInﬂammation Interleukin 6Tumor necrosis factor alpha Nuclear factor κB c-Fos 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/64/main.PMC5006729.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.0212352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/64/main.PMC5006729.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/64/main.PMC5006729.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Colorectal cancer HMG-CoA reductase Histone deacetylaseStatin hydroxamatePreclinical model 1.,Non-OADS,/arxiv_data1/oa_pdf/66/2f/main.PMC5006731.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.019 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/66/2f/main.PMC5006731.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/2f/main.PMC5006731.pdf
"The first patients were included at the Karolinska University Hospital in Stockholm County in 2010 and subsequently expanded to include additional hospitals in Stockholm and in four additional counties of Sweden (Supplementary Table 1, Supplemental digital content 1, http://links.lww.com/ EJEM/A91 ).",Non-OADS,/arxiv_data1/oa_pdf/ca/d0/mej-23-344.PMC5006795.pdf
"Major developments of the screening process and nurse intervention are outlined in Supplementary Table 2, Supplemental digital content 1 (http://links.lww.com/EJEM/A91 ).",Non-OADS,/arxiv_data1/oa_pdf/ca/d0/mej-23-344.PMC5006795.pdf
"Ethical approval was obtained separately in all five counties where the intervention was implemented (Supplementary table 3, Supplemental digital content 1, http://links.lww.com/EJEM/A91 ).",Non-OADS,/arxiv_data1/oa_pdf/ca/d0/mej-23-344.PMC5006795.pdf
"expansion, hiring of many new study nurses, and a large influx of patients (Supplementary Figures 1, Supplemental digital content 1, http://links.lww.com/EJEM/A91 and 2, Supplemental digital content 1, http://links.lww.com/EJEM/ A91).",Non-OADS,/arxiv_data1/oa_pdf/ca/d0/mej-23-344.PMC5006795.pdf
Available at: http://www.rasch.org/rmt/rmt94n.htm.,Non-OADS,/arxiv_data1/oa_pdf/e4/da/opx-93-1147.PMC5006798.pdf
"Repetitive sequences were masked using R EPEAT- MASKER v4.0.5 ( http://www.repeatmasker.org ), followed by ab initio gene prediction using G ENEMARK-ES 2.0 [13].",OADS,/arxiv_data1/oa_pdf/8b/b7/main.PMC5006800.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.07.003,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/main.PMC5006800.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,7 7 –82 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8b/b7/main.PMC5006800.pdf
A core genome alignment in XMFA format was obtained which was converted into FASTA format using a PerlScript ( https://github.com/lskatz/lskScripts ).,OADS,/arxiv_data1/oa_pdf/8b/b7/main.PMC5006800.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,7 7 –82 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8b/b7/main.PMC5006800.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,7 7 –82 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8b/b7/main.PMC5006800.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,7 7 –82 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8b/b7/main.PMC5006800.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,7 7 –82 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8b/b7/main.PMC5006800.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Human papillomavirusVaccineMemory B cells 1.,Non-OADS,/arxiv_data1/oa_pdf/cf/12/main.PMC5006801.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.06.042 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/12/main.PMC5006801.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/12/main.PMC5006801.pdf
"Regardless of what happens, translational research in the UK will likely endure and thrive, and scientists and health researchers mustEBioMedicine 10 (2016) 1 –2 http://dx.doi.org/10.1016/j.ebiom.2016.08.007 2352-3964/© 2016 Published by Elsevier B.V.",Non-OADS,/arxiv_data1/oa_pdf/5d/18/main.PMC5006802.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/18/main.PMC5006802.pdf
"Drugs Act, 1978, http://apps.who.int/medicinedocs/docu-ments/s18829en/s18829en.pdf (accessed 29 April 2016).",Non-OADS,/arxiv_data1/oa_pdf/12/79/10.1177_2050312116654590.PMC5006804.pdf
"Southeast Asian J Trop Med Public Health 2005; 36(6): 1562–1567, http://www.tm.mahidol.ac.th/seameo/2005_36_6/28-3573.pdf (accessed 26 February 2016).",Non-OADS,/arxiv_data1/oa_pdf/12/79/10.1177_2050312116654590.PMC5006804.pdf
"Department of Drug Administration (DDA), Government of Nepal, http://www.dda.gov.np (accessed 7 May 2015).",OADS,/arxiv_data1/oa_pdf/12/79/10.1177_2050312116654590.PMC5006804.pdf
"Boston, MA: Allyn & Bacon, 2003, http://wps.ablongman.com/wps/media/objects/385/394732/george4answers.pdf (accessed 25 March 2016).",Non-OADS,/arxiv_data1/oa_pdf/12/79/10.1177_2050312116654590.PMC5006804.pdf
"About GSS, n.d., http://www3.norc.org/GSS+Website/ About+GSS/ (accessed 20 November 2015).",Non-OADS,/arxiv_data1/oa_pdf/65/81/10.1177_2050312116652567.PMC5006807.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/2d/main.PMC5006808.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.07.001,OADS,/arxiv_data1/oa_pdf/28/2d/main.PMC5006808.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/40/main.PMC5006809.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.06.006,OADS,/arxiv_data1/oa_pdf/39/40/main.PMC5006809.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/bd/main.PMC5006810.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.06.003,OADS,/arxiv_data1/oa_pdf/71/bd/main.PMC5006810.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/e2/main.PMC5006811.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.06.005,OADS,/arxiv_data1/oa_pdf/7d/e2/main.PMC5006811.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.05.002,OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
"CA Cancer J Clin 64(1), 9 –29.http://dx.doi.org/10.3322/caac.21208 .",Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
"Association of the Nordic Cancer RegistriesDanish Cancer Society; 2011 [Available at: http://www.ancr.nu.Accessed December 4, 2015].",Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
http://dx.doi.org/10.1093/jnci/dji112 .,OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
http://dx.doi.org/10.1097/JTO.0b013e31826bb7b2 .,Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
http://dx.doi.org/10.1056/NEJMoa040938 .,OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
http://dx.doi.org/10.1126/science.1099314 .,Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
http://dx.doi.org/10.1056/NEJMoa0810699 .,Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
http://dx.doi.org/ 10.1371/journal.pone.0106053 .,Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
"Surg Today 29(6), 493 –503 [Available at: http://www.ncbi.nlm.nih.gov/pubmed/10385363.",Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
http://dx.doi.org/ 10.1136/thx.2005.042275 .,Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
"Anticancer Res 27(6C), 4481 –4489 [Available at: http://www.ncbi.nlm.nih.gov/pubmed/18214064.",Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
http://dx.doi.org/10.1186/2049-6958-5-5-305 .,Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
http://dx.doi.org/10.1093/carcin/bgn107 .,Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
http://dx.doi.org/10.1038/nrm1962 .,Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
http://dx.doi.org/10.1056/NEJMoa060096 .,OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
"Clin Cancer Res 7(7), 1850 –1855 [Available at: http://www.ncbi.nlm.- nih.gov/pubmed/11448895.",Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
"Clin Cancer Res 10(1 Pt 1), 136 –143 [Available at: http://www.ncbi.nlm.nih.- gov/pubmed/14734462.",Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
"Ann Thorac Surg 72(6), 1868 –1876 [Available at: http://www.ncbi.nlm.nih.gov/pubmed/11789762.",Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
http://dx.doi.org/10.1093/jnci/djq025 .,OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
http://dx.doi.org/10.1016/j.clon.2015.07.004 .Translational Oncology Vol.,OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
http://dx.doi.org/10.1038/onc.2012.402 .,Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
http://dx.doi.org/10.1158/1078-0432.CCR-13-1836 .,Non-OADS,/arxiv_data1/oa_pdf/77/f4/main.PMC5006812.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/bync-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/17/main.PMC5006813.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.05.005,OADS,/arxiv_data1/oa_pdf/3a/17/main.PMC5006813.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/dc/main.PMC5006814.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.05.006,OADS,/arxiv_data1/oa_pdf/6f/dc/main.PMC5006814.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/1e/main.PMC5006815.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.06.004,OADS,/arxiv_data1/oa_pdf/9f/1e/main.PMC5006815.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/0a/main.PMC5006816.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.05.001,OADS,/arxiv_data1/oa_pdf/56/0a/main.PMC5006816.pdf
Acta Radiol Open 4. http://dx.doi.org/10.1177/2058460115604340 .,OADS,/arxiv_data1/oa_pdf/56/0a/main.PMC5006816.pdf
http://dx.doi.org/10.1371/journal.pone.0135156 .,Non-OADS,/arxiv_data1/oa_pdf/56/0a/main.PMC5006816.pdf
"BMC Cancer 14, 356. http://dx.doi.org/10.1186/1471-2407-14-356 .",Non-OADS,/arxiv_data1/oa_pdf/56/0a/main.PMC5006816.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/a2/main.PMC5006817.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.03.005,OADS,/arxiv_data1/oa_pdf/e3/a2/main.PMC5006817.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.05.004,OADS,/arxiv_data1/oa_pdf/a9/ee/main.PMC5006818.pdf
"2014, Article ID 501213, 12 pages, 2014 2014 , 501213. http://dx.doi.org/10.1155/2014/501213 .",Non-OADS,/arxiv_data1/oa_pdf/a9/ee/main.PMC5006818.pdf
"2014, Article ID 890697, 9 pages, 2014 2014 , 890697. http://dx.doi.org/10.1155/2014/890697 .",Non-OADS,/arxiv_data1/oa_pdf/a9/ee/main.PMC5006818.pdf
Retrieved from http://link.spri nger.com/article/10.1007/ s00221-014-4143-2/fulltext.html 18.,Non-OADS,/arxiv_data1/oa_pdf/f3/c5/CDEP-9-79.PMC5006841.pdf
"Haplotype Phasing PHASE software (http://stephenslab.uchicago.edu/software.html) version 2.1 was used to reconstruct haplotypes from genotypic data,when phase could not be directly inferred from family structure.Haplotypes were reconstructed by incorporating the genotypes of SNPs rs6814736, rs7667745, rs1751848, rs762847, rs7658462, rs31293, rs1730768, rs12641989 and rs16844364, as well as therepeat sizes at D4S127 and the CCG repeat (as a microsatellite locus ).",OADS,/arxiv_data1/oa_pdf/9b/c6/AJMG-168-135.PMC5006842.pdf
To view this mini commentaryvisit http://dx.doi.org/10.1111/1471-0528.13297.,Non-OADS,/arxiv_data1/oa_pdf/f4/61/BJO-122-1748.PMC5006847.pdf
Available at: http://www.internetworldstats.com/.,Non-OADS,/arxiv_data1/oa_pdf/dc/19/ADB-21-460.PMC5006854.pdf
Available at: http://ec.europa.eu/eurostat/en/web/products- statistics-in-focus/-/KS-SF-11-066.,Non-OADS,/arxiv_data1/oa_pdf/dc/19/ADB-21-460.PMC5006854.pdf
Raw array data have been submit-ted to the Gene Expression Omnibus (http://www.ncbi.nlm.nih.-gov/geo/) under accession number GSE59996.,OADS,/arxiv_data1/oa_pdf/02/ff/TPJ-81-695.PMC5006856.pdf
Gene annotation and gene ontology (GO) clustering were per- formed using MADIBA (http://madiba.bi.up.ac.za/) and AMIGO(http://amigo.geneontology.org/cgi-bin/amigo/go.cgi).,OADS,/arxiv_data1/oa_pdf/02/ff/TPJ-81-695.PMC5006856.pdf
Phase enrich- ment was determined using Phaser (http://phaser.mocklerlab.org/).,OADS,/arxiv_data1/oa_pdf/02/ff/TPJ-81-695.PMC5006856.pdf
"cDNA was synthesized using 3 –5lg total RNA with a Superscript II kit (Invitrogen, http://www.lifetechnologies.com/it/ en/home/brands/invitrogen.html) and oligo(dT) primer, accordingto the manufacturer’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/02/ff/TPJ-81-695.PMC5006856.pdf
"Images were obtained every 30 min, and analyzed using Metamorph (http://www.moleculardevices.com) and BRASS (http://millar.bio.ed.ac.uk/PEBrown/BRASS/BrassPage.htm).",OADS,/arxiv_data1/oa_pdf/02/ff/TPJ-81-695.PMC5006856.pdf
"Plates were kept under constant white light for 6 h, the moved to darkness for 18 h and into E30-LED cabinets (Percival, http://www.percival-scientiﬁc.com/) for 3 days under continuous red light.",Non-OADS,/arxiv_data1/oa_pdf/02/ff/TPJ-81-695.PMC5006856.pdf
"After3 days, seedlings were placed ﬂat on agar plates, and hypoco- tyls were measured using ImageJ (http://rsbweb.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/02/ff/TPJ-81-695.PMC5006856.pdf
"Stimuli Movie clips We purchased a collection of non-Italian TV commercial clips from an Advertising Archive (http://www.coloribus.com/) and reproduced 160 short clips using a video editingsoftware (Final Cut Pro, Apple Inc.).",Non-OADS,/arxiv_data1/oa_pdf/6e/88/HBM-36-2495.PMC5006857.pdf
"We presented the stimuliusing Cogent Toolbox (http://www.vislab.ucl.ac.uk/cogent.php) implemented in MATLAB 7.4 (The Math-Works, Natick, MA).",OADS,/arxiv_data1/oa_pdf/6e/88/HBM-36-2495.PMC5006857.pdf
"Additionalsequences from the superorder Thoracica Darwin, 1854were retrieved from GenBank (http://www.ncbi.nlm.nih.gov/genbank/) and included in the analyses (TableS2, Supporting information).",OADS,/arxiv_data1/oa_pdf/d0/98/MEC-24-673.PMC5006861.pdf
Ranges of genome size for barnacles were obtained from theAnimal Genome Size Database (http://www.genomesize.com) .Barcode tags were 10 base pairs long.,OADS,/arxiv_data1/oa_pdf/d0/98/MEC-24-673.PMC5006861.pdf
"Satura-tion in codon partitions was also evaluated for eachcoding region.Phylogenetic inferences Nonsaturated data sets from individual Sanger-basedmarkers were analysed in RAXML -HPC2 v8.0 (Stamatakis 2006), as implemented in the CIPRES Science Gateway v3.3 (http://www.phylo.org), for a ﬁrst-pass phyloge-netic inference using the maximum-likelihood optimal-ity criterion.",OADS,/arxiv_data1/oa_pdf/d0/98/MEC-24-673.PMC5006861.pdf
MCMC runswere analysed with the programs TRACER v1.5 (Rambaut & Drummond 2007) and AWTY (http://ceb.csit.,OADS,/arxiv_data1/oa_pdf/d0/98/MEC-24-673.PMC5006861.pdf
Available from http://www.geneious.com/.,Non-OADS,/arxiv_data1/oa_pdf/d0/98/MEC-24-673.PMC5006861.pdf
"Rambaut A, Drummond AJ (2007) Tracer v1.5, Available from http://beast.bio.ed.ac.uk/Tracer.",OADS,/arxiv_data1/oa_pdf/d0/98/MEC-24-673.PMC5006861.pdf
"Data accessibility Supporting information: Nucleotide alignments, input ﬁles, are tree ﬁles available from the Dryad DigitalRepository: http://doi.org/10.5061/dryad.7kn5k.",OADS,/arxiv_data1/oa_pdf/d0/98/MEC-24-673.PMC5006861.pdf
"Data for known barnacle genome sizes obtained from the Animal Genome Size Database (http://www.genomesize.com) .C-value is deﬁned as the amount of DNA in picograms in the nucleus, where the gen- ome size in Mbp = 978 9C-value.",OADS,/arxiv_data1/oa_pdf/d0/98/MEC-24-673.PMC5006861.pdf
"7, e1178421 (13 pages)http://dx.doi.org/10.1080/2162402X.2016.1178421",Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Blood 2008; 112:461-9; PMID:18650461; http://dx.doi.org/10.1182/blood-2007-09-077438 2.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
J Immunol 2011; 186:1538-45; PMID:21191066; http://dx.doi.org/10.4049/jimmunol.1000951 3.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Onco- gene 2008; 27:5944-58; PMID:18836475; http://dx.doi.org/10.1038/ onc.2008.272 4.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Annu Rev Immunol 2005; 23:225-74; PMID:15771571; http://dx.doi.org/10.1146/annurev.immunol.23.021704.115526 5.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Oncogene 2008; 27:5932-43; PMID:18836474; http://dx.doi.org/10.1038/onc.2008.267 6.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Lancet 2000; 356:1795-9; PMID:11117911; http://dx.doi.org/; http://dx.doi.org/10.1016/ S0140-6736(00)03231-1 7.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
J Biomed Biotechnol 2010; 2010:901564-7;PMID:20445748; http://dx.doi.org/10.1155/2010/901564 9.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
J Surg Res2011; 171:637-49; PMID:20828749; http://dx.doi.org/10.1016/j.jss.2010.05.012 10.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Br J Haematol 1999; 104:144-51; PMID:10027727; http://dx.doi.org/10.1046/j.1365-2141.1999.01129.x 11.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Mol Immunol 2008; 45:3917-25; PMID:18657862; http://dx.doi.org/10.1016/j.molimm.2008.06.016 12.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Oncoimmunology 2013; 2:e26011; PMID:24327939;http://dx.doi.org/10.4161/onci.26011e1178421-10 V. B€UCKLEIN ET AL.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
J Transl Med 2013; 11:262; PMID:24138752; http://dx.doi.org/ 10.1186/1479-5876-11-262 14.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Cancer Immunol Immunother2011; 60:1195-205; PMID:21644031; http://dx.doi.org/10.1007/ s00262-011-1050-2 15.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Int J Cancer 2003; 106:905-12; PMID:12918068; http://dx.doi.org/10.1002/ ijc.11321 17.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Front Immunol 2012;3:395; PMID:23269924; http://dx.doi.org/10.3389/ ﬁmmu.2012.00395 18.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
N Engl J Med 2005; 353:701-11; PMID:16107623; http://dx.doi.org/10.1056/NEJMra041866 19.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Ann Oncol 2010;21(Suppl 5):v198-203; PMID:20555081; http://dx.doi.org/10.1093/ annonc/mdq209 20.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Ann Oncol 2010; 21:2436-41; PMID:20439343; http://dx.doi.org/10.1093/annonc/mdq238 21.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Lancet Oncol 2010; 11:561-70; PMID:20434400; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Ann Oncol 2011; 22:1266-72; PMID:21183581; http://dx.doi.org/10.1093/annonc/mdq608 23.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
BMJ 2010; 341:c7170; PMID:21190968; http://dx.doi.org/ 10.1136/bmj.c7170 24.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Int Immunol 2001; 13:459-63; PMID:11282985; http://dx.doi.org/ 10.1093/intimm/13.4.459 25.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
J Exp Med 2012; 209:1869-82;PMID:22927549; http://dx.doi.org/10.1084/jem.20112738 26.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Cell Stress Chaperones 2002; 7:365-73; PMID:12653481; http://dx.doi.org/ 10.1379/1466-1268(2002)007 <0365:IOTGIM >2.0.CO;227.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Cell Stress Chaperones 2001; 6:337-44;PMID:11795470; http://dx.doi.org/10.1379/1466-1268(2001) 006<0337:AMHPSN >2.0.CO;2 28.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Immunol Lett 2005; 100:7-13; PMID:16109445; http://dx.doi.org/10.1016/j.imlet.2005.07.004 29.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
BMC Cancer 2009; 9:186; PMID:19531227; http://dx.doi.org/10.1186/1471- 2407-9-186 31.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
J Immunol 2004; 172:7335-40; PMID:15187109;http://dx.doi.org/; http://dx.doi.org/10.4049/jimmunol.172.12.7335 32.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
PLoSOne 2013; 8:e76928; PMID:24204708; http://dx.doi.org/10.1371/ journal.pone.0076928 33.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
J Immunol 2010; 185:5732-42;PMID:20926796; http://dx.doi.org/10.4049/jimmunol.1002092 34.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Immunity 1997; 7:753-63;PMID:9430221; http://dx.doi.org/10.1016/S1074-7613(00)80394-5 35.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Mol Immunol 2005; 42:501-10;PMID:15607806; http://dx.doi.org/10.1016/j.molimm.2004.07.034 36.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Blood 2010; 116:3865-74; PMID:20733159; http://dx.doi.org/10.1182/blood-2010-04-282301 37.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
J Leukocyte Biol 2009; 85:88- 97; PMID:18820174; http://dx.doi.org/10.1189/jlb.0208107 38.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Front Immunol 2013; 4:422; PMID:24367364; http://dx.doi.org/ 10.3389/ ﬁmmu.2013.00422 39.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Nat Immunol 2002; 3:991-8; PMID:12407406; http://dx.doi.org/10.1038/ni1102-991 40.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Nat Rev Immunol 2006; 6:715-27; PMID:16977338; http://dx.doi.org/10.1038/nri1936 41.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Oncoimmunology 2015; 4:e985082; PMID:25949868;http://dx.doi.org/10.4161/2162402X.2014.985082 43.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Clin Cancer Res 2013; 19:4079-91; PMID:23785047; http://dx.doi.org/10.1158/1078-0432.CCR-12-3847 44.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
"Prinz PU, Mendler AN, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylgly- cerol kinase as key regulator and target for therapeutic intervention.Int J Cancer 2014; 135:1832-41; PMID:24615391; http://dx.doi.org/10.1002/ijc.28837 45.",Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
J Clin Invest 2011; 121:3609- 22; PMID:21841316; http://dx.doi.org/10.1172/JCI45816 46.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Cancer Immunol Immunother 2010; 60:1-13; PMID:20697893; http://dx.doi.org/10.1007/s00262-010-0898-x 47.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Pancreas 2015; 44:386-93;PMID:25621568; http://dx.doi.org/10.1097/MPA.0000000000000288 48.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Clin Cancer Res 2006; 12:718-25; PMID:16467081; http://dx.doi.org/10.1158/1078-0432.CCR-05-0857 49.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Cancer Res 2009;69:3563-9; PMID:19351841; http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
J Surg Res 2015; 194:185-93; PMID:25475022; http://dx.doi.org/10.1016/j.jss.2014.10.030 51.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Ageing Res Rev 2013; 12:1069-78; PMID:23660515; http://dx.doi.org/10.1016/j.arr.2013.04.003 52.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Oncoim-munology 2015; 4:e990773; PMID:25949906; http://dx.doi.org/ 10.4161/2162402X.2014.990773 53.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
J Transl Med 2015; 13:180; PMID:26040463; http://dx.doi.org/10.1186/s12967- 015-0535-8 55.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Cancer Chemother Pharmacol 1996; 37:445-50; PMID:8599867; http://dx.doi.org/10.1007/s002800050410 56.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
J Exp Med 1988; 168:2355-60; PMID:3199072; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Mol Cancer Ther 2007; 6:644-54; PMID:17308061; http://dx.doi.org/10.1158/1535-7163.MCT-06-0358 58.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Breast Cancer Res 2016;18:10; PMID:26810608; http://dx.doi.org/10.1186/s13058-015-0669-x 59.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Leukemia 2010; 24:583-91; PMID:20033055; http://dx.doi.org/10.1038/leu.2009.269 60.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
J Maxillofac Surg 1986; 14:270-5; PMID:3464682; http://dx.doi.org/10.1016/S0301-0503(86)80303-4 61.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
"Cancer Res 2014; 74:7298-308; PMID:25351955; http://dx.doi.org/10.1158/0008-5472.CAN-14-1339 62. Cooper MA, Fehniger TA, Caligiuri MA.",Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Trends Immunol 2001; 22:633-40;PMID:11698225; http://dx.doi.org/10.1016/S1471-4906(01)02060-9 63.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Blood 2006; 107:159-66; PMID:16150947;http://dx.doi.org/10.1182/blood-2005-04-1351 64.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Mol Cancer 2014; 13:34; PMID:24565056; http://dx.doi.org/10.1186/1476-4598- 13-34 65.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Clin Cancer Res 2011; 17:2628-37;PMID:21224372; http://dx.doi.org/10.1158/1078-0432.CCR-10-2084 66.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Leuk Lymphoma 2006; 47:1229-38; PMID:16923551; http://dx.doi.org/10.1080/ 10428190600565503 67.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
CellImmunol 2006; 239:22-30; PMID:16630603; http://dx.doi.org/ 10.1016/j.cellimm.2006.03.002 68.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Neoplasia 2004; 6:558-68; PMID:15548365; http://dx.doi.org/10.1593/neo.04316 69.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Clin CancerRes 2011; 17:6287-97; PMID:21844012; http://dx.doi.org/10.1158/1078-0432.CCR-11-1347 70.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Exp Hematol 2000; 28:96-103; PMID:10658681; http://dx.doi.org/10.1016/S0301-472X(99)00129-0 71.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
Eur J Cancer 1994; 30A:1078-83; PMID:7654433; http://dx.doi.org/ 10.1016/0959-8049(94)90460-X 72.,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
J Exp Med 1974; 140:718-30; PMID:4278109; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
J Immunol 2012; 188:5990-6000; PMID:22573804;http://dx.doi.org/10.4049/jimmunol.1103028ONCOIMMUNOLOGY e1178421-13,Non-OADS,/arxiv_data1/oa_pdf/03/a6/koni-05-07-1178421.PMC5006893.pdf
"9 The increased PD-L1 expression could be suppressed with the © Blanca Homet Moreno, Stephen Mok, Begonya Comin-Anduix, Siwen Hu-Lieskovan, and Antoni Ribas *Correspondence to: Antoni Ribas; Email: aribas@mednet.ucla.edu.Submitted: 03/20/2015; Revised: 05/09/2015; Accepted: 05/12/2015 http://dx.doi.org/10.1080/2162402X.2015.1052212 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
N Engl J Med 2012; 366:2455-65; PMID:22658128; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
N Engl J Med 2013;369:134-44; PMID:23724846; http://dx.doi.org/ 10.1056/NEJMoa1305133 3.,OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992; http://dx.doi.org/10.1056/NEJMoa1003466 4.,OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
N Engl J Med 2011; 364:2517-26; PMID:21639810; http://dx.doi.org/ 10.1056/NEJMoa11046215.,OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
N Engl J Med2012; 366:2443-54; PMID:22658127; http://dx.doi.org/ 10.1056/NEJMoa1200690 6.,OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Blood 2012; 119:651-65; PMID:22053109; http://dx.doi.org/10.1182/ blood-2011-04-325225 7.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
N Engl J Med2012; 367:1694-703; PMID:23020132; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Cancer Res 2010; 70:5213-9; PMID:20551059; http://dx.doi.org/10.1158/0008-5472.CAN-10-01189.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Vemurafenib enhances MHC induction in BRAF homozygous melanoma cells.Oncoimmunology 2013; 2:e22890; PMID:23483066; http://dx.doi.org/10.4161/onci.22890 11.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Oncoimmu- nology 2012; 1:1476-83; PMID:23264894; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Clin Cancer Res 2013; 19:393-403; PMID:23204132; http://dx.doi.org/10.1158/1078-0432.CCR-12-1626 www.tandfonline.com e1052212-7 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Pigment Cell Melanoma Res 2013; 26:499-508; PMID:23557327; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Clin Cancer Res 2012; 18:1386-94; PMID:22156613; http://dx.doi.org/10.1158/1078-0432.CCR-11-2479 1 5 .,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Cancer Res2012; 72:3928-37; PMID:22693252; http://dx.doi.org/ 10.1158/0008-5472.CAN-11-2837 16.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
J DermatolSci 2005; 40:95-103; PMID:16085391; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Clin Cancer Res 2013; 19:598-609; PMID:23095323; http://dx.doi.org/10.1158/1078-0432.CCR-12-2731 19.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Sci Transl Med 2015; 18: 18;7(279):279ra41; PMID:25787767; http://dx.doi.org/10.1126/scitranslmed.aaa4691 20.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Clin Cancer Res 2013; 19:997-1008; PMID:23460531;http://dx.doi.org/10.1158/1078-0432.CCR-12-2214 21.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Nat Rev Cancer 2007; 7:95-106; PMID:17251916; http://dx.doi.org/10.1038/nrc2051 22.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
In t J Cancer 2008; 122:2784-90; PMID:18360825; http://dx.doi.org/10.1002/ijc.23457 23.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Cancer Res 2008; 68:7264-9; PMID:18794112; http://dx.doi.org/ 10.1158/0008-5472.CAN-08-1365 24.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Cancer Res 2012; 72:3163-74; PMID:22570253; http://dx.doi.org/10.1158/0008-5472.CAN-12-0210 26.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
J Immunol 2000; 164:2160-9; http://dx.doi.org/10.4049/jimmunol.164.4.2160 27.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Nat Rev Immu- nol 2003; 3:609-20; PMID:12974476; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Annu Rev Immunol 2005;23:23-68; PMID:15771565; http://dx.doi.org/ 10.1146/annurev.immunol.23.021704.115839 29.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Nat Med 2004; 10:1088-94; PMID:15448685; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
J Immunol 2000; 165:3043-50; http://dx.doi.org/10.4049/jimmunol.165.6.3043 34.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Nat Med 1997; 3:682-5; PMID:9176498; http://dx.doi.org/10.1038/nm0697-682 36.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Nat Med 2006; 12:693-8; PMID:16680149; http://dx.doi.org/10.1038 /nm1405 38.,OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
J Clin Investig 2013; 123:1371-81; PMID:23454771; http://dx.doi.org/10.1172/JCI66236 39.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
J Clin Oncol 2014; 32:2248-54; PMID:24958825; http://dx.doi.org/10.1200/JCO.2013.52.1377 40.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Cancer Discov 2012; 2:608-23; PMID:22719018; http://dx.doi.org/10.1158/2159- 8290.CD-11-031441.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Oncoimmunology2012; 1:609-17; PMID:22934253; http://dx.doi.org/ 10.4161/onci.20226 43.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Annu Rev Immunol 2010; 28:57-78; PMID:20307208; http://dx.doi.org/ 10.1146/annurev-immunol-030409-101243 44.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
PLoS One 2012; 7:e34467; PMID:22496812; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Nature 2014; 515:568-71; PMID:25428505; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Oncoimmunology 2013; 2:e24320; PMID:23762807; http://dx.doi.org/ 10.4161/onci.24320 47.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Cancer Discov 2014; 4:674-87; PMID:24589924; http://dx.doi.org/10.1158/2159-8290.CD-13-0458 48.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
"Clin Cancer Res 2014; 20:5064- 74; PMID:24714771; http://dx.doi.org/10.1158/ 1078-0432.CCR-13-3271 49. Cooper ZA, Juneja VR, Sage PT, Frederick DT, Piris A, M i t r aD ,L oJ A ,H o d iF S ,F r e e m a nG J ,B o s e n b e r gM W et al.",Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Cancer Immunol Res 2014; 2:643-54; PMID:24903021; http://dx.doi.org/10.1158/2326-6066.CIR-13-0215 50.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Oncoimmunology 2014; 3:e29126; PMID:25083331; http://dx.doi.org/10.4161/onci.29126 51.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Immunol Rev 2008;222:162-79; PMID:18364001; http://dx.doi.org/ 10.1111/j.1600-065X.2008.00602.x 52.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Nat Rev Immunol 2009; 9:162-74; PMID:19197294; http://dx.doi.org/10.1038/nri2506 53.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
Blood 2008; 111:4233-44; PMID:18272812; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f8/17/koni-05-07-1052212.PMC5006894.pdf
"7, e1195535 (11 pages)http://dx.doi.org/10.1080/2162402X.2016.1195535",Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
Int J Hematol 2013; 98:627-633; PMID:24046178; http://dx.doi.org/10.1007/s12185- 013-1433-6 2.,Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
Oncology 2015; 89 Suppl 1:28-32; PMID:26551150; http://dx.doi.org/ 10.1159/000431062 3.,Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.Cell Stem Cell 2015; 17:341-352; PMID:26279267; http://dx.doi.org/ 10.1016/j.stem.2015.07.011 4.,Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
Oncotarget 2015; 6:33823-33833; PMID:26413815; http://dx.doi.org/10.18632/ oncotarget.5257 5.,OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
Int J Biochem Cell Biol 2015; 59:11-20; PMID:25483439; http://dx.doi.org/10.1016/j.biocel.2014.11.017 6.,OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
PLoS One 2013; 8:e72488; PMID:23967307; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
J Leukoc Biol 2012; 91:189-196; PMID:21844165; http://dx.doi.org/10.1189/jlb.1010591 8.,Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
J Biol Chem 2013; 288:34529-34544; PMID:24121505; http://dx.doi.org/10.1074/jbc.M113.488478 9.,OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
"cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression.J Virol 2015; 89:3723-3736; PMID:25609823; http://dx.doi.org/10.1128/JVI.00006-15 10.",Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
J Virol 2013; 87:4835-4845; PMID:23408620; http://dx.doi.org/10.1128/JVI.01085-12 11.,Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
Cell Immunol 2007; 250:68-74; PMID:18353298; http://dx.doi.org/10.1016/j.cellimm.2008.01.006 12.,OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
Nat Rev Immunol 2004; 4:499-511; PMID:15229469; http://dx.doi.org/10.1038/nri1391 13.,Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
J Cell Mol Med 2015; 19:1065-1076; PMID:25754930; http://dx.doi.org/10.1111/jcmm.12500 15.,Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
Eur J Immunol 2014; 44:3068-3080;PMID:25041786; http://dx.doi.org/10.1002/eji.201444500 16.,Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
Glycobiology 2002; 12:111- 118; PMID:11886844; http://dx.doi.org/10.1093/glycob/12.2.111 18.,Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
Mol Immunol 2011; 48:1778-1783; PMID:21621846; http://dx.doi.org/10.1016/j.molimm.2011.05.004 19.,Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
J Cell Biol2004; 164:769-779; PMID:14993236; http://dx.doi.org/10.1083/ jcb.200307137 20.,OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
PLoS One 2013; 8:e60807;PMID:23585851; http://dx.doi.org/10.1371/journal.pone.0060807 22.,Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
Appl Biochem Biotechnol 2008; 144:181-189; PMID:18456949; http://dx.doi.org/10.1007/s12010-007-8112-0 23.,Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
Cell MolLife Sci 2014; 71:699-710; PMID:23872956; http://dx.doi.org/10.1007/ s00018-013-1421-2 24.,OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
Anal Biochem 1996; 236:262-269; PMID:8660503; http://dx.doi.org/10.1006/abio.1996.0165 25.,Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
Mol Aspects Med 1993; 14:287-371; PMID:8277832; http://dx.doi.org/ 10.1016/0098-2997(93)90002-UONCOIMMUNOLOGY e1195535-11,Non-OADS,/arxiv_data1/oa_pdf/a7/ec/koni-05-07-1195535.PMC5006895.pdf
"7, e1151591 (13 pages)http://dx.doi.org/10.1080/2162402X.2016.1151591",Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Jama 2013; 310:2435-42; PMID:24327038; http://dx.doi.org/10.1001/jama.2013.280490.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
JAMA InternMed 2014; 174:564-74; PMID:24535015; http://dx.doi.org/10.1001/jamainternmed.2013.14673.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
A review of 223 cases.Transplantation 1988; 46:53-6; PMID:3293286; http://dx.doi.org/ 10.1097/00007890-198807000-00008.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Ann Intern Med1988; 108:566-7; PMID:3348565; http://dx.doi.org/10.7326/0003- 4819-108-4-566.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Inﬂamm Res 2008; 57 Suppl 1:S23-4; PMID:18345506; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Eur J Cell Biol 2008; 87:227-36;PMID:18258331; http://dx.doi.org/10.1016/j.ejcb.2007.12.003.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Gut 2012; 61:753-64; PMID: 21873469; http://dx.doi.org/10.1136/gutjnl-2011-300007.8.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Br J Pharmacol 2010; 161:755-67; PMID:20636392; http://dx.doi.org/10.1111/j.1476-5381.2010.00961.x.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
"Immunol Allergy Clin North Am 2006; 26:245-59, vii; PMID:16701143; http://dx.doi.org/10.1016/j.iac.2006.02.006.",OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Agents Actions 1994; 43:17-20; PMID:7741034; http://dx.doi.org/10.1007/BF02005757.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Cancer Biol Ther 2006; 5:1462-71; PMID:17012845; http://dx.doi.org/10.4161/cbt.5.11.3273.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Lancet 1988; 2:990-2; PMID:2902494; http://dx.doi.org/10.1016/S0140-6736(88)90743-X.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Eur J Cancer Clin Oncol 1988; 24:161-7; PMID:3356203; http://dx.doi.org/10.1016/0277-5379(88)90247-7.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Semin Cancer Biol 2000; 10:3-10; PMID:10888265;http://dx.doi.org/10.1006/scbi.2000.0301.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Immunol 2005; 174:636-45; http://dx.doi.org/10.4049/jimmunol.174.2.636.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Immunol 2009; 182:240-9; PMID:19109155; http://dx.doi.org/10.4049/jimmunol.182.1.240.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Hepatology 2009;50:799-807; PMID:19551844; http://dx.doi.org/10.1002/hep.23054.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Cancer Immunol Immunother 2012; 61:827-38;PMID:22080405; http://dx.doi.org/10.1007/s00262-011-1143-y.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Immunol 2008; 181:3291-300; PMID:18714001; http://dx.doi.org/10.4049/ jimmunol.181.5.3291.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Blood 2008; 111:4233-44; PMID:18272812; http://dx.doi.org/10.1182/blood-2007-07-099226.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Cancer Res 2006; 66:1123-31;PMID:16424049; http://dx.doi.org/10.1158/0008-5472.CAN-05-1299.ONCOIMMUNOLOGY e1151591-11,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Cancer Immunol Immunother 2013; 62:383-91; PMID:22926062; http://dx.doi.org/10.1007/s00262-012-1343-0.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Cancer Res2010; 70:3052-61; PMID:20388795; http://dx.doi.org/10.1158/0008- 5472.CAN-09-3690.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
JImmunother Cancer 2013; 1:10; PMID:24829747; http://dx.doi.org/ 10.1186/2051-1426-1-10.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Immunol 2009; 182:4499-506; PMID:19342621; http://dx.doi.org/10.4049/jimmunol.0802740.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Clin Invest 2001; 108:1865-73; PMID:11748270; http://dx.doi.org/10.1172/JCI200113930.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Br J Pharmacol2010; 160:1378-86; PMID:20590628; http://dx.doi.org/10.1111/j.1476-5381.2010.00800.x.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Immunol 2010; 184:2116-23; PMID:20083654; http://dx.doi.org/10.4049/jimmunol.0803894.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Scand JImmunol 1996; 43:9-15; PMID:8560202; http://dx.doi.org/10.1046/ j.1365-3083.1996.d01-14.x.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Int Immunopharmacol2001; 1:85-96; PMID:11367520; http://dx.doi.org/10.1016/S0162-3109 (00)00268-X.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Int Immunopharmacol 2001; 1:135-45; PMID:11367511; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Cell Immunol 1989; 121:60-73; PMID:2541932; http://dx.doi.org/ 10.1016/0008-8749(89)90005-1.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Nat Med 2011; 17:87-95; PMID:21170045; http://dx.doi.org/ 10.1038/nm.2278.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Leukoc Biol 2014; 96:151-9; PMID:24610880; http://dx.doi.org/10.1189/jlb.5A1213-644R.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Int Immunopharmacol 2009; 9:900-9; PMID:19336265; http://dx.doi.org/10.1016/j.intimp.2009.03.015.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
In ﬂamm Res 1995; 44 Suppl 1:S68-9; PMID:8521007; http://dx.doi.org/10.1007/BF01674400.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Immunol 2003; 170:270-8; PMID:12496409; http://dx.doi.org/10.4049/jimmunol.170.1.270.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Br J Cancer 2014; 110:83-93; PMID:24281006; http://dx.doi.org/ 10.1038/bjc.2013.695.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
PloS One 2013; 8:e56567; PMID:23451056; http://dx.doi.org/10.1371/journal.pone.00-56567.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Interferon Cytokine Res 1999; 19:1135-44; PMID:10547153; http://dx.doi.org/10.1089/107999099313073.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Clin Oncol 2002; 20:125-33;PMID:11773161; http://dx.doi.org/10.1200/JCO.20.1.125.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Br JCancer 2000; 82:167-70; PMID:10638985; http://dx.doi.org/10.1054/bjoc.1999.0895.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Pharmacoepidemiol Drug Saf 2013; 22:632-40; PMID:23576472; http://dx.doi.org/10.1002/pds.3441.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Microbiome 2014; 2:42; PMID:25426290; http://dx.doi.org/10.1186/2049-2618-2-42.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Nature 2013; 504:451-5; PMID:24226773; http://dx.doi.org/10.1038/ nature12726.e1151591-12 A. VILA-LEAHEY ET AL.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Immunity 2010; 32:815-27; PMID:20620945; http://dx.doi.org/10.1016/j.immuni.2010.06.001.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Oncotarget 2015; 6:9387-96; PMID:25831236; http://dx.doi.org/10.18632/oncotarget.3328.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
BMCCancer 2014; 14:498; PMID:25011475; http://dx.doi.org/10.1186/1471-2407-14-498.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Immunotherapy 2013; 5:1075-87;PMID:24088077; http://dx.doi.org/10.2217/imt.13.102.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Immunol 2015; 194:5529-38; http://dx.doi.org/10.4049/ jimmunol.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
1403215; PMID:26008983; http://dx.doi.org/10.18632/oncotarget.4189 62.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Immunol 2010; 185:203-10; PMID:20525890; http://dx.doi.org/10.4049/jimmunol.0903573.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Breast Cancer Res 2013; 15:R79;PMID:24021059; http://dx.doi.org/10.1186/bcr3473.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Transl Med 2015; 13:47; PMID:25638150; http://dx.doi.org/10.1186/s12967-015-0410-7.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
PloSOne 2015; 10:e0127028; PMID:25992611; http://dx.doi.org/10.1371/journal.pone.0127028.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Immunol 2009; 182:5693-701; PMID:19380816; http://dx.doi.org/10.4049/jimmunol.0900092.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Virol 2012; 86:13689-96; PMID:23055553; http://dx.doi.org/10.1128/JVI.01595-12.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Nat Med 2007; 13:828-35; PMID:17603493; http://dx.doi.org/10.1038/nm1609.71.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Exp Med 2003; 198:1741-52; PMID:14657224;http://dx.doi.org/10.1084/jem.20022227.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Cancer Res 2008; 68:3467-75; PMID:18451175; http://dx.doi.org/10.1158/0008- 5472.CAN-07-5301.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Clin Oncol 2007; 25:2546-53;PMID:17577033; http://dx.doi.org/10.1200/JCO.2006.08.5829.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
"W e i z m a nN ,K r e l i nY ,S h a b t a y - O r b a c hA ,A m i tM ,B i n e n b a u mY , Wong RJ, Gil Z. Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase.Oncogene 2014; 33:3812-9; PMID:23995783; http://dx.doi.org/ 10.1038/onc.2013.357.",Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Blood 2007; 109:5346-54; PMID:17327412; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Cancer Immunol Res 2013; 1:64-76; PMID:24777249; http://dx.doi.org/10.1158/2326- 6066.CIR-13-0030.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Leukoc Biol 2015; 97:573-82; PMID:25583578; http://dx.doi.org/10.1189/jlb.4A0314-139R.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Gastroenter- ology 2008; 135:234-43; PMID:18485901; http://dx.doi.org/ 10.1053/j.gastro.2008.03.020.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Shock 2004; 22:460-6; PMID:15489639; http://dx.doi.org/10.1097/01.shk.0000142249.08135.e9.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
J Leukoc Biol 2005; 78:114-21; PMID:15845645; http://dx.doi.org/10.1189/jlb.0604341.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Nature 2011; 475:222-5; PMID:21654748; http://dx.doi.org/10.1038/nature10138.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Int J Pharm 2003;256:109-15; PMID:12695016; http://dx.doi.org/10.1016/S0378-5173 (03)00067-X.,OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
Curr Protoc Immunol 2001; Chapter 20:Unit 20 2; PMID:18432775; http://dx.doi.org/10.1002/0471142735.im2002s39ONCOIMMUNOLOGY e1151591-13,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/koni-05-07-1151591.PMC5006904.pdf
"7, e1182278 (10 pages)http://dx.doi.org/10.1080/2162402X.2016.1182278",Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Nat Rev Cancer 2014; 14:159-72; PMID:24561443; http://dx.doi.org/ 10.1038/nrc3677 2.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Nature 2008; 456:643-7; PMID:18931657; http://dx.doi.org/10.1038/nature07391 3.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Cell Rep 2012; 1:191-9; PMID:22832193;http://dx.doi.org/10.1016/j.celrep.2012.01.005 4.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Histochem CellBiol 2008; 130:1063-78; PMID:18946678; http://dx.doi.org/10.1007/s00418-008-0525-5 5.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Nature 2015; 523:337-41; PMID:26030524; http://dx.doi.org/10.1038/nature14432 6.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
J Exp Med 2007; 204:2349-62; PMID:17846148; http://dx.doi.org/ 10.1084/jem.20062596 7.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Adv Drug Deliv Rev 2016 Apr 1; 99(Pt B):148-60; PMID:26705849; http://dx.doi.org/10.1016/j.addr.2015.12.011 8.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
J Immunol 2014; 192:5002-11; PMID:24795456; http://dx.doi.org/10.4049/jimmunol.1302492 9.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Neoplasia 2010; 15:341-52; PMID:20835756; http://dx.doi.org/ 10.1007/s10911-010-9193-x 10.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Trends Immunol 2011; 32:12-8; PMID:21147035; http://dx.doi.org/10.1016/j.it.2010.11.002 11.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Ann Plast Surg 2007; 59:464-72; PMID:17901744;http://dx.doi.org/10.1097/01.sap.0000257149.42922.7e 13.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Blood 2011; 118:205-15; PMID:21596851; http://dx.doi.org/10.1182/blood-2010-12-326447 14.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
J Oncol 2012; 2012:204946; PMID:22481918; http://dx.doi.org/10.1155/2012/204946 15.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Am J Pathol 2002; 161:947-56; PMID:12213723; http://dx.doi.org/10.1016/S0002-9440(10)64255-1 16.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Cancer Cell 2005; 7:121-7; PMID:15710325; http://dx.doi.org/10.1016/j.ccr.2005.01.017 17.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Oncogene 2011; 30:4901-9;PMID:21666710; http://dx.doi.org/10.1038/onc.2011.187 18.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Dev Biol 2012; 362:24-41; PMID:22094019; http://dx.doi.org/10.1016/j.ydbio.2011.10.033 20.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Cellreports 2014; 6:155-67; PMID:24388748; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Neoplasia 2014; 16:586-94; PMID:25117980; http://dx.doi.org/10.1016/j.neo.2014.07.003 22.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
J Pathol 2003; 201:544-54; PMID:14648657; http://dx.doi.org/10.1002/path.1467 23.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Nat Commun 2014; 5:4944; PMID:25229256; http://dx.doi.org/10.1038/ncomms5944 24.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Oncogene 2016;35:196-205; PMID:25772247; http://dx.doi.org/10.1038/onc.2015.73 25.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Scienti ﬁc Rep 2016; 6:20739; PMID:26857144; http://dx.doi.org/10.1038/srep20739 26.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Nature 2005; 438:750-1; PMID:16341000; http://dx.doi.org/10.1038/438750b27.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Clin Exp Metastasis2014; 31:67-79; PMID:23963763; http://dx.doi.org/10.1007/s10585- 013-9610-9 28.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Int J Cancer J Int du Cancer 2012; 130:787-97; PMID:21387301; http://dx.doi.org/10.1002/ijc.26035 29.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Nat Commun 2014; 5:4715;PMID:25178650; http://dx.doi.org/10.1038/ncomms5715 30.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
J Clin Investig 2007; 117:3660-3; PMID:18060028; http://dx.doi.org/10.1172/ JCI34237 31.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Neoplasia 2013; 15:848-62; PMID:23814496; http://dx.doi.org/10.1593/neo.13706 32.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Breast Cancer Res 2013; 15:R79;PMID:24021059; http://dx.doi.org/10.1186/bcr3473 34.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Eur J Cancer 2002; 38:1413-9; PMID:12091074; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Oncogene 2007; 26:2997-3005; PMID:17130836; http://dx.doi.org/10.1038/sj.onc.1210114 36.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
J Biol Chem 2008;283:11155-63; PMID:18319253; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Cancer 2003; 97:2978-87; PMID:12784332; http://dx.doi.org/10.1002/cncr.11437 38.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Mol Cancer 2015; 14:35; PMID:25744065; http://dx.doi.org/10.1186/s12943-015-0306-4 39.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Cancer Cell 2007; 11:526-38; PMID:17560334; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Blood 2013; 121:3768-77; PMID:23479571; http://dx.doi.org/ 10.1182/blood-2012-04-425314 41.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Mol Cancer Res 2008; 6:1276-88; PMID:18708360; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Nature 2001; 410:50-6;PMID:11242036; http://dx.doi.org/10.1038/35065016 43.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
J Exp Med 2006; 203:2763-77; PMID:17116732; http://dx.doi.org/10.1084/jem.20051759 44.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
J Cancer Res Therapeutics 2014; 10 Suppl:C125-30; PMID:25450269; http://dx.doi.org/10.4103/0973-1482.145827 45.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
J Immunol 2016; 196:1443-8;PMID:26773145; http://dx.doi.org/10.4049/jimmunol.1501634 46.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
J Immunol 2007; 178:1136-43; PMID:17202377; http://dx.doi.org/10.4049/jimmunol.178.2.1136 4 7 .,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Oncogene 2007; 26:6604-18; PMID:17471235; http://dx.doi.org/10.1038/sj.onc.1210481 48.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Investig Ophthalmol Visual Sci 2012; 53:1244-50; PMID:22281820; http://dx.doi.org/10.1167/iovs.11-8668 49.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Clin Cancer Res 2010; 16:3044-56; PMID:20501621; http://dx.doi.org/10.1158/1078-0432.CCR-09-3368 50.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Breast 2015;24:182-90; PMID:25747197; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
J Clin Oncol 2010; 28: 780-7; PMID:20048182; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Cancer Res 2013; 73:7254-64;PMID:24158094; http://dx.doi.org/10.1158/0008-5472.CAN-13-0750 5 3 .,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Scienti ﬁc Rep 2014; 4:7139; PMID:25409905; http://dx.doi.org/10.1038/srep07139 54.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
"Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling.Mol Cancer Ther 2008; 7:3129-40; PMID:18852116; http://dx.doi.org/10.1158/1535-7163.MCT-08-0013 55.",Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Cur-rent cancer drug targets 2012; 12:857-72; PMID:22515521; http://dx.doi.org/10.2174/156800912802429265 56.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Front Oncol2015; 5:176; PMID:26284197; http://dx.doi.org/10.3389/ fonc.2015.00176 57.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
CA Cancer J Clin 2011; 61:250-81; PMID:21617154; http://dx.doi.org/10.1017/S0009840X10002799 58.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Circulation 2011; 123:1335-51; PMID: 21444892; http://dx.doi.org/10.1161/CIRCULATIONAHA.107.704098 59.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Angiogenesis 2014; 17:347-57; PMID:23892627; http://dx.doi.org/10.1007/s10456-013-9365-6 60.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Investigation of cell death mechanisms in human lymphatic endothelial cells undergoing photodynamic therapy.Photodiagnosis and photodynamic therapy 2016; Jun;14:57-65;PMID:26868051; http://dx.doi.org/10.1016/j.pdpdt.2016.02.004.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Cell 1999; 99:23-33; PMID:10520991; http://dx.doi.org/10.1016/S0092-8674(00)80059-8 63.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Breast Cancer Res Treat 2012; 131:837-48;PMID:21479551; http://dx.doi.org/10.1007/s10549-011-1502-6 65.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Cancer Metastasis Rev 1991; 10:11-22;PMID:1680575; http://dx.doi.org/10.1007/BF00046840 66.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Carcinogenesis 2005; 26:943-50; PMID:15774488; http://dx.doi.org/10.1093/carcin/bgi070 67.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
J Immunol2013; 191:395-406; PMID:23733875; http://dx.doi.org/10.4049/ jimmunol.1202002 68.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Gene Ther2003; 10:1519-27; PMID:12900768; http://dx.doi.org/10.1038/sj.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Oncology Lett 2012; 3:1213-5; PMID:22783420; http://dx.doi.org/10.3892/ol.2012.641 70.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
"Takahashi K, Mizukami H, Saga Y, Takei Y, Urabe M, Kume A, Machida S, Fujiwara H, Suzuki M, Ozawa K. Suppression of lymph node and lung metastases of endometrial cancer by muscle-mediated expression of soluble vascular endothelial growth factor receptor-3.Cancer Sci 2013; 104:1107-11; PMID:23614535; http://dx.doi.org/10.1111/cas.12184 71.",OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Int J Cancer J Int du Cancer 2012; 131:298-309;PMID:21823121; http://dx.doi.org/10.1002/ijc.26353 72.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Protein and peptide letters 2012; 19:969-74; PMID:22512651; http://dx.doi.org/10.2174/092986612802084465 73.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Endocrinology 2011; 152:4062-71; PMID:21862622; http://dx.doi.org/10.1210/en.2011-1081 7 4 .,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Cancers 2014; 6:472-90; PMID: 24589997; http://dx.doi.org/10.3390/cancers6010472 75.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
"Kashima K, Watanabe M, Satoh Y, Hata J, Ishii N, Aoki Y. Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing anti-body to vascular endothelial growth factor-D. Cancer Sci 2012; 103:2144-52; PMID:22937829; http://dx.doi.org/10.1111/cas.12010 76.",OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
CancerRes 2015; 75:2177-86; PMID:25808871; http://dx.doi.org/10.1158/ 0008-5472.CAN-14-2464 77.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Cancer Res 2011; 71:7103-12; PMID:21975930; http://dx.doi.org/10.1158/0008-5472.CAN-10-3192 78.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
BMC Cancer 2015; 15:527; PMID:26187792; http://dx.doi.org/10.1186/s12885-015-1521-5 79.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Breast Cancer Res 2011; 13:R66; PMID:21693010; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
Int J Cancer J Int du Cancer 2014; 135:1487-96; PMID:24347491; http://dx.doi.org/10.1002/ijc.28669e1182278-10 J. STACHURA ET AL.,OADS,/arxiv_data1/oa_pdf/54/04/koni-05-07-1182278.PMC5006909.pdf
"7, e1171446 (11 pages)http://dx.doi.org/10.1080/2162402X.2016.1171446",Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Pharmacol Ther 1994; 64:529-64; PMID:7724661; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Surg Oncol 2006; 15:25-8; PMID:16814541; http://dx.doi.org/10.1016/j.suronc.2006.05.002 3.,OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Nat Rev Cancer 2012; 12:278-87; PMID:22437872; http://dx.doi.org/10.1038/ nrc3236 5.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Semin Thorac Cardiovasc Surg 2004; 16:3-12; PMID:15366682; http://dx.doi.org/10.1053/j.semtcvs.2003.12.002 6.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Recent Prog Horm Res 2004; 59:1-12; PMID:14749494; http://dx.doi.org/10.1210/rp.59.1.1 7.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Adv Exp Med Biol 2014; 804:93-118;PMID:24924170; http://dx.doi.org/10.1007/978-3-319-04843-7_5 8.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Cancer Cell 2014; 25:282-303; PMID:24651011; http://dx.doi.org/10.1016/j.ccr.2014.02.025 9.,OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Lancet Oncol 2014; 15:e58-68;PMID:24480556; http://dx.doi.org/10.1016/S1470-2045(13)70477-7 10.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Bull Cancer 2014; 101:765-71; PMID:25091659; http://dx.doi.org/10.1684/bdc.2014.1940 12.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Curr Clin Pharmacol 2008; 3:51-5; PMID:18690878; http://dx.doi.org/10.2174/157488408783329931 13.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Drug Discov Today 2006; 11:81-8; PMID:16478695; http://dx.doi.org/10.1016/S1359-6446 (05)03638-X 14.,OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
J Clin Oncol 2005; 23:2162-71; PMID:15800309; http://dx.doi.org/10.1200/JCO.2005.01.014 15.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Cancer Chemother Pharmacol 2014; 74:819-29; PMID:25119184; http://dx.doi.org/10.1007/s00280-014-2560-3 16.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Oncology 2001; 61 Suppl 2:31-6; PMID:11694785; http://dx.doi.org/10.1159/000055399 17.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
N Engl J Med 2008; 358:1109-17; PMID:18337601; http://dx.doi.org/10.1056/NEJMoa074943 18.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Cancer Med 2014; 4(1):36-42; PMID:25296628; http://dx.doi.org/10.1002/cam4.333.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Curr AllergyAsthma Rep 2014; 14:453; PMID:24994467; http://dx.doi.org/10.1007/ s11882-014-0453-5 20.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Cancer Immunol Immunother 2012; 61:1575-84; PMID:22576054; http://dx.doi.org/10.1007/s00262-012-1273-x 21.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
"Immunol Allergy Clin North Am 2014; 34:615-32, ix; PMID:25017680; http://dx.doi.org/10.1016/j.iac.2014.04.008 22.",Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Expert Rev Vaccines 2011; 10:1281-9; PMID:21919618; http://dx.doi.org/10.1586/erv.11.105 23.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Breast Cancer Res 2006; 8:201; PMID:16524451; http://dx.doi.org/10.1186/ bcr1368 24.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
J Mol Cell Cardiol 2006; 41:228-35; PMID:16769082; http://dx.doi.org/10.1016/j.yjmcc.2006.04.007 25.,OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation.Am J Physiol Heart Circ Physiol 2012; 302:H2139-47; PMID:22427524; http://dx.doi.org/10.1152/ajpheart.00063.2012 26.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Expert Opin Biol Ther 2009; 9:493-506; PMID:19344285; http://dx.doi.org/10.1517/14712590902870386 27.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Cancer Immunol Immunother 2005; 54:677-84; PMID:15565329; http://dx.doi.org/10.1007/s00262-004-0632-7 28.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
JNatl Cancer Inst 2005; 97:1663-70; PMID:16288119; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Eur J Immunol 2006; 36:1267-74; PMID:16568495; http://dx.doi.org/10.1002/eji.200535279 30.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Clin Cancer Res 2007;13:6501-8; PMID:17975163; http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Immunol Lett 2007; 113:1-5;PMID:17825923; http://dx.doi.org/10.1016/j.imlet.2007.07.008 32.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Cancer Res 2007; 67:3406-11; PMID:17409451; http://dx.doi.org/10.1158/ 0008-5472.CAN-06-3758 33.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
J Immunol 2004; 173:394-401; PMID:15210798; http://dx.doi.org/10.4049/jimmunol.173.1.394 34.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Novel AAV-based genetic vaccines encoding truncated denguevirus envelope proteins elicit humoral immune responses in mice.Microbes Infect 2012; 14:1000-7; PMID:22626929; http://dx.doi.org/ 10.1016/j.micinf.2012.05.002 35.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Vaccine 2011; 29:1690-9; PMID:21195079; http://dx.doi.org/10.1016/j.vaccine.2010.12.03736.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Front Immunol 2014; 5:5; PMID:24478774; http://dx.doi.org/10.3389/ ﬁmmu.2014.00005 37.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Mol Ther 2008; 16:1648-56; PMID:18682697; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Clin Microbiol Rev 2008; 21:583-93; PMID:18854481; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Circ Res 2014; 114:1827-46; PMID:24855205; http://dx.doi.org/10.1161/CIRCRESAHA.114.302331 41.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Front Mol Neurosci 2014; 7:50; PMID:24917785; http://dx.doi.org/10.3389/fnmol.2014.00050 42.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Orthod Craniofac Res 2007; 10:1-14;PMID:17284242; http://dx.doi.org/10.1111/j.1601-6343.2007.00381.x 43.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Hum Gene Ther 2005; 16:408-16; PMID:15871672; http://dx.doi.org/10.1089/hum.2005.16.408 44.,OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Development of AAVLP (HPV16/31L2) particles as broadly protective HPV vaccine candidate.PLoS One 2012; 7:e39741; PMID:22761884; http://dx.doi.org/10.1371/ journal.pone.0039741 45.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Exp Cell Res 2013; 319:1146-55; PMID:23499740; http://dx.doi.org/10.1016/j.yexcr.2013.03.002 46.,OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Onco Immunol 2015; 4:e1005500; PMID:26155401; http://dx.doi.org/10.1080/2162402X.2015.1005500 47.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Onco Immunol 2013; 2:e26403;PMID:24482744; http://dx.doi.org/10.4161/onci.26403 49.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Developments in virus-like particle-based vaccines for HIV.Expert Rev Vaccines 2013; 12:119-27; PMID:23414404; http://dx.doi.org/10.1586/erv.12.152 50.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Cell Rep 2015; S2211-1247(15):00143- 6; PMID:25753415; http://dx.doi.org/10.1016/j.celrep.2015.02.015 51.,OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Melanoma Res 2005; 15:111-7; PMID:15846144;http://dx.doi.org/10.1097/00008390-200504000-00005 52.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
2008; 172:1500-8; PMID:18467709; http://dx.doi.org/10.2353/ ajpath.2008.070776 53.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Exp Eye Res 2006; 82:210-8; PMID:16102751;http://dx.doi.org/10.1016/j.exer.2005.06.010 54.,OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Immunol Cell Biol 2004; 82:488-96; PMID:15479434; http://dx.doi.org/10.1111/j.0818-9641.2004.01272.x 55.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Int Arch Allergy Immunol 2001; 126:135-9; PMID:11729351; http://dx.doi.org/10.1159/000049504 56.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Nat Rev Genet 2011;12:341-55; PMID:21499295; http://dx.doi.org/10.1038/nrg2988 58.,OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Curr Gene Ther 2013; 13:434-52;PMID:24195602; http://dx.doi.org/10.2174/15665232113136660007 59.,OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Hum Gene Ther 2005; 16:401-7; PMID:15871671; http://dx.doi.org/10.1089/hum.2005.16.401 60.,OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Viral Immunol 2014; 27:438- 48; PMID:25247267; http://dx.doi.org/10.1089/vim.2014.0059 61.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Int J Cancer 1999; 81:748-54; PMID:10328228; http://dx.doi.org/10.1002/(SICI) 1097-0215(19990531)81:5 <748::AID-IJC14 >3.0.CO;2-6 64.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Nature 2003; 421:756-60; PMID:12610629; http://dx.doi.org/10.1038/nature01392 65.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Mol Ther 2002; 6:272-8; PMID:12349826; http://dx.doi.org/10.1006/mthe.2002.0659 66.,OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
J Virol 2000; 74:8635-47; PMID:10954565; http://dx.doi.org/10.1128/JVI.74.18.8635-8647.2000 67.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
BMC Infect Dis 2004; 4:33; PMID:15355548; http://dx.doi.org/10.1186/1471-2334-4-33 68.,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
Nucleic Acids Res 1988; 16:10881-90; PMID:2849754; http://dx.doi.org/10.1093/nar/16.22.10881ONCOIMMUNOLOGY e1171446-11,Non-OADS,/arxiv_data1/oa_pdf/66/fd/koni-05-07-1171446.PMC5006910.pdf
"7, e1191732 (10 pages)http://dx.doi.org/10.1080/2162402X.2016.1191732",Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Eur J Surg Oncol 2007; 33:102-8; PMID:17161577; http://dx.doi.org/10.1016/j.ejso.2006.10.032 2.,OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Int J Cancer 2013; 132:385-400; PMID:22532371; http://dx.doi.org/ 10.1002/ijc.27616 3.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
J Clin Oncol 2009; 27:6199-206; PMID:19917835; http://dx.doi.org/10.1200/JCO.2009.23.4799 4.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Ann Oncol 20 Suppl 6:vi30-4; PMID:19617295;http://dx.doi.org/10.1093/annonc/mdp250 5.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Cancer Treat Rev 2003; 29:241-52; PMID:12927565; http://dx.doi.org/10.1016/S0305- 7372(03)00074-4 6.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Lancet Oncol 2015; 16:522-30; PMID:25840693; http://dx.doi.org/10.1016/S1470-2045(15)70122-1 7.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Immunity 2013; 39:38-48; PMID:23890062; http://dx.doi.org/10.1016/j.immuni.2013.07.004 8.,OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Nat Rev Cancer 2012; 12:265-77; PMID:22437871; http://dx.doi.org/ 10.1038/nrc3258 9.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
"Lancet Oncol 2014; 15:e257-67; PMID:24872109; http://dx.doi.org/10.1016/S1470-2045(13)70585-0 10. de Vries IJ, Bernsen MR, Lesterhuis WJ, Scharenborg NM, Strijk SP, Gerritsen MJ, Ruiter DJ, Figdor CG, Punt CJ, Adema GJ.",OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
J Clin Oncol 2005; 23:5779-87; PMID:16110035; http://dx.doi.org/10.1200/JCO.2005.06.478 11.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Nature medicine 2004; 10:475-80;PMID:15122249; http://dx.doi.org/10.1038/nm1039 12.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Clin Cancer Res 2012; 18:5460-70; PMID:22896657; http://dx.doi.org/10.1158/1078-0432.CCR-11-336813.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
"Gajewski TF, Meng Y, Blank C, Brown I, Kacha A, Kline J, Harlin H. Immune resistance orchestrated by the tumor microenvironment.Immunol Rev 2006; 213:131-45; PMID:16972901; http://dx.doi.org/10.1111/j.1600-065X.2006.00442.x 14.",OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Cancer Res 2012; 72:876-86; PMID:22174368; http://dx.doi.org/10.1158/0008-5472.CAN-11-1792 15.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Nat Rev Cancer 2011; 11:805-12; PMID:22020206; http://dx.doi.org/10.1038/nrc3153 16.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Cancer Res 2012; 72:6102-10; PMID:23010076; http://dx.doi.org/10.1158/0008- 5472.CAN-12-2479 17.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Nat Rev Immunol 2002; 2:85-95; PMID:11910899; http://dx.doi.org/10.1038/nri724 18.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Cancer Res 2012; 72:6102- 10; PMID:23010076; http://dx.doi.org/10.1158/0008-5472.CAN-12- 2479 20.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Circ Cardiovasc Qual Outcomes 2011; 4:363-71; PMID:21586725; http://dx.doi.org/10.1161/CIRCOUTCOMES.110.957951 23.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Oncoimmunology 2016; 5:e1057673; PMID:26942068; http://dx.doi.org/10.1080/2162402X.2015.1057673 24.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
JExp Med 1996; 183:1965-71; PMID:8642306; http://dx.doi.org/10.1084/jem.183.5.1965 25.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Int J Cancer 1997; 70:302-9; PMID:9033632; http://dx.doi.org/10.1002/(SICI)1097-0215(19970127)70:3%3c302:: AID-IJC10%3e3.0.CO;2-H 26.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Science 2015; 348:69-74; PMID:25838375; http://dx.doi.org/ 10.1126/science.aaa4971 27.,OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Science 2015; 348:760-1; PMID:25977539; http://dx.doi.org/10.1126/science.aab3465ONCOIMMUNOLOGY e1191732-9,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Cancer Immunol Immunother 2011; 60:249-60; PMID:21069321; http://dx.doi.org/10.1007/s00262-010-0942-x 30.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Cancer Res 2013; 73:19-29;PMID:23087058; http://dx.doi.org/10.1158/0008-5472.CAN-12-1127 32.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Oncoimmunology 2015; 4:e1019197; PMID:26405571; http://dx.doi.org/10.1080/2162402X.2015.1019197 33.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
J Immu- nol Methods 2002; 268:131-40; PMID:12215381; http://dx.doi.org/ 10.1016/S0022-1759(02)00189-834.,OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Methods MolMed 2005; 109:113-26; PMID:15585917; http://dx.doi.org/10.1385/1- 59259-862-5:113 36.,OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Cancer Immu-nol Immunother 2016; 65:327-39; PMID:26861670; http://dx.doi.org/10.1007/s00262-016-1796-7 37.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Cancer Res 2009; 69:2927-34; PMID:19318559; http://dx.doi.org/10.1158/ 0008-5472.CAN-08-3920 38.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
Cancer Immunol Immunother 2012; 61:2003-11; PMID:22527252; http://dx.doi.org/10.1007/s00262-012- 1263-ze1191732-10 S. BOUDEWIJNS ET AL.,Non-OADS,/arxiv_data1/oa_pdf/5e/f5/koni-05-07-1191732.PMC5006921.pdf
"7, e1185582 (9 pages)http://dx.doi.org/10.1080/2162402X.2016.1185582",Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
N Engl J Med 1994; 331:154-60; PMID:8008029; http://dx.doi.org/10.1056/NEJM199407213310303 2.,OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Hematol Oncol Clin North Am 1998; 12:247-58; PMID:9561898;http://dx.doi.org/10.1016/S0889-8588(05)70508-6 4.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Blood 2010; 116:1919-23; PMID:20519626; http://dx.doi.org/10.1182/blood- 2010-04-2790835.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Dev Cell 2010; 18:884-901; PMID:20627072; http://dx.doi.org/10.1016/j.devcel.2010.05.012 7.,OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Plos Med 2007; 4:e253; PMID:17696642; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Nat Med 2008; 14:81-7; PMID:18157139; http://dx.doi.org/10.1038/nm1694 9.,OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Pathology 2015; 47:557-63; PMID:26308130; http://dx.doi.org/10.1097/PAT.0000000000000314 10.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Thyroid 2014; 24:1385-93; PMID:24955518; http://dx.doi.org/10.1089/thy.2014.0134 11.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Blood 2014; 124:1655-8; PMID:24982505; http://dx.doi.org/10.1182/blood-2014-05-577361 12.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Ann N Y Acad Sci2004; 1022:295-305; PMID:15251975; http://dx.doi.org/10.1196/ annals.1318.045 13.,OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Blood 2012; 120:e28-34; PMID:22859608; http://dx.doi.org/10.1182/blood-2012-06-429597 14.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
J Exp Med 2014; 211:669-83; PMID:24638167; http://dx.doi.org/10.1084/jem.20130977 15.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Nature 2002; 417:949-54; PMID:12068308;http://dx.doi.org/10.1038/nature00766 16.,OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
J Exp Med 2006; 203:1651-6; PMID:16801397; http://dx.doi.org/10.1084/jem.20051848 17.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Nat Rev Immunol 2010;10:490-500; PMID:20559327; http://dx.doi.org/10.1038/nri2785 18.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Br J Dermatol 2014; 170:103-9;PMID:24116716; http://dx.doi.org/10.1111/bjd.12641 19.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Proc Natl Acad Sci US A 2002; 99:12293-7; PMID:12218188; http://dx.doi.org/10.1073/ pnas.192461099 20.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Cancer Res 2006; 66:3381-5;PMID:16585157; http://dx.doi.org/10.1158/0008-5472.CAN-05-4303 21.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Tumor-associated B7-H1 pro- motes T-cell apoptosis: a potential mechanism of immune evasion.Nat Med 2002; 8:793-800; PMID:12091876; http://dx.doi.org/10.1038/ nm0902-1039c 22.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Onco- target 2015; 6:19819-25; PMID:26110571; http://dx.doi.org/10.18632/oncotarget.4378 24.,OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Cell Res 2006; 16:3-10; PMID:16467870; http://dx.doi.org/10.1038/sj.cr.7310002 25.,OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
J Exp Med 2011; 208:469-78; PMID:21339327; http://dx.doi.org/ 10.1084/jem.2010187627.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
N Engl J Med 2015; 373:726-36; PMID:26287849; http://dx.doi.org/10.1056/NEJMoa1502309 2 8 .,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
N Engl J Med 2013; 369:134-44; PMID:23724846; http://dx.doi.org/10.1056/NEJMoa1305133 29.,OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
N Engl J Med 2012; 366:2455-65; PMID:22658128; http://dx.doi.org/10.1056/ NEJMoa1200694 30.,OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
BRAF inhibition is asso- ciated with enhanced melanoma antigen expression and a more favor- able tumor microenvironment in patients with metastatic melanoma.Clin Cancer Res 2013; 19:1225-31; PMID:23307859; http://dx.doi.org/10.1158/1078-0432.CCR-12-1630 3 1 .,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
Sci Transl Med 2015; 7:241r-279r; PMID:25787767; http://dx.doi.org/10.1126/scitranslmed.aaa4691 32.,Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
"Azim HJ, Peccatori FA, Brohee S, Branstetter D, Loi S, Viale G, Piccart M, Dougall WC, Pruneri G, Sotiriou C. RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.Breast Cancer Res 2015; 17:24; PMID:25849336; http://dx.doi.org/10.1186/s13058-015-0538-7 33.",Non-OADS,/arxiv_data1/oa_pdf/a6/9d/koni-05-07-1185582.PMC5006923.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
"7, e1196312 (11 pages)http://dx.doi.org/10.1080/2162402X.2016.1196312",Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
N Engl J Med 2015; 372:2521-32; PMID:25891173; http://dx.doi.org/10.1056/NEJMoa1503093 2.,OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Metastasis Rev 2015; 34:115-28; PMID:25589384; http://dx.doi.org/10.1007/s10555-014-9542-0 3.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Immunol Immunother 2013; 62:1137-48; PMID:23666510; http://dx.doi.org/10.1007/s00262-013-1434-6 4.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Nat Med 2012; 18:1254-61; PMID:22842478; http://dx.doi.org/10.1038/ nm.2883 5.,OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Immunol Immunother 2013; 62:1421-30; PMID:23764929; http://dx.doi.org/10.1007/s00262-013-1447-1 6.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Front Immu-nol 2014; 5:147; PMID:24772111; http://dx.doi.org/10.3389/ﬁmmu.2014.00147 7.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Immunol 2012; 189:5147-54; PMID:23100512; http://dx.doi.org/ 10.4049/jimmunol.1200274 8.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Immunol Immunother 2014; 63:247-57; PMID:24357148; http://dx.doi.org/10.1007/s00262-013-1508-5 9.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
PLoSOne 2012; 7:e40677; PMID:22815789; http://dx.doi.org/10.1371/jour- nal.pone.0040677 10.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Immunol Immunother 2009; 58:941-53; PMID:18979098;http://dx.doi.org/10.1007/s00262-008-0609-z 11.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Nat Biotechnol 2007; 25:911-20; PMID:17664940; http://dx.doi.org/10.1038/nbt1323 12.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Nat Rev Immunol 2012; 12:253-68; PMID:22437938; http://dx.doi.org/10.1038/nri3175 13.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Nat Rev Immunol 2009; 9:162-74; PMID:19197294; http://dx.doi.org/10.1038/nri2506 14.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Immunol 2008; 181:5791-802; PMID:18832739; http://dx.doi.org/10.4049/ jimmunol.181.8.5791 15.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
AnnN Y Acad Sci 2014; 1319:47-65; PMID:24965257; http://dx.doi.org/ 10.1111/nyas.12469 16.,OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Immunol Res 2014; 2014:659294; PMID:25436215; http://dx.doi.org/10.1155/2014/659294 18.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Immu- nol 2007; 179:977-83; PMID:17617589; http://dx.doi.org/10.4049/jimmunol.179.2.977 20.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Nat Immunol 2012; 13:843-50;PMID:22863752; http://dx.doi.org/10.1038/ni.2388 21.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Res 2010; 70:68- 77; PMID:20028852; http://dx.doi.org/10.1158/0008-5472.CAN-09-2587 23.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Immunol 2002; 168:689-95; PMID:11777962; http://dx.doi.org/10.4049/jimmunol.168.2.689 24.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Nat Med 2007; 13:828-35; PMID:17603493; http://dx.doi.org/10.1038/nm1609 26.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Exp Med 2011; 208:1949-62; PMID:21930770; http://dx.doi.org/10.1084/ jem.20101956 27.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Gastroenterology 2008; 135:234-43; PMID:18485901; http://dx.doi.org/10.1053/j.gastro.2008.03.020 28.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Res 2008; 68:5439-49; PMID:18593947;http://dx.doi.org/10.1158/0008-5472.CAN-07-6621 29.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Res 2006; 66:1123-31; PMID:16424049; http://dx.doi.org/10.1158/0008-5472.CAN-05-1299 30.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Annu Rev Med 2015; 66:311-28; PMID:25587654; http://dx.doi.org/10.1146/annurev-med-051113- 024537 31.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Trends Immunol 2011; 32:19-25; PMID:21067974; http://dx.doi.org/10.1016/ j.it.2010.10.002 32.,OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Immunol 2009; 182:5693-701; PMID:19380816;http://dx.doi.org/10.4049/jimmunol.0900092 33.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J ClinInvest 2013; 123:1580-9; PMID:23454751; http://dx.doi.org/10.1172/ JCI60083 34.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Exp Med 2008; 205:2235-49;PMID:18809714; http://dx.doi.org/10.1084/jem.20080132 35.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Clin Invest 2013;123:4595-611; PMID:24216507; http://dx.doi.org/10.1172/JCI67580 36.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Biol Chem 2013; 288:11676-88; PMID:23486482; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Blood 2008; 111:4233-44; PMID:18272812; http://dx.doi.org/10.1182/blood-2007-07-099226 38.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Clin Invest 2013;123:4464-78; PMID:24091328; http://dx.doi.org/10.1172/JCI68189 39.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin.Ann Surg 2010; 251:120-6; PMID:20032720; http://dx.doi.org/ 10.1097/SLA.0b013e3181bfda1c 40.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Immunol 2005; 174:636-45; PMID:15634881; http://dx.do i.org/10.4049/jimmunol.174.2.636 41.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Res 2012; 72:1373-83; PMID:22282665; http://dx.doi.org/10.1158/0008-5472.CAN-11-2772 42.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
ClinCancer Res 2014; 20:2831-7; PMID:24879823; http://dx.doi.org/ 10.1158/1078-0432.CCR-13-3141 43.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Int J Cancer 2013; 133:1653-63; PMID:23526263; http://dx.doi.org/10.1002/ijc.28168 44.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Curr Oncol Rep 2011; 13:103-11; PMID:21318618; http://dx.doi.org/10.1007/s11912-011-0154-3 46.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Lab Invest 2011; 91:598-608; PMID:21321535; http://dx.doi.org/10.1038/labinvest.2010.205 49.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Int Immunopharmacol 2011; 11:856-61; PMID:21315783; http://dx.doi.org/10.1016/j.intimp.2011.01.030 51.,OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Res 2010; 70:3526-36; PMID:20406969; http://dx.doi.org/10.1158/0008-5472.CAN-09-3278 52.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Mol Cancer 2013; 12:17; PMID:23497256; http://dx.doi.org/10.1186/1476- 4598-12-17 53.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Can- cer Immunol Immunother 2008; 57:1115-24; PMID:18193223; http://dx.doi.org/10.1007/s00262-007-0441-x 54.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Can-cer Immunol Immunother 2013; 62:225-36; PMID:22864396; http://dx.doi.org/10.1007/s00262-012-1324-3 55.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Immunol Res 2013; 1:158-62; PMID:24777678; http://dx.doi.org/10.1158/2326-6066.CIR-13-0016 57.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
PLoS One 2014; 9:e87705; PMID:24498358; http://dx.doi.org/10.1371/ journal.pone.0087705 58.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Exp Med 2006; 203:2691-702; PMID:17101732;http://dx.doi.org/10.1084/jem.20061104 60.,OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Proc Natl Acad Sci U S A 2011; 108:17111-6; PMID:21969559; http://dx.doi.org/ 10.1073/pnas.1108121108 61.,OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
"Weed DT, Vella JL, Reis IM, De la Fuente AC, Gomez C, Sargi Z, Naz- arian R, Califano J, Borrello I, Sera ﬁni P. Tadala ﬁl reduces myeloid- derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma.Clin Cancer Res 2015; 21:39-48; PMID:25320361; http://dx.doi.org/ 10.1158/1078-0432.CCR-14-1711 62.",Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Clin Cancer Res 2015; 21:30-8; PMID:25564570; http://dx.doi.org/10.1158/1078-0432.CCR-14-1716 63.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Immunol Res 2014; 2:725-31; PMID:24878583; http://dx.doi.org/10.1158/2326-6066.CIR-13-0213 64.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Am J Physiol Regul Integr Comp Physiol 2013; 304:R473-87; PMID:23389111; http://dx.doi.org/10.1152/ajpregu.00355.2012 65.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Blood 2011; 118:5498-505; PMID:21972293; http://dx.doi.org/10.1182/blood-2011-07-365825 66.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Clin Invest 2010; 120:457-71;PMID:20093776; http://dx.doi.org/10.1172/JCI40483DS1 67.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Int Immunopharmacol 2011;11:890-8; PMID:21244860; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Immunol Immunother 2010; 59:697-706; PMID:19882154; http://dx.doi.org/ 10.1007/s00262-009-0786-4 69.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Int J Cancer2012; 131:741-51; PMID:21898392; http://dx.doi.org/10.1002/ijc.26411 70.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
ClinCancer Res 2008; 14:8270-8; PMID:19088044; http://dx.doi.org/ 10.1158/1078-0432.CCR-08-0165 71.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Immunol Immunother 2013; 62:909-18;PMID:23589106; http://dx.doi.org/10.1007/s00262-013-1396-8 72.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Res 2007; 67:11021-8;PMID:18006848; http://dx.doi.org/10.1158/0008-5472.CAN-07-2593 73.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
JImmunotoxicol 2012; 9:292-300; PMID:22283566; http://dx.doi.org/ 10.3109/1547691X.2011.642418 74.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cell Immunol 2010; 263:79-87; PMID:20346445; http://dx.doi.org/10.1016/j.cellimm.2010.03.001 75.,OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Immu- nol 2013; 190:2464-71; PMID:23359505; http://dx.doi.org/10.4049/jimmunol.1202781 76.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Clin Cancer Res2010; 16:4583-94; PMID:20702612; http://dx.doi.org/10.1158/1078- 0432.CCR-10-0733 77.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Res 2005; 65:9525-35;PMID:16230418; http://dx.doi.org/10.1158/0008-5472.CAN-05-0529 78.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Biother Radiopharm 2012; 27:495-503;PMID:22746287; http://dx.doi.org/10.1089/cbr.2012.1219 79.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Immu- nity 2016; 44:303-15; PMID:26885857; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Prev Res (Phila) 2012; 5:205-15;PMID:22030090; http://dx.doi.org/10.1158/1940-6207.CAPR-11-0247 81.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Int J Immunophar- macol 1999; 21:675-88; PMID:12609462; http://dx.doi.org/10.1016/ S0192-0561(99)00044-2 82.,OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Otolaryngol Head Neck Surg 2009; 140:235-40; PMID:19201295; http://dx.doi.org/10.1016/j.otohns.2008.11.011 83.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Hum Immunol 2010; 71:659-65; PMID:20438786; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
J Clin Oncol 2015; 33:910-5; PMID:25624439; http://dx.doi.org/10.1200/JCO.2014.57.9334e1196312-10 N. DE HAAS ET AL.,OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Cancer Treat Rev 2014; 40:872-82;PMID:24830939; http://dx.doi.org/10.1016/j.ctrv.2014.04.004 86.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Toxins (Basel) 2014; 6:914-33; PMID:24594636; http://dx.doi.org/10.3390/ toxins603091487.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
Arthritis Rheumatol 2015;67:893-902; PMID:25545152; http://dx.doi.org/10.1002/art.39007 88.,Non-OADS,/arxiv_data1/oa_pdf/7c/20/koni-05-07-1196312.PMC5006927.pdf
"7, e1149667 (11 pages)http://dx.doi.org/10.1080/2162402X.2016.1149667",Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Cancer Res 2007; 67:1883-6; PMID:17332313; http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Expert Opin Biol Ther 2013; 13:517-26; PMID:23289642; http://dx.doi.org/10.1517/14712598.2013.751971 4.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
J Gastroenterol Hepatol 2012; 27:39-50; PMID:22188027; http://dx.doi.org/10.1111/j.1440-1746.2011.06883.x 5.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
N Eng JMed 2000; 342:69-77; PMID:10631274; http://dx.doi.org/10.1056/ NEJM200001133420201 6.,OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Onco Immunol 2015; 4:e976052; PMID:25949894; http://dx.doi.org/10.4161/2162402X.2014.976052 7.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
"Gut 2001; 48:360-6; PMID:11171826; http://dx.doi.org/10.1136/gut.48.3.360 8 .L eD T ,U r a mJ N ,W a n gH ,B a r t l e t tB R ,K e m b e r l i n gH ,E y r i n g A D ,S k o r aA D ,L u b e rB S ,A z a dN S ,L a h e r uDe ta l .P D - 1B l o c k - ade in Tumors with Mismatch-Repair De ﬁciency.",Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
N Eng J Med 2015; 372:2509-20; PMID:26028255; http://dx.doi.org/10.1056/ NEJMoa1500596 9.,OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Am J Pathol 2001; 158:1289-99; PMID:11290547; http://dx.doi.org/10.1016/S0002-9440(10)64080-1 10.,OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Nature Rev Cancer 2008; 8:523-34; PMID:18574464; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Int J Biochem Cell Biol 2005; 37:1254-68; PMID:15778089; http://dx.doi.org/10.1016/j.biocel.2004.12.011 12.,OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Curr Opin Cell Biol 2004; 16:343-9; PMID:15261665; http://dx.doi.org/10.1016/j.ceb.2004.06.012 13.,OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Biochim Biophys Acta 2012; 1826:13-22; PMID:22426159; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Int J Biochem Cell Biol 2007; 39:2076-82; PMID:17689130; http://dx.doi.org/10.1016/j.biocel.2007.05.022 16.,OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Adv Genet 2010; 69:97-114; PMID:20807604; http://dx.doi.org/10.1016/S0065-2660(10)69006-2 19.,OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Cancer Res 2011; 71:7029-37; PMID:21948968; http://dx.doi.org/10.1158/0008-5472.CAN-11-1015 20.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Int Immunol 2005; 17:133-44; PMID:15611321; http://dx.doi.org/10.1093/intimm/dxh194 23.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
"Clin TranslationalImmunol 2015 4, e30; PMID:25671128; http://dx.doi.org/10.1038/ cti.2014.29 24.",Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Oncoimmunol2013; 2:e23901; PMID:23762789; http://dx.doi.org/10.4161/onci.23901 25.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
The evolving paradigm of cell- nonautonomous UPR-based regulation of immunity by cancer cells.Oncogene 2016; 35:269-78; PMID:25893303; http://dx.doi.org/10.1038/onc.2015.108 26.,OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
"BiP, an anti-in ﬂammatory ER protein, is a potential new therapy for the treatment of rheumatoid arthritis.Novartis Found Symp 2008; 291:212-6; discussion 6 –24; PMID:18575276; http://dx.doi.org/10.1002/9780470754030.ch16 27.",Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Immunol 2009; 128:218-26; PMID:19740378; http://dx.doi.org/ 10.1111/j.1365-2567.2009.03103.x 28.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Nature Rev Cancer 2015; 15:686-94; PMID:26493648; http://dx.doi.org/10.1038/nrc4018 29.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Oncogene 2013; 32:805-18; PMID:22508478; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
J Natl Cancer Inst 2004; 96:1300-10; PMID:15339968; http://dx.doi.org/10.1093/jnci/djh243 31.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Clin CancerRes 2013; 19:2107-16; PMID:23470966; http://dx.doi.org/10.1158/1078-0432.CCR-12-2991 32.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Cancer Immunol Immunother 2008; 57:1635-45; PMID:18386000; http://dx.doi.org/10.1007/s00262-008-0497-2 33.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Immuno-Gastroenterol 2012; 1:108-18; http://dx.doi.org/10.7178/ig.19 34.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Hum Pathol 2004; 35:808-16; PMID:15257543; http://dx.doi.org/10.1016/j.humpath.2004.01.022 35.,OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Cancer Res 2014; 74:3238-47; PMID:24755471; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
Cancer Res 2012; 72:1651- 60; PMID:22315352; http://dx.doi.org/10.1158/0008-5472.CAN-11-2788ONCOIMMUNOLOGY e1149667-11,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/koni-05-07-1149667.PMC5006930.pdf
"7, e1164918 (13 pages)http://dx.doi.org/10.1080/2162402X.2016.1164918",Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Science 2002; 296:1655-7; PMID:12040186; http://dx.doi.org/10.1126/science.296.5573.1655 2.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Immunol 2008; 180:4218-26; PMID:18322234; http://dx.doi.org/10.4049/jimmunol.180.6.4218 3.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Leukoc Biol 2010; 88:1259-69; PMID:20884649; http://dx.doi.org/10.1189/jlb.0110001 4.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Immunol 2010; 185:468-76;PMID:20505137; http://dx.doi.org/10.4049/jimmunol.0902221 5.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Immunol 2014; 192:5343-53; PMID:24771857; http://dx.doi.org/10.4049/jimmunol.14002806.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Nature 2014;510:402-6; PMID:24805236; http://dx.doi.org/10.1038/nature13239 7.,OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Immunity 2008; 29:565-77; PMID:18848473; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Immunol 2015; PMID:26246144; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Blood 2013; 121(18):3619-30; PMID:23444404; http://dx.doi.org/10.1182/blood-2012- 08-448290 12.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Exp Med 2014; 211:781-90; PMID:24778419; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Immunity 2014; 40:642-56; PMID:24837101; http://dx.doi.org/ 10.1016/j.immuni.2014.04.016 15.,OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Methods Mol Biol2015; 1267:145-64; PMID:25636468; http://dx.doi.org/10.1007/978-1- 4939-2297-0_7 16.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Nucleic Acids Res 2009; 37:e45; PMID:19237396; http://dx.doi.org/10.1093/nar/gkp045 17.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Nat Protoc 2009; 4:44-57; PMID:19131956; http://dx.doi.org/10.1038/ nprot.2008.211 18.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Nat Immunol 2001; 2 (3):261-8; PMID:11224527; http://dx.doi.org/10.1038/85330 20.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Exp Med 2008; 205:2839-50;PMID:18981237; http://dx.doi.org/10.1084/jem.20081430 21.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
ClinExp Immunol 2011; 164:417-27; PMID:21413942; http://dx.doi.org/10.1111/j.1365-2249.2011.04374.x 22.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Science 2008; 322(5904):1097-100; PMID:19008445; http://dx.doi.org/10.1126/science.1164206 23.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Immunol Methods 2013; 389:29-37;PMID:23279944; http://dx.doi.org/10.1016/j.jim.2012.12.006 24.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Immunol Methods 2003; 281:65-78; PMID:14580882; http://dx.doi.org/10.1016/ S0022-1759(03)00265-5 25.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Immunol Methods 2004; 294:15-22; PMID:15604012; http://dx.doi.org/10.1016/j.jim.2004.08.008 26.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
MolImmunol 2008; 45:2790-6; PMID:18339426; http://dx.doi.org/ 10.1016/j.molimm.2008.02.001 27.,OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Immunol2014; 193:1717-27; PMID:25015834; http://dx.doi.org/10.4049/jimmunol.1302167 28.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Arthritis Res Ther 2015; 17:230; PMID:26307404; http://dx.doi.org/10.1186/s13075-015-0742-y 29.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Exp Med 2003; 197:657-67; PMID:12615906; http://dx.doi.org/10.1084/jem.20021101 31.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Nat Rev Immunol 2015; 15:599-614; PMID:26403194; http://dx.doi.org/10.1038/nri3901 32.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Biomed Biotechnol 2012; 2012:718617; PMID:22665990;http://dx.doi.org/10.1155/2012/718617 34.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Cancer Res 2013; 73:7199-210;PMID:24165160; http://dx.doi.org/10.1158/0008-5472.CAN-13-0827 35.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Nature 2013;494:116-20; PMID:23334413; http://dx.doi.org/10.1038/nature11809 36.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Pediatr Gas- troenterol Hepatol Nutr 2013; 16:17-21; PMID:24010101; http://dx.doi.org/10.5223/pghn.2013.16.1.17 37.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Mol Syst Biol 2014; 10:766;PMID:25432777; http://dx.doi.org/10.15252/msb.20145645 38.,OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Exp Med 2002; 196:1099- 104; PMID:12391021; http://dx.doi.org/10.1084/jem.20020861 39.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Nat Rev Immunol 2013; 13:566-77; PMID:23827956; http://dx.doi.org/10.1038/nri3477 40.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Immunol Rev 2010; 234(1):18-31; PMID:20193009; http://dx.doi.org/10.1111/ j.0105-2896.2009.00870.x 41.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Annu Rev Immunol 2015; 33:445-74; PMID:25622193; http://dx.doi.org/10.1146/annurev-immunol-032414-112043 42.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Exp Med 2002; 196:1091-7; PMID:12391020; http://dx.doi.org/10.1084/jem.20021215 4 3 .,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Leukoc Biol 2009; 86:557-66; PMID:19451397; http://dx.doi.org/10.1189/jlb.1008647 46.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
J Exp Med 2008; 205:2235-49; PMID:18809714; http://dx.doi.org/10.1084/jem.20080132 47.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Immunology 1999; 97:159-65; PMID:10447727; http://dx.doi.org/10.1046/j.1365-2567.1999.00738.x 50.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Stem Cells 1994; 12:456-65; PMID:7804122; http://dx.doi.org/ 10.1002/stem.5530120502 51.,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Arch Surg 1988; 123:462-4; PMID:3348737; http://dx.doi.org/10.1001/ archsurg.1988.01400280072012 54.,OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
Haematologica 2014; 99:392- 8; PMID:24056815; http://dx.doi.org/10.3324/haematol.2013.092460ONCOIMMUNOLOGY e1164918-13,Non-OADS,/arxiv_data1/oa_pdf/1c/c9/koni-05-07-1164918.PMC5006931.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/de/euv397.PMC5006960.pdf
The full-length version of this report can be viewed at: http://www.escardio.org/Guidelines-&-E ducation/E-learnin g/Clinical-cases/ Electrophysiology/EP-Case-Reports .,Non-OADS,/arxiv_data1/oa_pdf/da/de/euv397.PMC5006960.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/7a/euv436.PMC5006961.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/b1/euw073.PMC5006962.pdf
All the analyses were perfo rmed using R (www.r-project.org).SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/8/e1600800/DC1table S1.,OADS,/arxiv_data1/oa_pdf/36/96/1600800.PMC5007069.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/8/e1600691/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/19/bc/1600691.PMC5007071.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/8/e1600902/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/5b/23/1600902.PMC5007072.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e4/08/2633.PMC5007084.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b0/a7/2642.PMC5007085.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/00/82/2653.PMC5007086.pdf
Two months after publication  it is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/63/c2/2662.PMC5007087.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/48/b7/2675.PMC5007088.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/53/bf/2688.PMC5007089.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/98/85/2697.PMC5007090.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/48/a6/2708.PMC5007091.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/24/4e/2726.PMC5007092.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/68/26/2735.PMC5007093.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f9/ec/2742.PMC5007094.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/66/ca/2757.PMC5007095.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f1/01/2784.PMC5007097.pdf
"As the aging population continues to grow, so, too, does the  number of individuals with AMD, thus presenting a large Molecular Vision  2016; 22:1062-1076 <http://www.molvis.org/molvis/v 22/1062 > Received 31 March 2016 | Accepted 27 August 2016 | Published 29 August 2016© 2016 Molecular Vision 1062Whole exome sequencing of extreme age-related macular  degeneration phenotypes Rebecca J. Sardell,1 Jessica N Cooke Bailey,2 Monique D. Courtenay,1 Patrice Whitehead,1 Reneé A. Laux,2  Larry D. Adams,1 Jorge A. Fortun,3 Milam A. Brantley Jr.,4 Jaclyn L. Kovach,3 Stephen G. Schwartz,3 Anita  Agarwal,4 William K. Scott,1 Jonathan L. Haines,2 Margaret A. Pericak-Vance1 1John P .",Non-OADS,/arxiv_data1/oa_pdf/e2/03/mv-v22-1062.PMC5007100.pdf
Molecular Vision  2016; 22:1062-1076 <http://www.molvis.org/molvis/v 22/1062 > © 2016 Molecular Vision  1063population of individuals with a disease for which treatment  options are limited.,Non-OADS,/arxiv_data1/oa_pdf/e2/03/mv-v22-1062.PMC5007100.pdf
Molecular Vision  2016; 22:1062-1076 <http://www.molvis.org/molvis/v 22/1062 > © 2016 Molecular Vision  1064via venipuncture and DNA extraction was extracted from  whole blood using the Pure Gene method and standard  protocols [ 48] and frozen at –80 ºC until use.,Non-OADS,/arxiv_data1/oa_pdf/e2/03/mv-v22-1062.PMC5007100.pdf
"Molecular Vision  2016; 22:1062-1076 <http://www.molvis.org/molvis/v 22/1062 > © 2016 Molecular Vision  1065Santa Clara, CA).",Non-OADS,/arxiv_data1/oa_pdf/e2/03/mv-v22-1062.PMC5007100.pdf
Molecular Vision  2016; 22:1062-1076 <http://www.molvis.org/molvis/v 22/1062 > © 2016 Molecular Vision  1066these rare or novel positions were predicted to be damaging  missense or stop or splice variant sites.,Non-OADS,/arxiv_data1/oa_pdf/e2/03/mv-v22-1062.PMC5007100.pdf
Molecular Vision  2016; 22:1062-1076 <http://www.molvis.org/molvis/v 22/1062 > © 2016 Molecular Vision  1067Table  2.,Non-OADS,/arxiv_data1/oa_pdf/e2/03/mv-v22-1062.PMC5007100.pdf
Molecular Vision  2016; 22:1062-1076 <http://www.molvis.org/molvis/v 22/1062 > © 2016 Molecular Vision  1068Table  3.,Non-OADS,/arxiv_data1/oa_pdf/e2/03/mv-v22-1062.PMC5007100.pdf
"Molecular Vision  2016; 22:1062-1076 <http://www.molvis.org/molvis/v 22/1062 > © 2016 Molecular Vision  1069damaging exonic SNVs, occurring in nine cases but in  only two controls (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/e2/03/mv-v22-1062.PMC5007100.pdf
"Molecular Vision  2016; 22:1062-1076 <http://www.molvis.org/molvis/v 22/1062 > © 2016 Molecular Vision  1070via inflammation through the protein’s role in regulating the  complement pathways [ 34,64], while ABCA1 is associated  with removal of cellular lipids and ACAD10 with fatty-acid  oxidation.",Non-OADS,/arxiv_data1/oa_pdf/e2/03/mv-v22-1062.PMC5007100.pdf
Molecular Vision  2016; 22:1062-1076 <http://www.molvis.org/molvis/v 22/1062 > © 2016 Molecular Vision  1071correction for multiple tests: ASRGL1  and BSDC1 .,Non-OADS,/arxiv_data1/oa_pdf/e2/03/mv-v22-1062.PMC5007100.pdf
Molecular Vision  2016; 22:1062-1076 <http://www.molvis.org/molvis/v 22/1062 > © 2016 Molecular Vision  1072APPENDIX 4.,Non-OADS,/arxiv_data1/oa_pdf/e2/03/mv-v22-1062.PMC5007100.pdf
Molecular Vision  2016; 22:1062-1076 <http://www.molvis.org/molvis/v 22/1062 > © 2016 Molecular Vision  1073Complement factor H polymorphism in age-related macular  degeneration.,Non-OADS,/arxiv_data1/oa_pdf/e2/03/mv-v22-1062.PMC5007100.pdf
"Molecular Vision  2016; 22:1062-1076 <http://www.molvis.org/molvis/v 22/1062 > © 2016 Molecular Vision  1074H, Ortmann W, Behrens TW, Stefansson K, Uitterlinden  AG, van Duijn CM, Vingerling JR, Klaver CC, Allikmets R,  Brantley MA Jr, Baird PN, Katsanis N, Thorsteinsdottir U,  Ioannidis JP, Daly MJ, Graham RR, Seddon JM.",Non-OADS,/arxiv_data1/oa_pdf/e2/03/mv-v22-1062.PMC5007100.pdf
Molecular Vision  2016; 22:1062-1076 <http://www.molvis.org/molvis/v 22/1062 > © 2016 Molecular Vision  107549.,Non-OADS,/arxiv_data1/oa_pdf/e2/03/mv-v22-1062.PMC5007100.pdf
Molecular Vision  2016; 22:1062-1076 <http://www.molvis.org/molvis/v 22/1062 > © 2016 Molecular Vision  107672.,Non-OADS,/arxiv_data1/oa_pdf/e2/03/mv-v22-1062.PMC5007100.pdf
"Geneva, World Health Organization, 2014. http://apps.who.int/ medicinedocs/documents/s21535en/s21535en.pdf 6 Bonnet M, Bastard M, du Cros P, et al.",Non-OADS,/arxiv_data1/oa_pdf/50/6d/ERJ-00704-2016.PMC5007218.pdf
"@ERSpublications Guidelines specifically addressing adolescent tuberculosis are needed for uniform and evidence- based management http://ow.ly/BMm63015LcY Nick Blok1, Martin van den Boom2, Connie Erkens1, Masoud Dara2and Susan van den Hof1,3 1KNCV Tuberculosis Foundation, The Hague, The Netherlands.2World Health Organization, WHO Regional Office for Europe, Copenhagen, Denmark.3Dept of Global Health, Academic Medical Center, and Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/50/6d/ERJ-00704-2016.PMC5007218.pdf
http://data.worldbank.org/about/country-and-lending-groups#Lower_ middle_income Date last updated: 2015.,Non-OADS,/arxiv_data1/oa_pdf/50/6d/ERJ-00704-2016.PMC5007218.pdf
"@ERSpublications First experience and challenges of compassionate use of new anti-TB drugs to treat MDR- and XDR-TB in children http://ow.ly/SWXF300a0UX Marina Tadolini1,21, Anthony J. Garcia-Prats2,21, Lia D ’Ambrosio3,4,21, Catherine Hewison5,21, Rosella Centis3,21, H. Simon Schaaf2,21, Ben J. Marais6, Hannetjie Ferreira7, Jose A. Caminero8,9, Sylvie Jonckheere10, Animesh Sinha11, Krzysztof Herboczek12, Zarema Khaidarkhanova13, Armen Hayrapetyan14, Naira Khachatryan15, Ia Urtkmelidze16, Carolina Loreti17, Susanna Esposito18, Alberto Matteelli19, Jennifer Furin20, Francis Varaine5and Giovanni Battista Migliori3 1Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.2Desmond Tutu TB Centre, Dept of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.3Fondazione S. Maugeri, IRCCS, Tradate, Italy.4Public Health Consulting Group, Lugano, Switzerland.5Médecins Sans Frontières, Paris, France.6Children ’s Hospital at Westmead and the Centre for Research Excellence in Tuberculosis, University of Sydney, Sydney, Australia.7MDR/XDR TB Unit, Tshepong Hospital Klerksdorp, Klerksdorp, South Africa.8MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France.9Pneumology Dept, Hospital General de Gran Canaria “Dr Negrin ”, Las Palmas de Gran Canaria, Spain.10Médecins Sans Frontières, Mumbai, India.11Médecins Sans Frontières, Moscow, Russian Federation.12Médecins Sans Frontières, London, UK.13Republican TB Dispensary, Grozny, Chechen Republic, Russian Federation.14Armenian National Tuberculosis Control Centre, Yerevan, Armenia.15Médecins Sans Frontières, Yerevan, Armenia.16National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.17Médecins Sans Frontières, Tbilisi, Georgia.18Paediatric Highly Intensive Care Unit, Dept of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca ’Granda Ospedale Maggiore Policlinico, Milan, Italy.19University Dept of Infectious and Tropical Diseases, University of Brescia and Brescia Spedali Civili General Hospital, Brescia, Italy.",Non-OADS,/arxiv_data1/oa_pdf/83/c2/ERJ-00705-2016.PMC5007219.pdf
"Geneva, World Health Organization, 2014. http://apps.who.int/ medicinedocs/documents/s21535en/s21535en.pdf 6 Bonnet M, Bastard M, du Cros P, et al.",Non-OADS,/arxiv_data1/oa_pdf/83/c2/ERJ-00705-2016.PMC5007219.pdf
"@ERSpublications Report of the first case, concerns and challenges of treatment of severe XDR-TB with both delamanid and bedaquiline http://ow.ly/WzeB3004Cmo Marina Tadolini1,7, Rangjung Dolma Lingtsang2,7,S i m o nT i b e r i3,7, Martin Enwerem4,7,L i aD ’Ambrosio5,6,7, Tsetan Dorji Sadutshang2,R o s e l l aC e n t i s5and Giovanni Battista Migliori5 1Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.2Delek Hospital, Dharamshala, India.3Division of Infection, Barts Health NHS Trust, London, UK.4Amity Health Consortium, Johannesburg, South Africa.5Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy.",Non-OADS,/arxiv_data1/oa_pdf/48/31/ERJ-00637-2016.PMC5007220.pdf
@ERSpublications #ICHOM Lung Cancer Standard Set of patient-centred outcomes: aligning global efforts to improve lung cancer care http://ow.ly/bFDR300EhY7 Copyright ©ERS 2016.,Non-OADS,/arxiv_data1/oa_pdf/bf/c6/ERJ-02049-2015.PMC5007221.pdf
"GLOBOCAN 2012: Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx Date last accessed: October 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/bf/c6/ERJ-02049-2015.PMC5007221.pdf
"https://cdn.movember.com/uploads/files/Funded Programs/Movember_Foundation_Prostate_Cancer_Outcomes_Info_Sheet.pdf Date last accessed: April 19, 2016.",Non-OADS,/arxiv_data1/oa_pdf/bf/c6/ERJ-02049-2015.PMC5007221.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all no n-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 32308 - http://dx.doi.org/10.3402/iee.v6.32308 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/15/57/IEE-6-32308.PMC5007245.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32308 - http://dx.doi.org/10.3402/iee.v6.32308",Non-OADS,/arxiv_data1/oa_pdf/15/57/IEE-6-32308.PMC5007245.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2016, 11: 31673 - http://dx.doi.org/10.3402/ljm.v11.31673 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/88/c3/LJM-11-31673.PMC5007247.pdf
"2 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 31673 - http://dx.doi.org/10.3402/ljm.v11.31673",Non-OADS,/arxiv_data1/oa_pdf/88/c3/LJM-11-31673.PMC5007247.pdf
"In addition, increased serum BNP levels were significantlyassociated with mean transcutaneous oxygen saturation(SpO 2)(pB0.0001), minimal SpO 2(p/C300.002), ODI ( p/C30 0.001), and total sleep time with SpO 2B90% (TST90) (p/C300.002) (Table 2).Serum BNP level change under nasal CPAP Citation: Libyan Journal of Medicine 2016, 11: 31673 - http://dx.doi.org/10.3402/ljm.v11.31673 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/88/c3/LJM-11-31673.PMC5007247.pdf
"4 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 31673 - http://dx.doi.org/10.3402/ljm.v11.31673",Non-OADS,/arxiv_data1/oa_pdf/88/c3/LJM-11-31673.PMC5007247.pdf
"Bold values indicate statistically significant difference.Serum BNP level change under nasal CPAP Citation: Libyan Journal of Medicine 2016, 11: 31673 - http://dx.doi.org/10.3402/ljm.v11.31673 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/88/c3/LJM-11-31673.PMC5007247.pdf
"6 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 31673 - http://dx.doi.org/10.3402/ljm.v11.31673",Non-OADS,/arxiv_data1/oa_pdf/88/c3/LJM-11-31673.PMC5007247.pdf
"BNP, brain natriuretic peptide; CPAP , continuous positive airway pressure.Serum BNP level change under nasal CPAP Citation: Libyan Journal of Medicine 2016, 11: 31673 - http://dx.doi.org/10.3402/ljm.v11.31673 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/88/c3/LJM-11-31673.PMC5007247.pdf
"8 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 31673 - http://dx.doi.org/10.3402/ljm.v11.31673",Non-OADS,/arxiv_data1/oa_pdf/88/c3/LJM-11-31673.PMC5007247.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ),whichpermitsnon-commercialre-use,distribution,andreproductioninanymedium,pro- vided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/de/fuw020.PMC5007285.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/4d/main.PMC5007293.pdf
http://dx.doi.org/10.1016/j.idcr.2016.07.009 2214-2509/ ã2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/03/4d/main.PMC5007293.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases 5 (2016) 49 –53 Contents lists available at ScienceDirect IDCases journal homepage: www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/03/4d/main.PMC5007293.pdf
"In addition, this mutation is not reported in 60,706 subjects in ExAC(http://exac.broadinstitute.org/) or in 2,535 subjects in 1000 Genomes Browser (http://www.1000genomes.org/1000-genomes- browsers).",Non-OADS,/arxiv_data1/oa_pdf/84/ec/hgv201627.PMC5007383.pdf
"Again,this mutation is not reported in 60,706 subjects in ExAC(http://exac.broadinstitute.org/) or in 2,535 subjects in 1000 Genomes Browser (http://www.1000genomes.org/1000-genomes- browsers).",Non-OADS,/arxiv_data1/oa_pdf/84/ec/hgv201627.PMC5007383.pdf
"To predict the effect of the mutation on splicing, weused three splice prediction programs, GenScan (http://genes.mit.edu/GENSCAN.html), Human Splicing Finder (http://www.umd.be/HSF/), and Net2Gene (http://www.cbs.dtu.dk/services/NetGene2/).These three programs predicted that the c.349+1G 4A variant would disrupt the splice donor site of exon 2.",Non-OADS,/arxiv_data1/oa_pdf/84/ec/hgv201627.PMC5007383.pdf
"These data suggest that these small repeatsmay have mediated the 4-bp deletions, but this hypothesis remains to be validated in future studies of more small deletions.In addition, using Tandem Repeat Finder (https://tandem.bu.edu/ trf/trf.html), we found in exon 3 a consensus sequence of ~ 34 bp (5′-AGGCCGAGACCCAGCGGTCTTCAATAGAAGTCCGGG-3 ′) that is repeated four times (three times over its full length and one timeover the ﬁrst 19 bp) (Figure 4a).",Non-OADS,/arxiv_data1/oa_pdf/84/ec/hgv201627.PMC5007383.pdf
"( a) Distribution of inverted, direct, and tandem repeats along KHDC3L cDNA using GeneQuest (DNASTAR, Madison, WI) with the following parameters (a minimum number of 5-bp that are o50-bp apart) and Tandem Repeat Finder (https://tandem.bu.edu/trf/trf.html).",OADS,/arxiv_data1/oa_pdf/84/ec/hgv201627.PMC5007383.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv)Role of KHDC3L gene in RHM M Rezaei et al 5 Ofﬁcial journal of the Japan Society of Human Genetics Human Genome Variation (2016) 16027",Non-OADS,/arxiv_data1/oa_pdf/84/ec/hgv201627.PMC5007383.pdf
"Corresponding author: In Sook Lee, MD, Department of Radiology, Pusan National University School of Medicine, 179 Gudeok-ro, Seo-gu, Busan 49241, Korea.• Tel: (8251) 240-7354 • Fax: (8251) 244-7534 • E-mail: lis@pusan.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/4e/kjr-17-565.PMC5007384.pdf
"The purpose of this review was to evaluate the MR  findings of early spondylodiscitis, atypical findings of iatrogenic infection, and the differentiation between spondylodiscitis and other disease entities mimicking infection.http://dx.doi.org/10.3348/kjr.2016.17.5.565 pISSN 1229-6929 ·  eISSN 2005-8330Review Article  | Musculoskeletal Imaging Original Article  | Experimental and Others",Non-OADS,/arxiv_data1/oa_pdf/f5/4e/kjr-17-565.PMC5007384.pdf
"Currently, clinical and laboratory-based measurements of http://dx.doi.org/10.3348/kjr.2016.17.5.581 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Musculoskeletal Imaging Received February 3, 2016; accepted after revision May 23, 2016.",Non-OADS,/arxiv_data1/oa_pdf/91/80/kjr-17-581.PMC5007385.pdf
"• Tel: (86) 13911047830  • Fax: (86) 1058516947 • E-mail: xiao65@263.net This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/80/kjr-17-581.PMC5007385.pdf
"• Tel: (822) 2001-1035  • Fax: (822) 2001-1030 • E-mail: radiology11@daum.net This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/f6/kjr-17-590.PMC5007386.pdf
"Increased SNR can be used to improve contrast  or spatial resolution, but the increased effects of the  magnetic susceptibility differences of tissues scanned at http://dx.doi.org/10.3348/kjr.2016.17.5.590 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Musculoskeletal Imaging",Non-OADS,/arxiv_data1/oa_pdf/26/f6/kjr-17-590.PMC5007386.pdf
"• Tel: (822) 3010-5682  • Fax: (822) 476-0090 • E-mail: radhskim@gmail.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/89/kjr-17-598.PMC5007387.pdf
Perfusion MR  imaging techniques have often been used in the evaluation  of malignant brain tumors and consist primarily of three http://dx.doi.org/10.3348/kjr.2016.17.5.598 pISSN 1229-6929  · eISSN 2005-8330Review Article  | Neuroimaging and Head & Neck,Non-OADS,/arxiv_data1/oa_pdf/a6/89/kjr-17-598.PMC5007387.pdf
http://dx.doi.org/10.1007/s00330-016-4261-2 85.,Non-OADS,/arxiv_data1/oa_pdf/a6/89/kjr-17-598.PMC5007387.pdf
"This study was supported by a grant from the Ministry for Health, Welfare & Family Affairs (HI13C0015) in Korea, and by a grant from Seoul National University College of Medicine (800-20130068).Corresponding author: Hyeonjin Kim, PhD, Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea.• Tel: (822) 740-8543 • Fax: (822) 743-6385• E-mail: hyeonjinkim@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kjr-17-620.PMC5007388.pdf
"Finally, we discuss the current status of 1H-MRS in the diagnosis of IDH-MT gliomas as a technical guideline for neuroradiologists.http://dx.doi.org/10.3348/kjr.2016.17.5.620 pISSN 1229-6929 ·  eISSN 2005-8330Review Article  | Neuroimaging and Head & Neck Original Article  | Experimental and Others",Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kjr-17-620.PMC5007388.pdf
http://s-provencher.com/pub/LCModel/manual/manual.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kjr-17-620.PMC5007388.pdf
"Neuromelanin has an important role in protecting against  oxidative stress-induced neuronal damage by toxic metals; http://dx.doi.org/10.3348/kjr.2016.17.5.633 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Neuroimaging and Head & Neck Received December 1, 2015; accepted after revision April 27,  2016.",Non-OADS,/arxiv_data1/oa_pdf/b6/2e/kjr-17-633.PMC5007389.pdf
"• Tel: (822) 2030-5544  • Fax: (822) 2030-5549 • E-mail: mdmoonwj@kuh.ac.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/2e/kjr-17-633.PMC5007389.pdf
"VOIs’ contours were defined semi-automatically using the level-set VOI tool of Medical Imaging Processing, Analysis  and Visualization (MIPAV) (http://mipav.cit.nih.gov/).",OADS,/arxiv_data1/oa_pdf/b6/2e/kjr-17-633.PMC5007389.pdf
"However, a conventional ADC, which assumes that diffusion- weighted signals would decay mono-exponentially with two http://dx.doi.org/10.3348/kjr.2016.17.5.641 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Neuroimaging and Head & Neck Received March 21, 2015; accepted after revision May 17, 2016.",Non-OADS,/arxiv_data1/oa_pdf/d4/19/kjr-17-641.PMC5007390.pdf
"• Tel: (822) 3010-4400  • Fax: (822) 476-4719 • E-mail: jeonghlee@amc.seoul.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/19/kjr-17-641.PMC5007390.pdf
"The IVIM imaging was reviewed by a neuroradiologist (with  3 years experience) and processed using an in-house,  developed plug-in for Image J software (National Institutes  of Health, Bethesda, MD, USA; http://rsbweb.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/d4/19/kjr-17-641.PMC5007390.pdf
"The DCE-MRI data were processed with AFNI software  (AFNI; National Institute of Mental Health, Bethesda, MD,  USA, http://afni.nimh.nih.gov/afni) (21).",OADS,/arxiv_data1/oa_pdf/d4/19/kjr-17-641.PMC5007390.pdf
"• Tel: (86) 13815868181  • Fax: (86) 25-83724440 • E-mail: wfy_njmu@163.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/66/kjr-17-650.PMC5007391.pdf
Korean J Radiol 2016;17(5):650-656 INTRODUCTION Accurate differentiation between benign and malignant http://dx.doi.org/10.3348/kjr.2016.17.5.650 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Neuroimaging and Head & Neck orbital tumors is very important for the pre-treatment  plan (1).,Non-OADS,/arxiv_data1/oa_pdf/d0/66/kjr-17-650.PMC5007391.pdf
"• Tel: (822) 3010-4400  • Fax: (822) 476-0090 • E-mail: jeonghlee@amc.seoul.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/85/kjr-17-657.PMC5007392.pdf
"It is composed  of multipolar ganglion cells with intervening nerve fibers,  and receives two or three branches from the ascending http://dx.doi.org/10.3348/kjr.2016.17.5.657 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Neuroimaging and Head & Neck",Non-OADS,/arxiv_data1/oa_pdf/c9/85/kjr-17-657.PMC5007392.pdf
"High-resolution MRI http://dx.doi.org/10.3348/kjr.2016.17.5.664 pISSN 1229-6929  · eISSN 2005-8330Pictorial Essay | Neuroimaging and Head & Neck Received August 23, 2015; accepted after revision June 5, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b4/4e/kjr-17-664.PMC5007393.pdf
"• Tel: (65) 6779 5555 • Fax: (65) 6779 5678  • E-mail: jim.hallinan@gmail.com  This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/4e/kjr-17-664.PMC5007393.pdf
"This research was supported by the Korea Ministry of Environment under the “The Environmental Health Action Program”.Corresponding author: Jeung Sook Kim, MD, PhD, Department of Radiology, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, 27 Dongguk-ro, Ilsandong-gu, Goyang 10326, Korea.• Tel: (8231) 961-7820 • Fax: (8231) 961-8281 • E-mail: jeungkim@dumc.or.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/38/kjr-17-674.PMC5007394.pdf
If compensation is to be http://dx.doi.org/10.3348/kjr.2016.17.5.674 pISSN 1229-6929 ·  eISSN 2005-8330Review Article  | Thoracic Imaging Original Article  | Experimental and Others,Non-OADS,/arxiv_data1/oa_pdf/d7/38/kjr-17-674.PMC5007394.pdf
"• Tel: (49) 7071 29 82087  • Fax: (49) 7071 29 5845 • E-mail: christina.schraml@med.uni-tuebingen.de This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/b6/kjr-17-684.PMC5007395.pdf
In http://dx.doi.org/10.3348/kjr.2016.17.5.684 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Thoracic Imaging,Non-OADS,/arxiv_data1/oa_pdf/f6/b6/kjr-17-684.PMC5007395.pdf
"Figures of merit  (FOM) were calculated for each imaging set and compared  using Jackknife FROC software (Jackknife alternative free- response receiver-operating characteristic, version 4.2.1;  http://www.devchakraborty.com), which provides a specific  analysis of observer free-response tasks (21, 22).",OADS,/arxiv_data1/oa_pdf/f6/b6/kjr-17-684.PMC5007395.pdf
"Corresponding author: Bo Kyoung Seo, MD, PhD, Department of Radiology, Korea University Ansan Hospital, Korea University College of Medicine, 123 Jeokgeum-ro, Danwon-gu, Ansan 15355, Korea.• Tel: (8231) 412-6872 • Fax: (8231) 412-5224 • E-mail: seoboky@korea.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/57/kjr-17-695.PMC5007396.pdf
We often face difficulties in interpreting and correlating the http://dx.doi.org/10.3348/kjr.2016.17.5.695 pISSN 1229-6929 ·  eISSN 2005-8330Pictorial Essay  | Breast Imaging Original Article  | Experimental and Others,Non-OADS,/arxiv_data1/oa_pdf/59/57/kjr-17-695.PMC5007396.pdf
"Corresponding author: Seong Ho Park, MD, PhD, Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea.• Tel: (822) 3010-5984 • Fax: (822) 476-4719• E-mail: parksh.radiology@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/2c/kjr-17-706.PMC5007397.pdf
The great need for quality reporting in clinical research explains http://dx.doi.org/10.3348/kjr.2016.17.5.706 pISSN 1229-6929 ·  eISSN 2005-8330Original Article  | Experimental and Others Original Article  | Experimental and Others,Non-OADS,/arxiv_data1/oa_pdf/c2/2c/kjr-17-706.PMC5007397.pdf
http://www.equator- network.org/.,Non-OADS,/arxiv_data1/oa_pdf/c2/2c/kjr-17-706.PMC5007397.pdf
https://en.wikipedia.org/wiki/Open_access_journal.,Non-OADS,/arxiv_data1/oa_pdf/c2/2c/kjr-17-706.PMC5007397.pdf
"• Tel: (822) 2228-2373  • Fax: (822) 393-3035 • E-mail: slee@yuhs.ac This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/3d/kjr-17-715.PMC5007398.pdf
"In addition, localized brain  cooling before reperfusion significantly reduces the infarct http://dx.doi.org/10.3348/kjr.2016.17.5.715 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Experimental and Others",Non-OADS,/arxiv_data1/oa_pdf/fa/3d/kjr-17-715.PMC5007398.pdf
"Alternatively,  ex-vivo  DT-MRI for animal models provides some valuable http://dx.doi.org/10.3348/kjr.2016.17.5.725 pISSN 1229-6929  · eISSN 2005-8330Brief Communication  | Experimental and Others Received December 12, 2015; accepted after revision April 29,  2016.",Non-OADS,/arxiv_data1/oa_pdf/5d/25/kjr-17-725.PMC5007399.pdf
"• Tel: (8628) 85164108  • Fax: (8628) 85422135 • E-mail: gaofabao_sub@163.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/25/kjr-17-725.PMC5007399.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/25/kjr-17-725.PMC5007399.pdf
"• Tel: (8242) 280-7333  • Fax: (8242) 253-0061 • E-mail: jscho@cnu.ac.kr  This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/8f/kjr-17-734.PMC5007400.pdf
http://dx.doi.org/10.3348/kjr.2016.17.5.734 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Gastrointestinal Imaging,Non-OADS,/arxiv_data1/oa_pdf/e0/8f/kjr-17-734.PMC5007400.pdf
"*These authors contributed equally to this work.Corresponding author: Sung Il Park, MD, Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.• Tel: (822) 2228-7400 • Fax: (822) 393-3035• E-mail: astarte@yuhs.ac This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/1c/kjr-17-742.PMC5007401.pdf
When the tumor is located at high-risk http://dx.doi.org/10.3348/kjr.2016.17.5.742 pISSN 1229-6929 ·  eISSN 2005-8330Original Article  | Gastrointestinal Imaging Original Article  | Experimental and Others,Non-OADS,/arxiv_data1/oa_pdf/64/1c/kjr-17-742.PMC5007401.pdf
"In  addition, because the sampled tissue has small volume  compared to liver parenchyma, liver biopsy intrinsically  involves sampling bias, as well as interobserver variation http://dx.doi.org/10.3348/kjr.2016.17.5.750 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Gastrointestinal Imaging Received February 16, 2016; accepted after revision June 24,  2016.",Non-OADS,/arxiv_data1/oa_pdf/e0/1e/kjr-17-750.PMC5007402.pdf
"• Tel: (822) 2072-3154  • Fax: (822) 743-6385 • E-mail: jmsh@snu.ac.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/1e/kjr-17-750.PMC5007402.pdf
"• Tel: (813) 3443-8111  • Fax: (813) 5449-5746 • E-mail: kiryu-tky@umin.ac.jp  This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/f6/kjr-17-758.PMC5007403.pdf
Liver enzymes http://dx.doi.org/10.3348/kjr.2016.17.5.758 pISSN 1229-6929  · eISSN 2005-8330Case Report  | Gastrointestinal Imaging,Non-OADS,/arxiv_data1/oa_pdf/0b/f6/kjr-17-758.PMC5007403.pdf
"Informed consent of patients was waived.http://dx.doi.org/10.3348/kjr.2016.17.5.763 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Genitourinary Imaging Received February 1, 2016; accepted after revision April 22, 2016.",Non-OADS,/arxiv_data1/oa_pdf/90/96/kjr-17-763.PMC5007404.pdf
"• Tel: (822) 3410-6457  • Fax: (822) 3410-0084 • E-mail: rapark@skku.edu This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/96/kjr-17-763.PMC5007404.pdf
"• Tel: (822) 2019-3723  • Fax: (822) 3462-5472 • E-mail: doctorlkh@yuhs.ac This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/64/kjr-17-771.PMC5007405.pdf
"Korean J Radiol 2016;17(5):771-778 INTRODUCTION Transarterial chemoembolization (TACE), first introduced http://dx.doi.org/10.3348/kjr.2016.17.5.771 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Intervention in Japan, is now well established for managing unresectable  hepatocellular carcinomas (HCC) showing prominent  hypervascular staining on angiography due to rich arterial  blood supply (1).",Non-OADS,/arxiv_data1/oa_pdf/b6/64/kjr-17-771.PMC5007405.pdf
"• Tel: (822) 2072-3073  • Fax: (822) 743-6385 • E-mail: leejy4u@snu.ac.kr  This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/04/kjr-17-779.PMC5007406.pdf
High-intensity focused ultrasound (HIFU) is an emerging http://dx.doi.org/10.3348/kjr.2016.17.5.779 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Intervention,Non-OADS,/arxiv_data1/oa_pdf/78/04/kjr-17-779.PMC5007406.pdf
"Disadvantages of surgical exploration include the http://dx.doi.org/10.3348/kjr.2016.17.5.789 pISSN 1229-6929  · eISSN 2005-8330Brief Communication  | Intervention Received May 18, 2016; accepted after revision June 5, 2016.",Non-OADS,/arxiv_data1/oa_pdf/20/09/kjr-17-789.PMC5007407.pdf
"• Tel: (86) 13805336810 • Fax: (86533) 6552498 • E-mail: zyfbb19901024@sina.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/09/kjr-17-789.PMC5007407.pdf
"• Tel: (8231) 787-7612  • Fax: (8231) 787-4011 • E-mail: yooncj1@gmail.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/73/kjr-17-797.PMC5007408.pdf
CT scan revealed a swelling of the remnant http://dx.doi.org/10.3348/kjr.2016.17.5.797 pISSN 1229-6929  · eISSN 2005-8330Case Report  | Intervention,Non-OADS,/arxiv_data1/oa_pdf/64/73/kjr-17-797.PMC5007408.pdf
"Corresponding author: Young Dae Cho, MD, Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea.• Tel: (822) 2072-2987 • Fax: (822) 743-6385• E-mail: aronnn@naver.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/5b/kjr-17-801.PMC5007409.pdf
"With the advances in endovascular technologies, reconstruction of VBDAs through stent-assisted coil embolization (SACE) or stent-only deployment http://dx.doi.org/10.3348/kjr.2016.17.5.801 pISSN 1229-6929 ·  eISSN 2005-8330Original Article  | Neurointervention Original Article  | Experimental and Others",Non-OADS,/arxiv_data1/oa_pdf/6b/5b/kjr-17-801.PMC5007409.pdf
Supplementary Materials The online-only Data Supplement is available with this  article at http://dx.doi.org/10.3348/kjr.2016.17.5.801.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/kjr-17-801.PMC5007409.pdf
http://dx.doi.org/10.1136/neurintsurg-2015-011947,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/kjr-17-801.PMC5007409.pdf
"• Tel: (822) 2030-5544  • Fax: (822) 2030-5549 • E-mail: mdmoonwj@naver.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/61/kjr-17-811.PMC5007410.pdf
http://dx.doi.org/10.3348/kjr.2016.17.5.811 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Thyroid,Non-OADS,/arxiv_data1/oa_pdf/28/61/kjr-17-811.PMC5007410.pdf
"• Tel: (90) 5345414979 • Fax: (90) 2862171350 • E-mail: drozturker@gmail.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/fe/kjr-17-822.PMC5007411.pdf
Adv  Med Sci  2015;60:300-306 Korean J Radiol 2016;17(5):822-822http://dx.doi.org/10.3348/kjr.2016.17.5.822 pISSN 1229-6929  · eISSN 2005-8330,OADS,/arxiv_data1/oa_pdf/5c/fe/kjr-17-822.PMC5007411.pdf
"• Tel: (90) 533 269 08 30  • Fax: (90) 252 421 04 15 • E-mail: serkanaribal@gmail.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/63/kjr-17-823.PMC5007412.pdf
J Ultrasound Med  2007;26:163-167 Korean J Radiol 2016;17(5):823-823http://dx.doi.org/10.3348/kjr.2016.17.5.823 pISSN 1229-6929  · eISSN 2005-8330,Non-OADS,/arxiv_data1/oa_pdf/db/63/kjr-17-823.PMC5007412.pdf
"• Tel: (8620) 81887233 • Fax: (8620) 81887233 • E-mail: e_xuli@163.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/0d/kjr-17-824.PMC5007413.pdf
PLoS One   2016;11:e0156207 Korean J Radiol 2016;17(5):824-824http://dx.doi.org/10.3348/kjr.2016.17.5.824 pISSN 1229-6929  · eISSN 2005-8330,OADS,/arxiv_data1/oa_pdf/5a/0d/kjr-17-824.PMC5007413.pdf
"825 Copyright © 2016 The Korean Society of RadiologyMultidetector CT Findings and Differential Diagnoses   of Malignant Pleural Mesothelioma and Metastatic  Pleural Diseases in Korea Yoon Kyung Kim, MD1, Jeung Sook Kim, MD2, Kyung Won Lee, MD3, Chin A Yi, MD4,   Jin Mo Goo, MD5, Soon-Hee Jung, MD6 1Department of Radiology, Gachon University Gil Medical Center, Incheon 21565, Korea; 2Department of Radiology, Dongguk University Ilsan Hospital,  Goyang 10326, Korea; 3Department of Radiology, Seoul National University Bundang Hospital, Seongnam 13620, Korea; 4Department of Radiology,  Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea; 5Department of Radiology, Seoul National University  College of Medicine, Seoul 03080, Korea; 6Department of Pathology, Yonsei University Wonju College of Medicine, Wonju 26426, Korea http://dx.doi.org/10.3348/kjr.2016.17.4.545 Korean J Radiol 2016;17(4):545-553 The publisher and authors would like to draw the reader’s attention to an error in the following article.",Non-OADS,/arxiv_data1/oa_pdf/e7/ff/kjr-17-825.PMC5007414.pdf
The correct spelling is Jin Mo Goo.Erratum Korean J Radiol 2016;17(5):825-825http://dx.doi.org/10.3348/kjr.2016.17.5.825 pISSN 1229-6929  · eISSN 2005-8330,Non-OADS,/arxiv_data1/oa_pdf/e7/ff/kjr-17-825.PMC5007414.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/b1/main.PMC5007418.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.08.020 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/3e/b1/main.PMC5007418.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/43/main.PMC5007420.pdf
http://dx.doi.org/10.1016/j.idcr.2016.08.003 2214-2509/ ã  2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/ac/43/main.PMC5007420.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  6  (2016)  9–12 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/ac/43/main.PMC5007420.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/34/af/main.PMC5007421.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.05.019 350,OADS,/arxiv_data1/oa_pdf/34/af/main.PMC5007421.pdf
"285 http://dx.doi.org/10.3345/kjp.2016.59.7.285Korean J Pediatr 2016;59(7):285-291 White matter injury following rotavirus infection  in neonates: new aspects to a forgotten entity, ‘fifth day fits’?",Non-OADS,/arxiv_data1/oa_pdf/5d/5c/kjped-59-285.PMC5007423.pdf
"Nevertheless, the principal anatomic substrate of infection/Corresponding author: Chan-Hoo Park, MD, PhD Department of Pediatrics, Gyeongsang National University School of Medicine, 15 Jinju-daero 816beon-gil, Jinju 52727, KoreaTel: +82-55-750-8161Fax: +82-55-752-9339E-mail: aroma@gnu.ac.kr  Received: 16 July, 2015 Revised: 8 September, 2015Accepted: 9 September, 2015 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrReview article Korean J Pediatr 2016;59(7):285-291 http://dx.doi.org/10.3345/kjp.2016.59.7.285pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/5d/5c/kjped-59-285.PMC5007423.pdf
http://dx.doi.org/10.3345/kjp.2016.59.7.285Yeom JS and Park CH •  Rotavirus infection and white matter injury in neonates 286inflammation-associated cerebral injury in term neonates is not  known.,OADS,/arxiv_data1/oa_pdf/5d/5c/kjped-59-285.PMC5007423.pdf
287 http://dx.doi.org/10.3345/kjp.2016.59.7.285Korean J Pediatr 2016;59(7):285-291 and subsequent cystic evolution in 6 patients18).,Non-OADS,/arxiv_data1/oa_pdf/5d/5c/kjped-59-285.PMC5007423.pdf
http://dx.doi.org/10.3345/kjp.2016.59.7.285Yeom JS and Park CH •  Rotavirus infection and white matter injury in neonates 288was identified in 17 neonates with the aforementioned DWI  pattern.,Non-OADS,/arxiv_data1/oa_pdf/5d/5c/kjped-59-285.PMC5007423.pdf
"289 http://dx.doi.org/10.3345/kjp.2016.59.7.285Korean J Pediatr 2016;59(7):285-291 enterovirus and parechovirus encephalitis11,29-34).",Non-OADS,/arxiv_data1/oa_pdf/5d/5c/kjped-59-285.PMC5007423.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.7.285Yeom JS and Park CH •  Rotavirus infection and white matter injury in neonates 290by contrast, is unlikely to penetrate the brain in cases of WMI  in newborns11,18).",Non-OADS,/arxiv_data1/oa_pdf/5d/5c/kjped-59-285.PMC5007423.pdf
291 http://dx.doi.org/10.3345/kjp.2016.59.7.285Korean J Pediatr 2016;59(7):285-291 19.,Non-OADS,/arxiv_data1/oa_pdf/5d/5c/kjped-59-285.PMC5007423.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.7.292Rao YK, et al.",OADS,/arxiv_data1/oa_pdf/cc/c8/kjped-59-292.PMC5007424.pdf
"Sixty Corresponding author: Yashwant Rao, MD Department of Pediatrics, Ganesh Shankar Vidy-arthi Memorial Medical College, Kanpur 208002, IndiaTel: +91-9919080807Fax: +91-512-2535483E-mail: ykraoneo@yahoo.co.in Received: 3 February, 2016 Revised: 11 May, 2016Accepted: 16 May, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrOriginal article Korean J Pediatr 2016;59(7):292-297 http://dx.doi.org/10.3345/kjp.2016.59.7.292pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/cc/c8/kjped-59-292.PMC5007424.pdf
293 http://dx.doi.org/10.3345/kjp.2016.59.7.292Korean J Pediatr 2016;59(7):292-297 percent of these children were diagnosed to have nutritional  rickets1).,Non-OADS,/arxiv_data1/oa_pdf/cc/c8/kjped-59-292.PMC5007424.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.7.292Rao YK, et al.",OADS,/arxiv_data1/oa_pdf/cc/c8/kjped-59-292.PMC5007424.pdf
295 http://dx.doi.org/10.3345/kjp.2016.59.7.292Korean J Pediatr 2016;59(7):292-297 be statistically significant.,OADS,/arxiv_data1/oa_pdf/cc/c8/kjped-59-292.PMC5007424.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.7.292Rao YK, et al.",OADS,/arxiv_data1/oa_pdf/cc/c8/kjped-59-292.PMC5007424.pdf
297 http://dx.doi.org/10.3345/kjp.2016.59.7.292Korean J Pediatr 2016;59(7):292-297 tation for improving bone mineral density in children.,Non-OADS,/arxiv_data1/oa_pdf/cc/c8/kjped-59-292.PMC5007424.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.7.298Jun H, et al.",OADS,/arxiv_data1/oa_pdf/61/30/kjped-59-298.PMC5007425.pdf
"Patients and materials We performed retrospective review of the medical records of 131 patients who were Corresponding author: Eun Jung Cheon, MD Department of Pediatrics, Konyang University Col-lege of Medicine, 158 Gwanjeodong-ro, Seo-gu, Daejeon 35365, Korea Tel: +82-42-600-9230Fax: +82-42-600-9090E-mail:ejcheon000@kyuh.ac.kr Received: 30 October, 2015 Revised: 22 May, 2016Accepted: 1 June, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrOriginal article Korean J Pediatr 2016;59(7):298-302 http://dx.doi.org/10.3345/kjp.2016.59.7.298pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/61/30/kjped-59-298.PMC5007425.pdf
299 http://dx.doi.org/10.3345/kjp.2016.59.7.298Korean J Pediatr 2016;59(7):298-302 hospitalized for KD at Konyang University Hospital between May  2013 and December 2014.,Non-OADS,/arxiv_data1/oa_pdf/61/30/kjped-59-298.PMC5007425.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.7.298Jun H, et al.",OADS,/arxiv_data1/oa_pdf/61/30/kjped-59-298.PMC5007425.pdf
"301 http://dx.doi.org/10.3345/kjp.2016.59.7.298Korean J Pediatr 2016;59(7):298-302 group I, fever lasted for a longer time and the serum level of acute  phase reactants such as WBC, CRP, ANC were higher than group  II.",Non-OADS,/arxiv_data1/oa_pdf/61/30/kjped-59-298.PMC5007425.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.7.298Jun H, et al.",OADS,/arxiv_data1/oa_pdf/61/30/kjped-59-298.PMC5007425.pdf
"303 http://dx.doi.org/10.3345/kjp.2016.59.7.303Korean J Pediatr 2016;59(7):303-307 Dietary habits and gastroesophageal reflux  disease in preschool children You Jin Choi, MD, Eun Kyo Ha, MD, Su Jin Jeong, MD Department of Pediatrics, Bundang CHA Medical Center, CHA University School of Medicine, Seongnam, Korea Purpose: To identify the relationship between dietary habits and childhood gastroesophageal reflux  disease (GERD) in preschool children.",Non-OADS,/arxiv_data1/oa_pdf/47/45/kjped-59-303.PMC5007426.pdf
"Childhood GERD may be influenced by numerous lifestyle factors4), there particularly Corresponding author: Su Jin Jeong, MD Department of Pediatrics, Bundang CHA Medical Center, CHA University School of Medicine, 59 Yatap-ro, Bundang-gu, Seongnam 13496, KoreaTel: +82-31-780-5230Fax: +82-31-780-5239E-mail: jinped@cha.ac.kr  Received: 5 February, 2016 Revised: 1 May, 2016Accepted: 4 May, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrOriginal article Korean J Pediatr 2016;59(7):303-307 http://dx.doi.org/10.3345/kjp.2016.59.7.303pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/47/45/kjped-59-303.PMC5007426.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.7.303Choi YJ, et al.",OADS,/arxiv_data1/oa_pdf/47/45/kjped-59-303.PMC5007426.pdf
305 http://dx.doi.org/10.3345/kjp.2016.59.7.303Korean J Pediatr 2016;59(7):303-307 children (104 boys [51.4%] and 98 girls [48.6%]).,Non-OADS,/arxiv_data1/oa_pdf/47/45/kjped-59-303.PMC5007426.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.7.303Choi YJ, et al.",OADS,/arxiv_data1/oa_pdf/47/45/kjped-59-303.PMC5007426.pdf
"307 http://dx.doi.org/10.3345/kjp.2016.59.7.303Korean J Pediatr 2016;59(7):303-307 JP, et al.",OADS,/arxiv_data1/oa_pdf/47/45/kjped-59-303.PMC5007426.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.7.308Yeom JS, et al.",OADS,/arxiv_data1/oa_pdf/e5/11/kjped-59-308.PMC5007427.pdf
"This report describes 2 young infants with an HPeV3 infection who presented Corresponding author: Ju-Young Chung, MD, PhD Department of Pediatrics, Inje University Sanggye-paik Hospital, Inje University College of Medicine, 1342 Dongil-ro, Nowon-gu, Seoul 01757, KoreaTel: + 82-2-950-1073Fax: +82-2-938-4109E-mail: chungjy@paik.ac.kr Received: 3 February, 2016 Revised: 12 May, 2016Accepted: 16 May, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrCase report Korean J Pediatr 2016;59(7):308-311 http://dx.doi.org/10.3345/kjp.2016.59.7.308pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/e5/11/kjped-59-308.PMC5007427.pdf
"309 http://dx.doi.org/10.3345/kjp.2016.59.7.308Korean J Pediatr 2016;59(7):308-311 with a prolonged fever, palmar-plantar erythema, and hyper - ferritinemia (>500 ng/mL).",Non-OADS,/arxiv_data1/oa_pdf/e5/11/kjped-59-308.PMC5007427.pdf
"http://dx.doi.org/10.3345/kjp.2016.59.7.308Yeom JS, et al.",OADS,/arxiv_data1/oa_pdf/e5/11/kjped-59-308.PMC5007427.pdf
311 http://dx.doi.org/10.3345/kjp.2016.59.7.308Korean J Pediatr 2016;59(7):308-311 Management of HPeV-3 infection is limited to supportive care.,Non-OADS,/arxiv_data1/oa_pdf/e5/11/kjped-59-308.PMC5007427.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/35/8d/main.PMC5007432.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.06.009 346,OADS,/arxiv_data1/oa_pdf/35/8d/main.PMC5007432.pdf
Available from: https://www.aad.org/Forms/Policies/ Uploads/PS/PS%20Appropriate%20Uses%20of%20Paraffin%20Sections%20in%20Association%20with%20Mohs%20Mir cographic%20Surgery.pdf .,Non-OADS,/arxiv_data1/oa_pdf/35/8d/main.PMC5007432.pdf
Available from: https://www.nccn.org/professionals/physician_gls/pdf/squamous.pdf .,Non-OADS,/arxiv_data1/oa_pdf/35/8d/main.PMC5007432.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/90/main.PMC5007433.pdf
"In vivo, CFH and Hb will co-exist and need to be distinguishedContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.08.003 2213-2317/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/1c/90/main.PMC5007433.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/90/main.PMC5007433.pdf
"(2016) , http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/90/main.PMC5007433.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/78/main.PMC5007434.pdf
"ROS promotes the dis- sociation of thioredoxin-interacting protein (TXNIP) from thior-edoxin and allows TXNIP to bind to NLRP3, and subsequentlyContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.08.006 2213-2317/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/8c/78/main.PMC5007434.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/78/main.PMC5007434.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/db/main.PMC5007435.pdf
The mechanisms involved areContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.08.008 2213-2317/ &2016 The Authors.,OADS,/arxiv_data1/oa_pdf/69/db/main.PMC5007435.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: Cx, connexin; Cx43, connexin43; TJs, tight junctions; AJs, adherens junctions; GJs, gap junctions; siRNA, small interfering RNA; Cx43þ/þ, Cx43 wide- type mouse; Cx43þ/-, Cx43 heterozygous mouse; Cx43-/-, Cx43 knockout mouse; JNK, c-Jun N-terminal kinase; GSH, glutathione; FBS, fetal bovine serum; LY, luciferyellow; SB203580, 4-(4- ﬂuorophenyl) /C02-(4-methylsul ﬁnylphenyl) /C05-(4-pyridyl) 1H-imidazole; SP600125, 2H-Dibenzo[cd, g]indazol-6-one; NAC, N-acetyl-cysteine; NRK, Normal rat kidney; SDS, sodium dodecyl sulphate; DNPH, 2,4-dini-trophenylhydrazine; OD, optical density; TER, transepithelial electrical resistance nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/69/db/main.PMC5007435.pdf
"The chemiluminescent signal was captured with a Fujiﬁlm luminescent image LAS-1000 analyzer (Fuji ﬁlm, Tokyo, Japan) and quanti ﬁed with the Image J software ( http://rsb.info.",OADS,/arxiv_data1/oa_pdf/69/db/main.PMC5007435.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.08.005 2213-2317/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/66/main.PMC5007436.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ALT, alanine aminotransferase; CN-PAGE, clear native polyacrylamide gel electrophoresis; CsA, cyclosporin A; GSH, glutathione; HIF1 α, hypoxia-inducible factor 1 alpha; iNOS, inducible nitric oxide synthase; MPT, mitochondrial permeability transition; NO, nitric oxide; ONOO-, peroxynitrite; RCR, respiratory control ratio; RNS, reactive nitrogen species; ROS, reactive oxygen species; SAM, S-adenosylmethionine; O 2/C15-, superoxide anion nCorresponding author at: Department of Pathology, University of Alabama at Birmingham, Volker Hall, Room G019B, 1670 University Boulevard, Birmin gham, AL 35294, United States.",Non-OADS,/arxiv_data1/oa_pdf/46/66/main.PMC5007436.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.08.010 2213-2317/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/c3/main.PMC5007445.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: 2-AG, 2-arachidonylglyceriol; 4-HNE, 4-hydroxynonenal; 4-ONE, 4-oxononenal; 8-OHdG, 8-hydroxy-2 ′-deoxyguanosine; AA, arachidonic acid; AC, adeno- carcinoma; AEA, anandamide; AKT, serine/threonine-speci ﬁc protein kinase; ALE, advanced lipoxidation-end products; ARE, antioxidant response element; Bach1, BTB and CNC homology 1, basic leucine zipper transcription factor; CAT, catalase; CB1/2, cannabinoid receptor type ½; COX-2, cyclooxygenase 2; Cul3, cullin-3; DGR, double glycine repeat domain; DHA, docosahexaenoic acid; EGFR, epidermal growth factor receptor; ERK1/2, mitogen-activated protein kinase 3/1; ESI, electrospr ay ionization; FAAH, fatty acid amide hydrolase; FAME, fatty acid methyl ester; GPR55, G protein-coupled receptor 55; GSH, glutathione; GSH-Px, glutathione peroxidase; GSSG , glutathione disul ﬁde; HO-1, heme oxygenase 1; JNK1/2, c-Jun N-terminal kinases ½; KAP1, KRAB-associated protein-1; Keap1, kelch-like associated protein 1; LA, linoleic acid; LC-MS, liquid chromatography –mass spectrometry; LOD, limit of detection; LOQ, limit of quanti ﬁcation; MAGL, monoacylglycerol lipase; MDA, malondialdehyde; N7-MeG, N7-methyl- guanine; NF κBp52, nuclear factor kappa-light-chain-enhancer of activated B cells, subunit p52; Nrf 1/2/3, nuclear factor erythroid-2 related factor 1/2/3; NS CLC, non-small cell lung cancer; p21, protein 21; p62, protein 62; PBS, phosphate-buffered saline; PUFA, polyunsatutated fatty acids; ROS, reactive oxygen specie s; SCC, squamous cell lung carcinoma; TBST, tris-buffered saline and tween 20; TIMP-1, tissue inhibitor of matrix metalloproteinases-1; TRV1, transient receptor potential cation channel subfamily V member 1; UPLC-MS/MS, ultra-performance liquid chromatography, tandem mass-spectrometry nCorrespondence to: Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, Poland.",Non-OADS,/arxiv_data1/oa_pdf/f0/c3/main.PMC5007445.pdf
"2012 (2012) 137289, http://dx.doi.org/ 10.5402/2012/137289 .",Non-OADS,/arxiv_data1/oa_pdf/f0/c3/main.PMC5007445.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/9a/main.PMC5007542.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.07.011 2211-3355/© 2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/c0/9a/main.PMC5007542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/9a/main.PMC5007542.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/c0/9a/main.PMC5007542.pdf
http://dx.doi.org/10.7326/M15-2766 (2016 May 3).,Non-OADS,/arxiv_data1/oa_pdf/c0/9a/main.PMC5007542.pdf
(Accessed at http://www.medpagetoday.com/ PublicHealthPolicy/PublicHealth/52273 on 29 June 2016).,Non-OADS,/arxiv_data1/oa_pdf/c0/9a/main.PMC5007542.pdf
http://dx.doi.org/10.1001/jama.2015.18271 .,Non-OADS,/arxiv_data1/oa_pdf/c0/9a/main.PMC5007542.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c0/9a/main.PMC5007542.pdf
"CMAJ 185 (3), 195. http://dx.doi.org/10.1503/cmaj.130087 (Epub 2013 Feb 4).",Non-OADS,/arxiv_data1/oa_pdf/c0/9a/main.PMC5007542.pdf
http://dx.doi.org/10.1080/13504622.2015.1108391 .,Non-OADS,/arxiv_data1/oa_pdf/c0/9a/main.PMC5007542.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Normal development Child and adolescent healthEpidemiologyLongitudinal study 1.,Non-OADS,/arxiv_data1/oa_pdf/62/67/main.PMC5007545.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.08.013 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/62/67/main.PMC5007545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/67/main.PMC5007545.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/62/67/main.PMC5007545.pdf
A full roster of the INMA PROJECT Investi- gators can be found at http://www.PROYECTOINMA.org /.,Non-OADS,/arxiv_data1/oa_pdf/62/67/main.PMC5007545.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/62/67/main.PMC5007545.pdf
"2, 261 –273 http://dx.doi.org/10.1080/15384101.2015.1121353",Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Photochem Photobiol 2015; 91:15 –26; PMID:25354245; http://dx.doi.org/10.1111/php.12377 2.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Cell Cycle 2007; 6:660 –6; PMID:17387276; http://dx.doi.org/10.4161/ cc.6.6.3984 3.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Microbiol Mol Biol Rev 2009; 73:134 –54; PMID:19258535; http://dx.doi.org/10.1128/MMBR.00034- 08 5.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
J Cell Sci 2012; 125:1633 –43; PMID:22499669; http://dx.doi.org/10.1242/jcs.094748 6.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Curr Biol 2000;10:1217 –20; PMID:11050392; http://dx.doi.org/10.1016/S0960-9822 (00)00725-9 7.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Curr Biol 2000; 10:1213 –6; PMID:11050391; http://dx.doi.org/10.1016/S0960-9822(00)00724-7 8.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Curr Biol 2000; 10:1221 –4; PMID:11050393; http://dx.doi.org/10.1016/S0960-9822 (00)00726-0 9.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Nucleic Acids Res 2013; 41:2328 –39; PMID:23303771; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Genome Res 2010; 20:447 –57; PMID:20103589; http://dx.doi.org/10.1101/gr.098947.109 12.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Genome Biol Evolu-tion 2011; 3:799 –811; PMID:21666225; http://dx.doi.org/10.1093/gbe/ evr054 13.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Japanese J Genet 1964; 39:136; http://dx.doi.org/10.1266/jjg.39.136 15.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
J Biol Chem2001; 276:44688 –94; PMID:11572873; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
JRadiat Res 1963; 4:85 –90; PMID:14193265; http://dx.doi.org/ 10.1269/jrr.4.85 17.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
MutatRes 1976; 35:129 –37; PMID:178997; http://dx.doi.org/10.1016/0027- 5107(76)90175-5 18.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Mutat Res 1985; 148:119 –28; PMID:3969076; http://dx.doi.org/10.1016/0027- 5107(85)90215-5 19.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Mutat Res 1995; 329:143 –52; PMID:7603496; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
"Mol Gen Genet 1981; 184:471 –8; PMID:7038396; http://dx.doi.org/ 10.1007/BF00352525 23. di Caprio L, Cox BS.",Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Mutat Res 1981; 82:69 –85; PMID:7022172; http://dx.doi.org/10.1016/0027-5107 (81)90139-1 24.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Mol Cell Biol 2002; 22:2419 –26; PMID: 11884624; http://dx.doi.org/10.1128/MCB.22.7.2419-2426.2002 26.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Mol Cell Biol 2007; 27:7758 –64; PMID:17785441; http://dx.doi.org/10.1128/MCB.01331-07 27.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Cell Res 2008; 18:162 –73; PMID:18157158; http://dx.doi.org/10.1038/ cr.2007.114 28.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Proc Natl Acad Sci U S A 2005;102:15954 –9; PMID:16247017; http://dx.doi.org/10.1073/ pnas.0504586102 29.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Embo J 2002; 21:5558 –66; PMID:12374756; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Mol Cell Biol 2003;23:474 –81; PMID:12509447; http://dx.doi.org/10.1128/MCB.23.2.474- 481.2003 32.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Mol Cell 2008; 30:519 –29; PMID:18498753; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
The preference for error-free or error-prone postreplication repair in Saccharomyces cerevisiaeexposed to low-dose methyl methanesulfonate is cell cycle dependent.Mol Cell Biol 2013; 33:1515 –27; PMID:23382077; http://dx.doi.org/ 10.1128/MCB.01392-12 36.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Nucleic Acids Res 2012; 40:170 –80; PMID:21908406; http://dx.doi.org/ 10.1093/nar/gkr596 37.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Embo J 1999; 18:4485 –97; PMID:10449414; http://dx.doi.org/10.1093/emboj/18.16.4485 41.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Proc Natl Acad Sci U S A 2010; 107:8219 –24; PMID:20404181; http://dx.doi.org/10.1073/ pnas.1003449107 43.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Cell 2010; 141:255 –67; PMID:20403322; http://dx.doi.org/ 10.1016/j.cell.2010.02.028 44.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Nature 2011; 465:951 –5; http://dx.doi.org/10.1038/nature09097 45.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
"Nature 1975; 254:245 –7; PMID:46594; http://dx.doi.org/10.1038/ 254245a0 47. al-Khodairy F, Carr AM.",Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
EMBO Rep 2003; 4:671 –7; PMID:12835754; http://dx.doi.org/10.1038/sj.embor.embor887 49.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
DNA Repair (Amst) 2004; 3:997 –1007; PMID:15279786; http://dx.doi.org/10.1016/ j.dnarep.2004.03.006 50.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Biophys J 1963; 3:379 –97; PMID:14062457; http://dx.doi.org/ 10.1016/S0006-3495(63)86828-9 51.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Timing and dose-dependence of radiation-induced division delay.Biophys J 1968; 8:1475 –86; PMID:5753223; http://dx.doi.org/10.1016/ S0006-3495(68)86567-1 52.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Biophys J 1971;11:540 –9; http://dx.doi.org/10.1016/S0006-3495(71)86233-1 53.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Mol Biol Cell 2006; 17:2976 –85; PMID:16641370; http://dx.doi.org/10.1091/ mbc.E05-11-1008 55.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
EMBO J 2010; 29:2048 –58; PMID:20453833; http://dx.doi.org/10.1038/emboj.2010.87 56.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
G3 2014; 4:1373 – 84; PMID:24875629; http://dx.doi.org/full_text 57.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Nucleic AcidsRes 1995; 23:383 –8; PMID:7885834; http://dx.doi.org/10.1093/nar/ 23.3.383 58.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
"Cell Cycle 2012; 11:668 –74; PMID:22373527; http://dx.doi.org/10.4161/cc.11.4.19117 60. al-Khodairy F, Fotou E, Sheldrick KS, Grif ﬁths DJ, Lehmann AR, Carr AM.",OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Mol Biol Cell 1994; 5:147 –60; PMID:8019001; http://dx.doi.org/ 10.1091/mbc.5.2.147 61.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Curr Biol 1995; 5:1179 –90; PMID:8548290; http://dx.doi.org/10.1016/ S0960-9822(95)00234-X 62.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Nucleic Acids Res 1997; 25:1553 –8; PMID:9092661; http://dx.doi.org/10.1093/nar/25.8.1553 63.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Int J Radiat Biol 1998; 74:173 –84; PMID:9712547; http://dx.doi.org/10.1080/ 095530098141564 64.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Mol Cell Biol 1988; 8:2342 –9; PMID:2841579; http://dx.doi.org/10.1128/MCB.8.6.2342 65.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Nucleic Acids Res 2012; 40:682 –91; PMID:21926160; http://dx.doi.org/10.1093/nar/gkr769272 A. J. CALLEGARI AND T. J. KELLY,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
"Kozmin SG, Jinks-Robertson S. The mechanism of nucleotide excision repair-mediated UV-induced mutagenesis in nonproliferating cells.Genetics 2013; 193:803 –17; PMID:23307894; http://dx.doi.org/ 10.1534/genetics.112.147421 67.",OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
DNA Repair (Amst) 2013; 12:878 –89; PMID:23988736; http://dx.doi.org/10.1016/j.dnarep.2013.07.008 68.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Activation of ubiquitin-dependent DNA damage bypass is mediated by replication protein a. Mol Cell 2008; 29:625 –36; PMID:18342608; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Mol Cell Biol 2008; 28:3905 –16; PMID:18426916; http://dx.doi.org/10.1128/MCB.02116-07 71.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
PLoS One 2015; 10:e0130000;PMID:26147350; http://dx.doi.org/10.1371/journal.pone.0130000 72.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Mol Cell 2010; 40:50 –62; PMID:20932474; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
DNA excision-repair processes in human cells can eliminate thecytotoxic and mutagenic consequences of ultraviolet irradiation.Mutat Res 1979; 62:311 –23; PMID:503098; http://dx.doi.org/10.1016/ 0027-5107(79)90087-3 74.,Non-OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Nat Commun 2013; 4:1502; PMID:23422670;http://dx.doi.org/10.1038/ncomms2502 76.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Mol Biol Cell 2006; 17:308 –16; PMID:16251353; http://dx.doi.org/10.1091/mbc.E05-07- 0657 77.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
EMBO J 2013; 32:2661 –71; PMID:24065128; http://dx.doi.org/10.1038/ emboj.2013.211 79.,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
Mol Cell 2008; 30:779 –89; PMID:18570879; http://dx.doi.org/10.1016/j.molcel.2008.04.020CELL CYCLE 273,OADS,/arxiv_data1/oa_pdf/2a/87/kccy-15-02-1121353.PMC5007584.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/c2/main.PMC5007586.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/c2/main.PMC5007586.pdf
http://dx.doi.org/10.1016/j.eucr.2016.07.006Urology Case Reports 9 (2016) 1 e3,Non-OADS,/arxiv_data1/oa_pdf/2e/c2/main.PMC5007586.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/c8/main.PMC5007588.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/c8/main.PMC5007588.pdf
http://dx.doi.org/10.1016/j.eucr.2016.07.003Urology Case Reports 9 (2016) 6 e8,Non-OADS,/arxiv_data1/oa_pdf/f1/c8/main.PMC5007588.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/1e/main.PMC5007596.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/1e/main.PMC5007596.pdf
http://dx.doi.org/10.1016/j.eucr.2016.07.013Urology Case Reports 9 (2016) 4 e5,Non-OADS,/arxiv_data1/oa_pdf/b0/1e/main.PMC5007596.pdf
The 561 annotated genes previously reported as upregulated in BxPC3-R cells relative to BxPC3 cells11(data are publicly available under Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/; series accessionnumber GSE73978) were uploaded to miRvestigator (http://mirvestigator.systemsbiology.net) 13and analyzed for overrepresented sequence motifs to identify miRNAs most likely involved in the regulation of these genes through their complementary seeds.,OADS,/arxiv_data1/oa_pdf/fe/f6/cgt201623a.PMC5007605.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information accompanies the paper on Cancer Gene Therapy website (http://www.nature.com/cgt)miRNA 374b in acquired cisplatin resistance R Schreiber et al 245 Cancer Gene Therapy (2016), 241 –245",Non-OADS,/arxiv_data1/oa_pdf/fe/f6/cgt201623a.PMC5007605.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/02/rjw132.PMC5007612.pdf
http://www.mayomedic allaboratories.com/ interpretive-guide/index.html?alpha =H&unit .,OADS,/arxiv_data1/oa_pdf/23/02/rjw132.PMC5007612.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/fb/rjw153.PMC5007613.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/a5/rjw152.PMC5007617.pdf
http://www.altmetric.com/details.php?domain = www.jaad.org&doi =10.1016/s0190-9622(85)70254-x (accessed).,OADS,/arxiv_data1/oa_pdf/1e/a5/rjw152.PMC5007617.pdf
Laryngoscope 1971; 81.http://onlinelibrary.wiley.com/doi/10.1288/00005537- 197110000-00006/pdf (accessed).,Non-OADS,/arxiv_data1/oa_pdf/1e/a5/rjw152.PMC5007617.pdf
Am J Sur Pathol 1988; 12:http://www.ncbi.nlm.nih.gov/pubmed/ 2847572 (accessed).,Non-OADS,/arxiv_data1/oa_pdf/1e/a5/rjw152.PMC5007617.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by- nc-sa/4.0/ rThe Author(s) 2016Editorial 2 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/69/7b/cti201640a.PMC5007625.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2016Editorial 2 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/69/9f/cti201650a.PMC5007629.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by- nc-nd/4.0/ rThe Author(s) 2016MAIT cells and the liver A Kurioka et al 11 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/cd/1b/cti201651a.PMC5007630.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/RSK2 regulates mitotic spindles YY Park et al 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/74/15/emm201661a.PMC5007638.pdf
"24–27Conservation scores (Phylo-P) for each mutated nucleotide were also considered.28 Prediction of alternative splicing by intronic variation was performedusing NetGene2 (http://www.cbs.dtu.dk/services/NetGene2/), Ex-skip(http://ex-skip.img.cas.cz/), and BDGP acceptor site prediction(http://www.fruit ﬂy.org/seq_tools/other.html).",OADS,/arxiv_data1/oa_pdf/66/46/emm201663a.PMC5007639.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)Genetic diagnosis of Korean NPHP-RC HG Kang et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/66/46/emm201663a.PMC5007639.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)HIRA phosphorylation during myogenic differentiation J-H Yang et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/dc/6c/emm201668a.PMC5007640.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experime ntal & Molecular Medicine website (http://www.nature.com/emm)Enhanced DC migration via SERCA2 inhibition by CCL21 CY Hong et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/85/e7/emm201669a.PMC5007641.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)Mitochondrial PDP1 regulates cardiac differentiation HJ Heo et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/90/5c/emm201670a.PMC5007642.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experime ntal & Molecular Medicine website (http://www.nature.com/emm)Role of HMGA1 in ovarian cancer stem cells DK Kim et al 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/ec/e4/emm201673a.PMC5007643.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/fc/ea/main.PMC5007655.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.05.021 357,OADS,/arxiv_data1/oa_pdf/fc/ea/main.PMC5007655.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 709–718 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.08.002 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/bb/b8/main.PMC5007657.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/b8/main.PMC5007657.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bb/b8/main.PMC5007657.pdf
Available online 27 July 2016; http://dx.doi.org/10.1016/j.simyco.2016.07.001 .,OADS,/arxiv_data1/oa_pdf/70/75/main.PMC5007658.pdf
This is an open access article under the CC BY-NC-ND li cense ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 83: 165 –191.,Non-OADS,/arxiv_data1/oa_pdf/70/75/main.PMC5007658.pdf
Fungal Biology .http://dx.doi.org/10.1016/j.funbio.2016.07.004 .,OADS,/arxiv_data1/oa_pdf/70/75/main.PMC5007658.pdf
"To view a copy of this li - cense, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Executive summary Principle of cell sheet engineering •	One of the key challenges in tissue engineering is vascularization.",Non-OADS,/arxiv_data1/oa_pdf/08/c7/rme-11-559.PMC5007660.pdf
"http://hdl.handle.net/1911/88472   9 Chen GN, Qi YY, Niu L et al.",OADS,/arxiv_data1/oa_pdf/08/c7/rme-11-559.PMC5007660.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Elosulfase alfaEnzyme replacement therapy Mucopolysaccharidoses Pregnancy 1.,Non-OADS,/arxiv_data1/oa_pdf/33/7a/main.PMC5007877.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: www.elsevier.com/locate/ymgmr http://dx.doi.org/10.1016/j.ymgmr.2016.08.002 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/7a/main.PMC5007877.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/7a/main.PMC5007877.pdf
"Case MPS typeDelivery, weeksof gestation Mode of delivery Sex baby Weight baby, kg Weight for age %ile Length baby, cm Length for age %ile APGAR Lactation 1 IHS 37 Planned CS Male 2.60 5 –10th 46 5th 9/9/10 No 2 IVA 40 Vaginal Male 3.33 25 –50th 53 90th 9/10/10 4 days 3 IVA 37 Planned CS Female 2.50 5th 46 10th 7/8/9 Short time 38 Planned CS Female 2.89 10–25th 48 25th 8/9/10 Short time 4 IVA 34 Planned CS Female 1.95 b3rd 43 b3rd NA NA 5 IVB 37 Planned CS Male 3.29 25–50th 51 50–75th 7/9/10 9 months 6 VI 40 Vaginal Female 3.36 50th 51.5 75th 10/10/10 NA 7 VI 37 Planned CS Female 2.37 b3rd NA NA 7/8 yes 8 VI 38 Planned CS Male 2.27 b3rd 44 b3rd 9/10/10 4 weeks Mean (SD) 37.6 (1.8) 2.73 (0.51) 47.8 (3.7) CS: Cesarean section; NA: not available.Centers for Disease Control and Prevention (CDC) weight and length for age percentiles (%iles) were derived from https://www.cdc.gov/growthcharts/html_charts/wtageinf.htm and https://www.cdc.gov/growthcharts/html_charts/lenageinf.htm .114 F.J. Stewart et al.",Non-OADS,/arxiv_data1/oa_pdf/33/7a/main.PMC5007877.pdf
"[21] J. Troko, Y. Poonawala, T. Geberhiwot, B. Martin, Multidisciplinary team approach is key for managing pregnancy and delivery in patient with rare, complex MPS I, JIMDRep (2016), http://dx.doi.org/10.1007/8904_2016_527 .",Non-OADS,/arxiv_data1/oa_pdf/33/7a/main.PMC5007877.pdf
Available online 29 July 2016; http://dx.doi.org/10.1016/j.simyco.2016.07.002 .,OADS,/arxiv_data1/oa_pdf/1b/d5/main.PMC5007882.pdf
This is an open access article under the CC BY-NC-ND li cense ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 83: 193 –233.,Non-OADS,/arxiv_data1/oa_pdf/1b/d5/main.PMC5007882.pdf
"Type material was obtained from the collections of the CBS-KNAWFungal Biodiversity Centre, Utrecht, The Netherlands (CBS);Facultat de Medicina, Universitat Rovira I Virgili, Reus, Spain(FMR), Institute of Hygiene and Epidemiology-Mycology Labo-ratory, Brussels, Belgium (IHEM), UAMH Centre for GlobalMicrofungal Biodiversity, University of Toronto, Canada (UAMH)and the University of Texas Health Science Center at San Antonio, Texas, USA (UTHSCSA) ( Table 1 ), and from different herbaria for which acronyms are listed according to Index Her-bariorum ( http://sweetgum.nybg.org/science/ih/ ).",Non-OADS,/arxiv_data1/oa_pdf/1b/d5/main.PMC5007882.pdf
The resulting trees were plotted using FigTree v. 1.4.2 ( http://tree.bio.ed.ac.uk/software/ ﬁgtree/ ).,OADS,/arxiv_data1/oa_pdf/1b/d5/main.PMC5007882.pdf
The alignments originated in this study have been deposited inTreeBASE ( http://www.treebase.org ) and taxonomic novelties in MycoBank ( Crous et al.,OADS,/arxiv_data1/oa_pdf/1b/d5/main.PMC5007882.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/20/78/JPI-7-34.PMC5007902.pdf
"International Journal of Preventive Medicine 2016, 7:102 http://www.ijpvmjournal.net/content/7/1/102Considering the antioxidative potential of probiotics,  the present study was planned to evaluate the  antihyperglycemic, antioxidant, and lipid‑lowering  effect of L. casei , Bifidobacterium  bifidum  alone and in  combination in diabetic Wistar rats.",Non-OADS,/arxiv_data1/oa_pdf/8b/14/IJPVM-7-102.PMC5007903.pdf
"International Journal of Preventive Medicine 2016, 7:102 http://www.ijpvmjournal.net/content/7/1/102Dosing of bacterial strain Single daily dose of L. casei  and B. bifidum  1 × 107 cfu/ml  suspended in 1  ml of distilled water was given to rats  orally by gavaging for 28 days.",Non-OADS,/arxiv_data1/oa_pdf/8b/14/IJPVM-7-102.PMC5007903.pdf
"International Journal of Preventive Medicine 2016, 7:102 http://www.ijpvmjournal.net/content/7/1/102Effect on muscle and liver glycogen content Significant increase in muscle glycogen was observed  on administration of L.  casei  (P  <  0.05, 171.69%),  B. bifidum  (P  <  0.01, 136.47%), and combination  (P  <  0.01, 173.58%) as compared to diabetic control.",Non-OADS,/arxiv_data1/oa_pdf/8b/14/IJPVM-7-102.PMC5007903.pdf
"International Journal of Preventive Medicine 2016, 7:102 http://www.ijpvmjournal.net/content/7/1/102as compared to diabetic control.",Non-OADS,/arxiv_data1/oa_pdf/8b/14/IJPVM-7-102.PMC5007903.pdf
"International Journal of Preventive Medicine 2016, 7:102 http://www.ijpvmjournal.net/content/7/1/102synthetase due to oxidative stress induced by diabetic  state.",Non-OADS,/arxiv_data1/oa_pdf/8b/14/IJPVM-7-102.PMC5007903.pdf
"International Journal of Preventive Medicine 2016, 7:102 http://www.ijpvmjournal.net/content/7/1/102Received:  13 Jul 15  Accepted:  18 Jul 16   Published:  22  Aug 16 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/8b/14/IJPVM-7-102.PMC5007903.pdf
"International Journal of Preventive Medicine 2016, 7:101 http://www.ijpvmjournal.net/content/7/1/101from 4853 subjects.",Non-OADS,/arxiv_data1/oa_pdf/2f/ce/IJPVM-7-101.PMC5007904.pdf
"International Journal of Preventive Medicine 2016, 7:101 http://www.ijpvmjournal.net/content/7/1/101Statistical analysis All calculations were carried out in the statistical software  environment R. For fitting a P‑spline on multinomial  data, we used the codes that written by Kassteele  et al .",OADS,/arxiv_data1/oa_pdf/2f/ce/IJPVM-7-101.PMC5007904.pdf
"International Journal of Preventive Medicine 2016, 7:101 http://www.ijpvmjournal.net/content/7/1/101probability of NS to CS  (initiation) for boys is higher  than girls.",Non-OADS,/arxiv_data1/oa_pdf/2f/ce/IJPVM-7-101.PMC5007904.pdf
"International Journal of Preventive Medicine 2016, 7:101 http://www.ijpvmjournal.net/content/7/1/101Estimates of transitional probabilities are ideally attained  from longitudinal studies, in which cigarette smoking  stages are assessed in subjects repeatedly over time.",Non-OADS,/arxiv_data1/oa_pdf/2f/ce/IJPVM-7-101.PMC5007904.pdf
"International Journal of Preventive Medicine 2016, 7:101 http://www.ijpvmjournal.net/content/7/1/101Financial support and sponsorship This study was a PhD thesis in Epidemiology supported  by Tehran University of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/2f/ce/IJPVM-7-101.PMC5007904.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/d5/67/JCIS-6-32.PMC5007905.pdf
Available  at: http://www.who.int/countryfocus/cooperation_ strategy/ccs_pak_en.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/92/9d/APC-9-210.PMC5007928.pdf
Available at: http://www.who.int/topics/poverty/en 12.,Non-OADS,/arxiv_data1/oa_pdf/92/9d/APC-9-210.PMC5007928.pdf
Available  at: http://culturesocial.blogspot.com/2011/08/ definition-types-and-social-problem.html15.,Non-OADS,/arxiv_data1/oa_pdf/92/9d/APC-9-210.PMC5007928.pdf
Retrieved from:  http://www.childrensheartlink.org/docs/globalreport 23.,Non-OADS,/arxiv_data1/oa_pdf/92/9d/APC-9-210.PMC5007928.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
"8, e1196309 (13 pages)http://dx.doi.org/10.1080/2162402X.2016.1196309",Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J Biol Chem 2000; 275:18897-904; PMID:10858447; http://dx.doi.org/10.1074/jbc.M002411200 4.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
"Arterioscler, Thromb Vasc Biol1997; 17:2341-9; PMID:9409200; http://dx.doi.org/10.1161/01.",Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Immunother- apy 2011; 3:395-406; PMID:21395381; http://dx.doi.org/10.2217/ imt.10.104 6.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J Lipid Res 2012; 53:1472-81; PMID:22589557; http://dx.doi.org/10.1194/jlr.M023234 7.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J Clin Investigat 2008; 118:364-75; PMID:18064300; http://dx.doi.org/10.1172/JCI31539 8.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Muco- sal Immunol 2015; 8:559-71; PMID:25336169; http://dx.doi.org/10.1038/mi.2014.88 9.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Arterioscler Thromb Vasc Biol 2011; 31:2543-51;PMID:21836069; http://dx.doi.org/10.1161/ATVBAHA.111.234716 10.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J Pharmacol Exp Therap 2008; 324:776-83; PMID:18042829; http://dx.doi.org/10.1124/jpet.107.129411 11.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J Immu-nol 2012; 188:2749-58; PMID:22327076; http://dx.doi.org/10.4049/jimmunol.1003445 12.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J Biol Chem 2005; 280:8031-40; PMID:15576377; http://dx.doi.org/10.1074/jbc.M405009200 13.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Diabetologia 2007; 50:643-53;PMID:17216278; http://dx.doi.org/10.1007/s00125-006-0574-z 14.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Cell 2010; 140:805-20; PMID:20303872; http://dx.doi.org/10.1016/j.cell.2010.01.022 16.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Clin Cancer Res: Off J Am Assoc Cancer Res 2011; 17:2619-27; PMID:21372217; http://dx.doi.org/10.1158/1078-0432.CCR-10- 1114 17.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Autoimmunity 2010; 43:196-203; PMID:20298124; http://dx.doi.org/10.3109/08916930903510872 18.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J Biol Chem 2007; 282:20047-51; PMID:17502369;http://dx.doi.org/10.1074/jbc.R70000420019.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
New Engl J Med2007; 356:115-24; PMID:17215529; http://dx.doi.org/10.1056/ NEJMoa065044 20.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Nat Med 2013; 19:837-49; PMID:23836234; http://dx.doi.org/10.1038/nm.3248 21.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
CancerRes 2007; 67:8285-92; PMID:17804743; http://dx.doi.org/10.1158/ 0008-5472.CAN-07-1025 24.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J Biol Chem 2004; 279:36072-82; PMID:15199068; http://dx.doi.org/10.1074/jbc.M314264200 25.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J Neurochem 2013; 126:261-73; PMID:23600947; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Ann Neurol 2014; 75:876-89; PMID:24752976; http://dx.doi.org/10.1002/ana.24159 27.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Sci- ence 2003; 300:1524-5; PMID:12791976; http://dx.doi.org/10.1126/science.1085536 28.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J Lipid Res 2004; 45:1256-65; PMID:15102890; http://dx.doi.org/10.1194/jlr.M300358-JLR200 31.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Virology 1983; 130:195-203; PMID:6314645; http://dx.doi.org/10.1016/0042-6822(83)90127-7 32.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J CellBiol 2007; 179:935-50; PMID:18056411; http://dx.doi.org/10.1083/ jcb.200706034 33.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Mol Biol Cell 2006; 17:2896-909; PMID:16624862; http://dx.doi.org/10.1091/mbc.E06-01-0076e1196309-12 M. VASQUEZ ET AL.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J Biol Chem 2009; 284:19826-34; PMID:19491399; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J Biol Chem 2009; 284:22878-87; PMID:19542230; http://dx.doi.org/10.1074/jbc.M109.018580 37.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Nat Immunol 2009; 10:1200-7; PMID:19801985; http://dx.doi.org/10.1038/ni.1792 39.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
PloS One 2013; 8:e80743; PMID:24349012; http://dx.doi.org/ 10.1371/journal.pone.0080743 40.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Cytokine 2015; 72:17-24; PMID:25544181; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Nat Immunol 2004; 5:1109-15; PMID:15496950; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J Biol Chem 2002; 277:34125-35; PMID:12110672; http://dx.doi.org/10.1074/jbc.M20426520044.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J Biol Chem 2006; 281:4348-53; PM ID:16368683; http://dx.doi.org/ 10.1074/jbc.M513154200 46.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
J Biol Chem2004; 279:14372-81; PMID:14726519; http://dx.doi.org/10.1074/jbc.M313793200 47.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Neuro-biol Aging 2005; 26:813-23; PMID:15718039; http://dx.doi.org/ 10.1016/j.neurobiolaging.2004.08.004 48.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Mol Cell Endocrinol 2002; 195:1-26; PMID:12354669; http://dx.doi.org/ 10.1016/S0303-7207(02)00222-8 49.,OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Nat Rev Immunol 2015; 15:231-42;PMID:25790790; http://dx.doi.org/10.1038/nri3806 51.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Cancer Res 2015; 75:497-507; PMID:25527611; http://dx.doi.org/10.1158/0008-5472.CAN-13-3356 52.,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
Gene Ther 2012; 19:271-8; PMID:21734727; http://dx.doi.org/10.1038/gt.2011.99ONCOIMMUNOLOGY e1196309-13,Non-OADS,/arxiv_data1/oa_pdf/a5/ed/koni-05-08-1196309.PMC5007953.pdf
"Publ ished with license by Taylor & Francis Group, LLC.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/3.0/ ), which permits unrestricted use, distribu- tion, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
"8, e1202390 (13 pages)http://dx.doi.org/10.1080/2162402X.2016.1202390",Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
N Engl JMed 2012; 366:2455; PMID:22658128; http://dx.doi.org/10.1056/NEJMoa1200694 2.,OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Annu Rev Immunol 2008; 26:677-704; PMID:18173375; http://dx.doi.org/10.1146/annurev.immunol.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
J Exp Med2000; 192:1027-34; PMID:11015443; http://dx.doi.org/10.1084/jem.192.7.1027 5.,OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
JExp Med 2009; 206:1327-37; PMID:19451266; http://dx.doi.org/ 10.1084/jem.20082173 7.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Immunity 1999; 11:141-51; PMID:10485649; http://dx.doi.org/10.1016/S1074-7613 (00)80089-8 8.,OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Immunol Lett 2002; 84:57-62; PMID:12161284; http://dx.doi.org/10.1016/S0165-2478(02)00142-6 9.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
J Immunol2002; 169:5538-45; PMID:12421930; http://dx.doi.org/10.4049/ jimmunol.169.10.5538 10.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
"J Clin Invest 2003; 111:363-70; PMID:12569162; http://dx.doi.org/10.1172/ JCI16015 11 Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K et al.",OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Tumor-associated B7-H1 pro- motes T-cell apoptosis: A potential mechanism of immune evasion.Nat Med 2002; 8:793-800; PMID:12091876; http://dx.doi.org/10.1038/nm730 12.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Sci Transl Med 2012; 4:127ra37; PMID:22461641; http://dx.doi.org/ 10.1126/scitranslmed.3003689 13.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Blood 2009; 114:1537-44; PMID:19423728; http://dx.doi.org/10.1182/blood-2008-12-195792 14.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Ann Oncol 2014; 25:2433-42; PMID:25223485; http://dx.doi.org/10.1093/annonc/mdu452 1 5 .,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Combinednivolumab and ipilimumab or monotherapy in untreated melanoma.N Engl J Med 2015; 373:23-34; PMID:26027431; http://dx.doi.org/ 10.1056/NEJMoa1504030 17.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Cancer Immunol Res 2015; 3:610-9; PMID:25701325; http://dx.doi.org/10.1158/2326-6066.CIR-14-0138 19.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
ISRN Oncol 2013; 2013:371854; PMID:23840967; http://dx.doi.org/10.1155/2013/371854 20.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
J Clin Oncol 2008; 26:3621-30; PMID:18640940;http://dx.doi.org/10.1200/JCO.2007.15.7198 21.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Oncogene 2001; 20:4101-6; PMID:11494138; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Mol Cancer 2010; 9:301; PMID:21092273;http://dx.doi.org/10.1186/1476-4598-9-301 23.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
J Biol Chem 2005; 280:10025-33; PMID:15644326; http://dx.doi.org/10.1074/jbc.M413673200 24.,OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Br J Haematol 2014; 164:304-7; PMID:24164421; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Clin Cancer Res 2011; 17:5626-37; PMID:21753155; http://dx.doi.org/10.1158/1078- 0432.CCR-11-0303 26.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
MAbs 2015; 7:321-30; PMID:25760768; http://dx.doi.org/10.1080/19420862.2015.1007811 27.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Int J Cancer 2004; 109:281-90; PMID:14750182; http://dx.doi.org/10.1002/ijc.11702e1202390-12 D. HENDRIKS ET AL.,OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Cancer Immunol Immunother 1997; 45:203-6; PMID:9435874; http://dx.doi.org/10.1007/s002620050433 29.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Scand J Immunol 2014; 79:305-14; PMID:24521472; http://dx.doi.org/10.1111/sji.12162 30.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Biochem J 2002;365:825-32; PMID:11936954; http://dx.doi.org/10.1042/BJ20020184 32.,OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Nat Med 2003; 9:562-7; PMID:12704383; http://dx.doi.org/10.1038/nm863 34.,OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Clin Cancer Res 2013; 19:3165-75; PMID:23613317; http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Cancer Immunol Res 2015; 3:1052-1062;PMID:25943534; http://dx.doi.org/10.1158/2326-6066.CIR-14-0191 36.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
J Clin Invest 1999;104:155-62; PMID:10411544; http://dx.doi.org/10.1172/JCI6926 37.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Expert Opin Biol Ther 2010; 10:1-18; PMID:19857186; http://dx.doi.org/ 10.1517/14712590903319656 38.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
J Clin Oncol 2010; 28:2839-46; PMID:20458040; http://dx.doi.org/10.1200/JCO.2009.25.1991 39.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
JImmunol 2014; 193:4021-31; PMID:25217163; http://dx.doi.org/ 10.4049/jimmunol.130324240.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
J Clin Oncol 2010; 28:1527-33; PMID:20159815; http://dx.doi.org/10.1200/JCO.2009.25.4847 41.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
"J Clin Oncol 2011; 29:4442-51; PMID:22010015; http://dx.doi.org/ 10.1200/JCO.2011.37.2623 42. de Bruyn M, Bremer E, Helfrich W. Antibody-based fusion proteins to target death receptors in cancer.",OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Cancer Lett 2013; 332:175-83;PMID:21215513; http://dx.doi.org/10.1016/j.canlet.2010.11.006 43.,OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
"J Clin Invest 2015; 125:487-9;PMID:25642709; http://dx.doi.org/10.1172/JCI80420 44. de Miguel D, Lemke J, Anel A, Walczak H, Martinez-Lostao L. Onto better TRAILs for cancer treatment.",Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Cell Death Differ Advance online publication 4 March 2016; 23(5):733-47; PMID:26943322; http://dx.doi.org/10.1038/cdd.2015.174 45.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Clin Transl Oncol 2015; 17:657-67; PMID:25967100; http://dx.doi.org/10.1007/s12094-015-1295-x 47.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Curr Drug Targets 2009; 10:94-103; PMID:19199904; http://dx.doi.org/10.2174/138945009787354593 48.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
PLoS One 2013; 8:e77050;PMID:24130833; http://dx.doi.org/10.1371/journal.pone.0077050 49.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Cancer Immunol Immunother 2015; 64:677-88; PMID:25742933; http://dx.doi.org/10.1007/s00262-015-1671-y 50.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Leukemia 2016; 30:484-491; PMID:26239198;http://dx.doi.org/10.1038/leu.2015.214 51.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
Clin Cancer Res 2004; 10:7466-74; PMID:15569976; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/koni-05-08-1202390.PMC5007955.pdf
"8, e1203498 (3 pages)http://dx.doi.org/10.1080/2162402X.2016.1203498",Non-OADS,/arxiv_data1/oa_pdf/3c/03/koni-05-08-1203498.PMC5007959.pdf
Curr Opin Chem Biol 2013; 17(3):385-92; PMID:23623807; http://dx.doi.org/10.1016/j.cbpa.2013.03.029 2.,OADS,/arxiv_data1/oa_pdf/3c/03/koni-05-08-1203498.PMC5007959.pdf
Sci- ence 2008; 321(5891):974-7; PMID:18703743; http://dx.doi.org/ 10.1126/science.1158545 3.,Non-OADS,/arxiv_data1/oa_pdf/3c/03/koni-05-08-1203498.PMC5007959.pdf
Clin Cancer Res 2015; 21(18):4035-9;PMID:26374073; http://dx.doi.org/10.1158/1078-0432.CCR-15-0612 4.,Non-OADS,/arxiv_data1/oa_pdf/3c/03/koni-05-08-1203498.PMC5007959.pdf
Sci Transl Med 2015; 7(287):287ra270; PMID:25972002; http://dx.doi.org/10.1126/scitranslmed.aaa4802 5.,Non-OADS,/arxiv_data1/oa_pdf/3c/03/koni-05-08-1203498.PMC5007959.pdf
Sci Rep 2015; 5:17943; PMID:26659273; http://dx.doi.org/10.1038/srep179436.,OADS,/arxiv_data1/oa_pdf/3c/03/koni-05-08-1203498.PMC5007959.pdf
Clin Cancer Res 2016 Jul 1; 22 (13):3286-97; PMID:26861458; http://dx.doi.org/10.1158/1078- 0432.CCR-15-1696 7.,Non-OADS,/arxiv_data1/oa_pdf/3c/03/koni-05-08-1203498.PMC5007959.pdf
PLoS One 2012; 7(5):e36412;PMID:22574157; http://dx.doi.org/10.1371/journal.pone.0036412 8.,Non-OADS,/arxiv_data1/oa_pdf/3c/03/koni-05-08-1203498.PMC5007959.pdf
[Epub ahead of print]; PMID:27117182; http://dx.doi.org/10.1158/1078-0432.CCR-15-2622 9.,Non-OADS,/arxiv_data1/oa_pdf/3c/03/koni-05-08-1203498.PMC5007959.pdf
J Immunother 2016 Jul 11; [Epub ahead of print]; PMID:27404941; http://dx.doi.org/10.1097/CJI.0000000000000132ONCOIMMUNOLOGY e1203498-3,Non-OADS,/arxiv_data1/oa_pdf/3c/03/koni-05-08-1203498.PMC5007959.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 3.0/), which permits unrestricted use, distribu- tion, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
"8, e1164364 (9 pages)http://dx.doi.org/10.1080/2162402X.2016.1164364",Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
J Exp Med 1996; 183:1461-72; PMID:8666904; http://dx.doi.org/10.1084/jem.183.4.1461 2.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Immunol Lett 2007; 112:1-8; PMID:17698207; http://dx.doi.org/10.1016/j.imlet.2007.06.009 3.,OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Front Immunol 2012; 3:350;PMID:23230435; http://dx.doi.org/10.3389/ ﬁmmu.2012.003504.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Cancer Res 2011; 71:5678-87; PMID:21846823; http://dx.doi.org/10.1158/0008-5472.CAN-11-0431 5.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Oncoimmunology 2012; 1:829-39; PMID:23162750; http://dx.doi.org/10.4161/onci.20492 6.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Cancer 1996;77:1303-10; PMID:8608507; http://dx.doi.org/10.1002/(SICI)1097-0142(19960401)77:7 <1303::AID-CNCR12 >3.0.CO;2-5 7.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Oncoimmunology 2014; 3:e28976; PMID:25083325; http://dx.doi.org/10.4161/onci.28976 8.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Nat Commun 2015; 6:7114; PMID:25968334; http://dx.doi.org/ 10.1038/ncomms8114 9.,OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Pediatr Blood Can-cer 2013; 60:175-84; PMID:23109216; http://dx.doi.org/10.1002/ pbc.24367 11.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Pediatr Dermatol2008; 25:291-5; PMID:18577030; http://dx.doi.org/10.1111/j.1525- 1470.2008.00669.x 12.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Blood 2013; 121:5006-14; PMID:23589673; http://dx.doi.org/10.1182/ blood-2012-09-455774 13.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Pediatr Blood Cancer 2007; 48:696-9; PMID:17252574; http://dx.doi.org/10.1002/pbc.21145 14.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Blood 2010; 116:1919- 23; PMID:20519626; http://dx.do i.org/10.1182/blood-2010-04-279083 15.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Blood 2014;124:1655-8; PMID:24982505; http://dx.doi.org/10.1182/blood-2014-05-577361 16.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Blood 2014; 123:3152-5; PMID:24652991; http://dx.doi.org/ 10.1182/blood-2013-06-511139 17.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
PLoS Med 2007; 4:e253; PMID:17696642; http://dx.doi.org/10.1371/journal.pmed.0040253ONCOIMMUNOLOGY e1164364-7,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Am J Surg Pathol 2014; 38:999-1006; PMID:24805861; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Hepatology 1995; 22:389-94;PMID:7635405; http://dx.doi.org/10.1002/hep.1840220203 23.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Arthritis Rheum 2003; 48:3187-201; PMID:14613282; http://dx.doi.org/10.1002/art.11311 24.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Arthritis Rheum 2005; 52:1773-84; PMID:15934082; http://dx.doi.org/10.1002/art.21062 25.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Ann Rheum Dis 2007; 66:720-6; PMID:17223654; http://dx.doi.org/10.1136/ard.2006.062042 2 6 .,OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Lymphat Res Biol 2011; 9:85-92; PMID:21688977; http://dx.doi.org/10.1089/lrb.2010.0018 27.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
PLoS One 2013; 8:e63470; PMID:23723985; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Exp Mol Pathol 2013; 94:121-5; PMID:22750048; http://dx.doi.org/10.1016/j.yexmp.2012.06.004 29.,OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Blood 2012; 120:e28-e34; PMID:22859608;http://dx.doi.org/10.1182/blood-2012-06-429597 30.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
"Nat Rev Immunol 2012; 12:762-73; PMID:23018291; http://dx.doi.org/10.1038/nri3298 31. de Chaisemartin L, Goc J, Damotte D, Validire P, Magdeleinat P, Ali- fano M, Cremer I, Fridman WH, Saut /C18es-Fridman C, Dieu-Nosjean MC et al.",OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Cancer Res 2011; 71:6391-9; PMID:21900403; http://dx.doi.org/10.1158/0008-5472.CAN-11-0952 32.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Nat Rev Immunol 2004; 4:360-70; PMID:15122201; http://dx.doi.org/10.1038/nri1354 33.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Nat Rev Immunol 2006; 6:205-17; PMID:16498451;http://dx.doi.org/10.1038/nri1786 34.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Immunol Today 1995;16:449-57; PMID:7546210; http://dx.doi.org/10.1016/0167-5699(95) 80023-9 35.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
J Exp Med 1994; 180:2219-26; PMID:7525849; http://dx.doi.org/10.1084/jem.180.6.2219 36.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
JClin Immunol 2014; 34:84-93; PMID:24254535; http://dx.doi.org/ 10.1007/s10875-013-9959-1 38.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Pathol Biol (Paris) 2007; 55:73-83; PMID:16815642; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
J Immunol 2002; 169:424-33;PMID:12077273; http://dx.doi.org/10.4049/jimmunol.169.1.424 40.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Blood 2004; 104:3021-7; PMID:15284119; http://dx.doi.org/10.1182/blood-2004-02-0701 41.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
J Immunol 2010; 184:4557-67; PMID:20220088; http://dx.doi.org/.4049/jimmunol.0902336 42.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
J Exp Med 2014; 211:669-83; PMID:24638167; http://dx.doi.org/10.1084/jem.20130977 43.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Br J Haematol 2014; 169(1):3-3; PMID:25430560; http://dx.doi.org/10.1111/bjh.13247 44.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Paediatr Drugs 2011; 13:75-86;PMID:21351807; http://dx.doi.org/10.2165/11538540-0000000-00-00000 45.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Curr Opin Pediatr 2008; 20:23-9; PMID:18197035;http://dx.doi.org/10.1097/MOP.0b013e3282f45ba4 46.,OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Pathol Int 2010; 60:27-34; PMID:20055949; http://dx.doi.org/10.1111/j.1440-1827.2009.02472.x 47.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Onco- target 2015; 6:19819-25; PMID:26110571; http://dx.doi.org/10.18632/ oncotarget.4378 48.,OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Cancer Res 2012; 72:3997-4007; PMID:22850419; http://dx.doi.org/10.1158/0008-5472.CAN-12-1377 49.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Arthritis Rheum 2009; 60:3217-24; PMID:19877042; http://dx.doi.org/10.1002/art.24913 51.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
PLoS One 2008; 3:e3262;PMID:18810271; http://dx.doi.org/10.1371/journal.pone.0003262 52.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Oncoim- munology 2013; 2:e26836; PMID:24498556; http://dx.doi.org/10.4161/onci.2683653.,OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Int Arch AllergyImmunol 2014; 164:13-26; PMID:24852691; http://dx.doi.org/ 10.1159/000362332 54.,OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
J Neurosurg 2000; 93:312-6; PMID:11012067; http://dx.doi.org/10.3171/spi.2000.93.2.0312 55.,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
Blood 2006; 108:432-40;PMID:16543475; http://dx.doi.org/10.1182/blood-2005-06-2383ONCOIMMUNOLOGY e1164364-9,Non-OADS,/arxiv_data1/oa_pdf/37/90/koni-05-08-1164364.PMC5007962.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
"8, e1199311 (10 pages)http://dx.doi.org/10.1080/2162402X.2016.1199311",Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Oncoimmunology [Internet] 2015; 4:e1046673; PMID:26451319; http://dx.doi.org/10.1080/2162402X.2015.1046673 2.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Sci Transl Med [Internet] 2015; 7:280ps7-280ps7; PMID:25810311; http://dx.doi.org/10.1126/scitranslmed.aaa3643 4.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Semin Oncol [Internet] 2015; 42:626-39; PMID:26320066; http://dx.doi.org/10.1053/j.seminoncol.2015.05.005 5.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Front Immunol [Internet] 2015; 6:286; PMID:26089823; http://dx.doi.org/10.3389/ ﬁmmu.2015.00286 6.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
J Exp Med 1991; 174:139-49; PMID:1711560; http://dx.doi.org/10.1084/jem.174.,OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Bone MarrowTransplant 2006; 38:621-7; PMID:16980990; http://dx.doi.org/ 10.1038/sj.bmt.1705503 9.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Int Immunol 2008; 20:841-8;PMID:18469328; http://dx.doi.org/10.1093/intimm/dxn042 11.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Exp Hematol 2009; 37:616-28; PMID:19375652; http://dx.doi.org/10.1016/j.exphem.2009.01.010 12.,OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Nat Immunol 2000; 1:119-26; PMID:11248803; http://dx.doi.org/10.1038/77793 14.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Science 1999; 285:727-9; PMID:10426993; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
J Immunol [Internet] 2005; 175:7819-28; PMID:16339517; http://dx.doi.org/10.4049/jimmunol.175.12.7819 17.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
J Cancer Res Clin Oncol[Internet] 2014; 141:839-49; PMID:25381063; http://dx.doi.org/10.1007/s00432-014-1864-3 18.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Blood 2011; 118:3301-10; PMID:21821703; http://dx.doi.org/10.1182/blood-2011-02-336321 19.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Ann Hematol 1997; 74:51-6; PMID:9063373; http://dx.doi.org/10.1007/s002770050257 21.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Science 2006; 311:1780-4;PMID:16556847; http://dx.doi.org/10.1126/science.1121411 23.,OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Adv Immunol [Internet] 1989; 47:187-376; PMID:2683611; http://dx.doi.org/10.1016/S0065-2776(08)60664-1 24.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Hum Immunol 2000; 61:1-6;PMID:10658972; http://dx.doi.org/10.1016/S0198-8859(99)00162-7 25.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
J Exp Med 1997; 186:1129-36;PMID:9314561; http://dx.doi.org/10.1084/jem.186.7.1129 26.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Cell Immunol 1992; 143:97-107; PMID:1377991; http://dx.doi.org/10.1016/0008-8749(92)90008-D 27.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Int J Cancer [Internet] 2008; 122:2526-34;PMID:18307255; http://dx.doi.org/10.1002/ijc.23365 28.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
ClinCancer Res [Internet] 2007; 13:1552- 61; PMID:17332301; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Nat Rev Cancer [Internet] 2012; 12:278-87; PMID:22437872; http://dx.doi.org/10.1038/nrc3236 31.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
Immunol Lett 1993;37:139-44; PMID:7505001; http://dx.doi.org/10.1016/0165-2478(93) 90023-U 32.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/koni-05-08-1199311.PMC5007963.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
"8, e1204505 (18 pages)http://dx.doi.org/10.1080/2162402X.2016.1204505",Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Eur J Cancer 2009; 45:261-7; PMID:19091550; http://dx.doi.org/10.1016/j.ejca.2008.10.028 2.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Br J Cancer 2006; 95:1362-6;PMID:17088912; http://dx.doi.org/10.1038/sj.bjc.6603443 3.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Am J Pathol 2007; 170:774-86; PMID:17255343; http://dx.doi.org/10.2353/ajpath.2007.060761 4.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Cancer Res 2006; 66:10365-76; PMID:17062557; http://dx.doi.org/10.1158/0008-5472.CAN-06-2977 5.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Oncogene 2008; 27:3145-55; PMID:18059331;http://dx.doi.org/10.1038/sj.onc.1210973 6.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
PLoS Med 2005; 2:e284; PMID:16124834; http://dx.doi.org/10.1371/journal.pmed.0020284 8.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
AmJ Pathol 2003; 163:2233-45; PMID:14633598; http://dx.doi.org/10.1016/S0002-9440(10)63581-X 9.,OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Histopathology 2012; 61:1065-71; PMID:22957497; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Lymphangiogenesis in regional lymph nodes is an independent prog-nostic marker in rectal cancer patients after neoadjuvant treatment.PLoS One 2011; 6:e27402; PMID:22087309; http://dx.doi.org/10.1371/ journal.pone.0027402 11.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Clin Cancer Res 2007; 13:5391-7; PMID:17875768;http://dx.doi.org/10.1158/1078-0432.CCR-07-1230 12.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Sci Rep 2015; 5:12255; PMID:26193241; http://dx.doi.org/10.1038/srep12255 13.,OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Neoplasia 2011; 13:748-57; PMID:21847366; http://dx.doi.org/10.1593/neo.11756 14.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Nature 2011; 479:542-6; PMID:22080953; http://dx.doi.org/10.1038/nature10540 15.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Exp Med 1976; 143:870-88; PMID:1255114; http://dx.doi.org/10.1084/jem.143.4.870 16.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Immunity 2006; 24:203-15; PMID:16473832; http://dx.doi.org/10.1016/j.immuni.2006.01.003 17.,OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Nature 2006; 440:540-4; PMID:16525420; http://dx.doi.org/10.1038/nature04606 18.,OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Br J Cancer 1984; 49:477-84; PMID:6424695; http://dx.doi.org/10.1038/bjc.1984.75 19.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Exp Med 2002; 195:651-6; PMID:11877488; http://dx.doi.org/10.1084/jem.20012023 20.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Nat Rev Immunol 2006; 6:659-70; PMID:16932751; http://dx.doi.org/10.1038/nri1919 21.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Cancer Res 2007; 67:5009-16; PMID:17510433; http://dx.doi.org/10.1158/0008-5472.CAN-06-4494 22.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Cell Rep 2012; 1:191-9; PMID:22832193;http://dx.doi.org/10.1016/j.celrep.2012.01.005 23.,OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Exp Med 2010; 207:1791-804; PMID:20660615; http://dx.doi.org/10.1084/jem.20092454 26.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Trends Immunol 2012; 33:271-80;PMID:22459312; http://dx.doi.org/10.1016/j.it.2012.02.00727.,OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Semin Immunol 1999; 11:73-83; PMID:10329494;http://dx.doi.org/10.1006/smim.1999.0163 28.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Blood 2012;119:978-89; PMID:22039261; http://dx.doi.org/10.1182/blood-2011- 06-364273 29.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Proc Natl Acad Sci U S A 2008; 105:10871-6; PMID:18663225; http://dx.doi.org/ 10.1073/pnas.0802278105 30.,OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Nat Rev Immunol 2012; 12:762-73; PMID:23018291; http://dx.doi.org/10.1038/nri3298 31.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Nature 1983; 304:30-4; PMID:6866086; http://dx.doi.org/10.1038/304030a0 32.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Exp Med 1990;171:801-17; PMID:2307933; http://dx.doi.org/10.1084/jem.171.3.801 33.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Immunology 2007; 120:1-7; PMID:17233737; http://dx.doi.org/10.1111/j.1365-2567.2006.02511.x 34.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Annu Rev Immunol 2014; 32:659-702; PMID:24655300; http://dx.doi.org/ 10.1146/annurev-immunol-032713-120145 37.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Nat Immunol 2008; 9:970-80; PMID:18711434; http://dx.doi.org/10.1038/ni.f.213 38.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Leukoc Biol 2004; 76:709-18; PMID:15197239; http://dx.doi.org/10.1189/jlb.1203643 40.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Annu Rev Immunol 2012; 30:69-94; PMID:22149932; http://dx.doi.org/10.1146/annurev-immunol-020711- 075011 41.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Immunol Rev 2003; 194:48-60; PMID:12846807; http://dx.doi.org/10.1034/j.1600- 065X.2003.00041.x 43.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Nature 2002; 416:94-9; PMID:11882900; http://dx.doi.org/10.1038/416094a 45.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Cell 1996; 87:1037-47; PMID:8978608; http://dx.doi.org/10.1016/S0092-8674(00)81798-5ONCOIMMUNOLOGY e1204505-17,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Immunity 2008; 28:122-33; PMID:18164221;http://dx.doi.org/10.1016/j.immuni.2007.11.017 4 7 .,OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Blood 2002; 99:1109-16; PMID: 11830455; http://dx.doi.org/10.1182/blood.V99.4.1109 48.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Nat Rev Immunol 2011; 11:403-15; PMID:21546914; http://dx.doi.org/10.1038/nri2974 49.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Immunology 2014; 142:347- 53; PMID:24597601; http://dx.doi.org/10.1111/imm.12272 5 0 .,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Exp Med 2010; 207:1475-83;PMID:20584883; http://dx.doi.org/10.1084/jem.20091343 51.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Biol Chem 2010; 285:22328-37; PMID:20463015; http://dx.doi.org/10.1074/jbc.M110.123299 52.,OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Immunopharmacol Immunotoxicol 1999; 21:565-82; PMID:10466080; http://dx.doi.org/10.3109/08923979909007126 53.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
JImmunol 2011; 186:3432-40; PMID:21289303; http://dx.doi.org/10.4049/jimmunol.1002169 54.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Mucosal Immunol 2014; 7:892-904; PMID: 24345804; http://dx.doi.org/10.1038/mi.2013.105 56.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Blood 2013; 121:2914-22; PMID:23422746; http://dx.doi.org/10.1182/blood-2012-07-445783 57.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Science 2007; 316:295-8; PMID:17363629; http://dx.doi.org/10.1126/science.1139221 58.,OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Exp Med 2009; 207:17-27; PMID:20026661; http://dx.doi.org/10.1084/jem.20091619 59.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Lipid Res 2014; 55:1839-46; PMID:24474820; http://dx.doi.org/10.1194/jlr.R046656 60.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Immunol 2006; 177:6081-90; PMID:17056534; http://dx.do i.org/10.4049/jimmunol.177.9.6081 63.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Mediators In ﬂamm 2016; 2016:8606878; PMID:26966342; http://dx.doi.org/10.1155/2016/8606878 64.,OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Cell Mol Med 2015; 19:2329-40; PMID:26171944; http://dx.doi.org/ 10.1111/jcmm.12635 65.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer.Clin Cancer Res 2015; 21:1925-34; PMID:25589614; http://dx.doi.org/10.1158/1078-0432.CCR-14-2031 66.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Pathol 2012; 226:806-13; PMID:22170282; http://dx.doi.org/10.1002/path.3975 68.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Immunol 2010; 185:4873-82; PMID:20833836; http://dx.doi.org/10.4049/jimmunol.1000676 69.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Exp Med 1965; 121:901-10; PMID:14319406; http://dx.doi.org/10.1084/jem.121.6.901 70.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Immunol 2015; 195:3531-6; PMID:26355150; http://dx.doi.org/10.4049/jimmunol.1500626 71.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
PLoS One 2014; 9:e95626; PMID:24752354; http://dx.doi.org/10.1371/journal.pone.0095626 72.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Transl Med 2011;9:214; PMID:22168571; http://dx.doi.org/10.1186/1479-5876-9-214 73.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Immunol Cell Biol 2012; 90:235-42;PMID:21556017; http://dx.doi.org/10.1038/icb.2011.35 74.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Cancer Cell 2014; 25:809-21; PMID:24909985; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Int Immunol 2015; 27:521-30; PMID:25999597; http://dx.doi.org/10.1093/intimm/dxv034 77.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
JExp Med 2014; 211:2583-98; PMID:25422496; http://dx.doi.org/ 10.1084/jem.20141132 78.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Clin Invest 2014; 124:943-52; PMID:24590280; http://dx.doi.org/10.1172/JCI73316 79.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
J Clin Cell Immu-nol 2014; 5:242 –250; PMID:25580369; http://dx.doi.org/10.4172/ 2155-9899.1000242.,OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
Cancer Cell 2006; 9:225-38; PMID:16530706; http://dx.doi.org/10.1016/j.ccr.2006.02.023e1204505-18 L. M. HABENICHT ET AL.,OADS,/arxiv_data1/oa_pdf/6e/9e/koni-05-08-1204505.PMC5007965.pdf
"8, e1201625 (9 pages)http://dx.doi.org/10.1080/2162402X.2016.1201625",Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
2013; 49:1374-403; PMID:23485231; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Melanoma Res 2015; 25:461-9; PMID:26426764; http://dx.doi.org/10.1097/CMR.0000000000000200 3.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
NEngl J Med 2010; 363:711-23; PMID:20525992; http://dx.doi.org/10.1056/NEJMoa1003466 4.,OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
N Engl J Med 2011;364:2517-26; PMID:21639810; http://dx.doi.org/10.1056/ NEJMoa1104621 5.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
J Clin Oncol 2014; 32:1020-30; PMID:24590637; http://dx.doi.org/10.1200/JCO.2013.53.0105 6.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
N Engl J Med 2015; 372:2521-32;PMID:25891173; http://dx.doi.org/10.1056/NEJMoa1503093 7.,OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
N Engl J Med2011; 364:2507-16; PMID:21639808; http://dx.doi.org/10.1056/ NEJMoa1103782 8.,OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
N Engl J Med 2015; 372:30-9; PMID:25399551; http://dx.doi.org/10.1056/NEJMoa1412690 9.,OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
N Engl JMed 2014; 371:1867-76; PMID:25265494; http://dx.doi.org/10.1056/NEJMoa1408868 10.,OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Lancet Oncol 2014; 15:e257-67;PMID:24872109; http://dx.doi.org/10.1016/S1470-2045(13)70585-0 11.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Oncoimmunology 2016; 5:e1057673; PMID:26942068; http://dx.doi.org/10.1080/2162402X.2015.1057673 12.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Cancer Res 2012; 72:6102-10; PMID:23010076; http://dx.doi.org/10.1158/0008-5472.CAN-12-2479 13.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Cancer Res 2013; 73:19-29;PMID:23087058; http://dx.doi.org/10.1158/0008-5472.CAN-12-1127 14.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Immunity 2013; 39:38-48; PMID:23890062; http://dx.doi.org/10.1016/j.immuni.2013.07.004 15.,OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Oncoimmunology 2013; 2:e23431; PMID:23802086; http://dx.doi.org/10.4161/onci.23431 16.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Oncoimmunology 2015; 4:e1019197;PMID:26405571; http://dx.doi.org/10.1080/2162402X.2015.101919717.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
"Gajewski TF, Meng Y, Blank C, Brown I, Kacha A, Kline J, Harlin H. Immune resistance orchestrated by the tumor microenvironment.Immunol Rev 2006; 213:131-45; PMID:16972901; http://dx.doi.org/10.1111/j.1600-065X.2006.00442.x 18.",OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Cancer Res 2012; 72:876-86; PMID:22174368; http://dx.doi.org/10.1158/0008-5472.CAN-11-1792 19.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
J Clin Oncol 2015; 33:1889-94; PMID:25667295; http://dx.doi.org/10.1200/JCO.2014.56.2736 20.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
J Clin Oncol 2015; 33:3193-8;PMID:26282644; http://dx.doi.org/10.1200/JCO.2015.60.8448 21.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Cancer Immunol Immunother 2011; 60:1137-46; PMID:21465316; http://dx.doi.org/10.1007/s00262-011-1011-9 23.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
N Engl J Med 2015; 373:23-34; PMID:26027431; http://dx.doi.org/ 10.1056/NEJMoa1504030 24.,OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
PloS one 2013; 8:e81624;PMID:24312329; http://dx.doi.org/10.1371/journal.pone.0081624 25.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Cancer Invest 2008; 26:624-33; PMID:18584354; http://dx.doi.org/ 10.1080/07357900802027073 26.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Cancer ImmunolImmunother 2014; 63:449-58; PMID:24609989; http://dx.doi.org/10.1007/s00262-014-1528-9 27.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Clin Cancer Res 2016; 22(12):2908-18; PMID:26787752; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Lancet Oncol 2015; 16:522-30; PMID: 25840693; http://dx.doi.org/10.1016/S1470-2045(15)70122-1 29.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Clin Cancer Res 2012; 18:5460-70;PMID:22896657; http://dx.doi.org/10.1158/1078-0432.CCR-11-3368e1201625-8 S. BOUDEWIJNS ET AL.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
"Vaccine 2015; 33:7377-85; PMID:26482147; http://dx.doi.org/10.1016/j.vaccine.2015.10.057 31. van Elsas A, Hurwitz AA, Allison JP.",Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
J Exp Med 1999; 190:355-66; PMID:10430624; http://dx.doi.org/10.1084/jem.190.3.355 32.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Cancer Immunol Res 2014; 2:448-58; PMID:24795357; http://dx.doi.org/10.1158/2326-6066.CIR-13-0220 33.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
J Clin Oncol 2016; 34(12):1330-8; PMID:26926680; http://dx.doi.org/ 10.1200/JCO.2015.63.4121 34.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Science 2015; 348:69-74; PMID:25838375; http://dx.doi.org/ 10.1126/science.aaa4971 35.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Science 2015; 348:803-8; PMID:25837513; http://dx.do i.org/10.1126/science.aaa3828 36.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Lancet Oncol 2010; 11:155-64; PMID:20004617; http://dx.doi.org/ 10.1016/S1470-2045(09)70334-1 37.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Efﬁcacy and safety of ipilimumab monotherapy in patients with pre- treated advanced melanoma: a multicenter single-arm phase II study.Ann Oncol 2010; 21:1712-7; PMID:20147741; http://dx.doi.org/ 10.1093/annonc/mdq013 38.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
J Clin Oncol 2009; 27:6199-206; PMID:19917835; http://dx.doi.org/10.1200/JCO.2009.23.4799 39.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Cancer Res 2009; 69:2927-34; PMID:19318559; http://dx.doi.org/10.1158/ 0008-5472.CAN-08-3920 40.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Clin Cancer Res 2011;17:5725-35; PMID:21771874; http://dx.doi.org/10.1158/1078- 0432.CCR-11-1261 41.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Cancer Res 2013; 73:1063-75; PMID:23345163; http://dx.doi.org/10.1158/0008-5472.CAN-12-2583 42.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Clin Cancer Res 2015; 22:2155-66; PMID:26712687; http://dx.doi.org/10.1158/ 1078-0432.CCR-15-2205 43.,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
Cancer Immu- nol Immunother 2016; 65:327-39; PMID:26861670; http://dx.doi.org/ 10.1007/s00262-016-1796-7ONCOIMMUNOLOGY e1201625-9,Non-OADS,/arxiv_data1/oa_pdf/64/3a/koni-05-08-1201625.PMC5007966.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
"8, e1192739 (14 pages)http://dx.doi.org/10.1080/2162402X.2016.1192739",Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
The normalized log2 transformed datasets was z-scored (setting the data to a mean D0 and a variance D1) and heat maps were generated using freely availably GeneE program ( http://www.broadinstitute.org/ ).,OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Nat Rev Cancer 2005; 5:65-72; PMID:15630416; http://dx.doi.org/10.1038/nrc1529 2.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Nat Rev Immunol 2008; 8:59-73; PMID:18097448; http://dx.doi.org/10.1038/nri2216 3.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Nat Rev Drug Discov 2011; 10:591-600; PMID:21804596; http://dx.doi.org/10.1038/nrd3500 4.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Clin Cancer Res 2014; 20:2831-7; PMID:24879823; http://dx.doi.org/ 10.1158/1078-0432.CCR-13-3141 5.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Oncogene 2009; 29:482- 91; PMID:19881547; http://dx.doi.org/10.1038/onc.2009.356 6.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
J Clin Invest 2011; 121:3100-8; PMID:21765211; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
J Immunol 2003; 170:4905-13; PMID:12734333; http://dx.doi.org/10.4049/jimmunol.170.10.4905 8.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Oncotarget 2014; 5:5190-1; PMID:25114034; http://dx.doi.org/10.18632/oncotarget.2266 9.,OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Nat Med2007; 13:54-61; PMID:17187072; http://dx.doi.org/10.1038/nm1523 10.,OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
EMBO J 2009; 28:578-90; PMID:19165151; http://dx.doi.org/10.1038/emboj.2009.1 11.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Immunity 2013; 38:729- 41; PMID:23562161; http://dx.doi.org/10.1016/j.immuni.2013.03.003e1192739-12 S. DI BLASIO ET AL.,OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Nat Med 2007; 13:1050-9; PMID:17704786;http://dx.doi.org/10.1038/nm1622 14.,OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Front Oncol2015; 5:7; PMID:25688334; http://dx.doi.org/10.3389/fonc.2015.00007 15.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Cell Cycle 2006; 5:812-7; PMID:16627996; http://dx.doi.org/10.4161/cc.5.8.2646 16.,OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
J Mol Med 2007; 85:1069-76; PMID:17891368; http://dx.doi.org/10.1007/s00109-007-0214-1 17.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Nat Med 2009; 15:1170-8; PMID:19767732; http://dx.doi.org/10.1038/nm.2028 18.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Blood2002; 100:4512-20; PMID:12393628; http://dx.doi.org/10.1182/blood- 2001-11-0097 19.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Blood 2007; 109:5371-9; PMID:17332250; http://dx.doi.org/10.1182/blood-2006-08-038422 20.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Genome Biol 2008; 9:R17-R; PMID:18218067; http://dx.doi.org/10.1186/gb-2008-9-1-r17 21.,OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Cancer Immunol Immunother 2010; 59:1573-82; PMID:20204387; http://dx.doi.org/10.1007/s00262-010-0833-1 22.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Blood 2013;121:459-67; PMID:23212525; http://dx.doi.org/10.1182/blood-2012-06-435644 23.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
J Assoc Pediatr Oncol Nurses 1989; 6:21-2; http://dx.doi.org/10.1177/104345428900600210 25.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Sci Transl Med 2010; 2:63ra94-63ra94;PMID:21178137; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Proc NatlAcad Sci U S A 2013; 110:3011-6; PMID:23388639; http://dx.doi.org/ 10.1073/pnas.1222861110 27.,OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
J Immunol 2004; 172:70-8; PMID:14688311; http://dx.doi.org/10.4049/jimmunol.172.1.70 29.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
EMBO J 2003; 22:6127-36;PMID:14609958; http://dx.doi.org/10.1093/emboj/cdg572 30.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
"SREC-I, a Type F Scavenger Receptor, Is an Endocytic Receptor for Calreticulin.J Biol Chem 2004; 279:51250-7; PMID:15371419; http://dx.doi.org/10.1074/jbc.M406202200 31. de Visser KE, Eichten A, Coussens LM.",OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Nat Rev Cancer 2006;6:24-37; PMID:16397525; http://dx.doi.org/10.1038/nrc1782 32.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Eur J Cancer 2013; 49:2965-7; PMID:23890942; http://dx.doi.org/10.1016/j.ejca.2013.06.019 33.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Neoplasia 2015; 17:661- 70; PMID:26408258; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
PLoS Biol 2005; 3:e185; PMID:15839733; http://dx.doi.org/10.1371/journal.pbio.0030185 35.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Immunity 2002; 17:211-20; PMID:12196292; http://dx.doi.org/10.1016/S1074-7613(02)00365-5 36.,OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Front Immunol 2015; 6:501; PMID:26483791; http://dx.doi.org/10.3389/ ﬁmmu.2015.00501 37.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.J Exp Med 2005; 202:1691-701; PMID:16365148; http://dx.doi.org/ 10.1084/jem.20050915 38.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Cyclophospha- mide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis.Cancer Res 2011; 71:768-78; PMID:21156650; http://dx.doi.org/10.1158/0008-5472.CAN-10-2788 39.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Blood 2007; 109:4839-45; PMID:17299090; http://dx.doi.org/10.1182/ blood-2006-10-054221 40.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Cell Death Differ 2007; 14:1848-50; PMID:17657249; http://dx.doi.org/10.1038/sj.cdd.4402201 41.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Cell Death Differ 2014; 21:59-68; PMID:23787997; http://dx.doi.org/10.1038/cdd.2013.73 42.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Cisplatin versus carboplatin:com- parative review of therapeutic management in solid malignancies.CritRev Oncol Hematol 2016;102:37-46; PMID:27105947; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Blood 2009; 113:5839-47; PMID:19351958; http://dx.doi.org/ 10.1182/blood-2008-10-184796 44.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Immunology 2013; 140:22-30; PMID:23621371; http://dx.doi.org/ 10.1111/imm.12117 45.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Front Immunol 2013; 4:53; PMID:23450201; http://dx.doi.org/10.3389/ ﬁmmu.2013.00053 4 7 .,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
"Demaria S, Santori FR, Ng B, Liebes L, Formenti SC, Vukmanovic S. Select forms of tumor cell apoptosis induce dendritic cell maturation.J Leukoc Biol 2005; 77:361-8; PMID:15569694; http://dx.doi.org/ 10.1189/jlb.0804478 49.",OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Cancer Immunol Immunother 2015; 64:1461-73; PMID:26275446; http://dx.doi.org/10.1007/s00262-015-1746-9 50.,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
J Immunol 2005; 175:4839-46; PMID:16210585; http://dx.doi.org/10.4049/jimmunol.175.8.4839 5 2 .,Non-OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
Bioinformatics 2004; 20:307-15;PMID:14960456; http://dx.doi.org/10.1093/bioinformatics/btg405e1192739-14 S. DI BLASIO ET AL.,OADS,/arxiv_data1/oa_pdf/c7/6e/koni-05-08-1192739.PMC5007971.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
"8, e1208875 (10 pages)http://dx.doi.org/10.1080/2162402X.2016.1208875",Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Arterioscler Thromb Vasc Biol 2012; 32:2097-103; PMID:22772752;http://dx.doi.org/10.1161/ATVBAHA.111.226837 2.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Blood 2013; 122:9-18; PMID:23678003;http://dx.doi.org/10.1182/blood-2013-02-482406 3.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Trends Mol Med 2013; 19:355-67; PMID:23601906; http://dx.doi.org/10.1016/j.molmed.2013.03.005 5.,OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Proc Natl Acad Sci USA2006; 103:13132-7; PMID:16916931; http://dx.doi.org/0605251103 6.,OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Cancer Immunol Immunother 2012; 61:917-26;PMID:22116345; http://dx.doi.org/10.1007/s00262-011-1155-7 7.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Cancer Res 2012; 72:2190-6; PMID:22396496; http://dx.doi.org/10.1158/0008-5472.CAN-12-0420 8.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
PLoS One 2014; 9:e116253; PMID:25549098; http://dx.doi.org/10.1371/journal.pone.0116253 9.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Cancer Immunol Res 2015; 3:506-17; PMID:25672397; http://dx.doi.org/10.1158/2326-6066.CIR-14-0211 10.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Cancer Discov 2014; 4:879-88; PMID:25035124; http://dx.doi.org/10.1158/2159-8290.CD-14-0341 11.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Comput Struct Bio- technol J 2015; 13:265-72; PMID:25941561; http://dx.doi.org/10.1016/ j.csbj.2015.03.008ONCOIMMUNOLOGY e1208875-9,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Acta Crystallogr D Biol Crystallogr 2008; 64:700-4; PMID:18560159; http://dx.doi.org/10.1107/S0907444908007877 14.,OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Mol Cancer 2013; 12:11-4598-12-11; PMID:23406016; http://dx.doi.org/10.1186/1476-4598-12-11 15.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Sci Transl Med 2015; 7:280sr1; PMID:25810313; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Front Immunol 2015; 5:673; PMID:25628622; http://dx.doi.org/10.3389/ ﬁmmu.2014.00673 18.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
J Immunotoxicol 2014; 11:311-8; PMID:24495309; http://dx.doi.org/10.3109/1547691X.2013.865094 19.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Curr Opin Immunol 2013; 25:230-7; PMID:23414607; http://dx.doi.org/ 10.1016/j.coi.2013.01.004 20.,OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Clin Cancer Res 2013; 19:5626-35; PMID:23983257; http://dx.doi.org/10.1158/1078-0432.CCR-13-0545 21.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
J Immunol 2008; 181:464-75; PMID:18566412; http://dx.doi.org/181/1/464 23.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Int J Cancer 2014; 134:1466-73; PMID:23982901; http://dx.doi.org/10.1002/ijc.28456 24.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
JImmunol 2013; 191:4165-73; PMID:24043904; http://dx.doi.org/10.4049/jimmunol.1301274 25.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Cancer Res 2014; 74:7239-49;PMID:25341542; http://dx.doi.org/10.1158/0008-5472.CAN-13-3581 26.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Comput Struct Bio- technol J 2015; 13:265-72; PMID:25941561; http://dx.doi.org/10.1016/j.csbj.2015.03.008 27.,OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
J Leukoc Biol 2015; 98:631-9; PMID:26089537; http://dx.doi.org/10.1189/jlb.3A0315-101R28.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Cancer Res 2010; 70:2245-55; PMID:20179192; http://dx.doi.org/10.1158/0008-5472.CAN-09-3109 30.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
"Forte G, Sorrentino R, Montinaro A, Luciano A, Adcock IM, Maiolino P, Arra C, Cicala C, Pinto A, Morello S. Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma.J Immunol 2012; 189:2226-33; PMID:22826317; http://dx.doi.org/10.4049/jimmunol.1200744 31.",Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
J Immunol 2011; 187:6120-9; PMID:22039302; http://dx.doi.org/ 10.4049/jimmunol.1101225 32.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Expert Rev Clin Immunol 2014; 10:897-914; PMID:24871693; http://dx.doi.org/ 10.1586/1744666X.2014.915739 33.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Immunotherapy 2015; 7:499-512; PMID: 26065476; http://dx.doi.org/10.2217/imt.15.16 34.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Cancer Res 2015; 75:2139-45; PMID:25977340; http://dx.doi.org/10.1158/0008-5472.CAN-15-0255 35.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
FrontImmunol 2013; 4:221; PMID:23935598; http://dx.doi.org/10.3389/ ﬁmmu.2013.00221 39.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
J Immunol Methods 2006; 313:129-39; PMID:16730741; http://dx.doi.org/10.1016/j.jim.2006.04.002 40.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
Acta Crystallogr D Biol Crystallogr 2008; 64:700-4; PMID:18560159; http://dx.doi.org/10.1107/S0907444908007877 41.,OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
J Biomol Screen 2012; 17:993-8; PMID:22522649; http://dx.doi.org/10.1177/1087057112443987 42.,Non-OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
2011; PMID:21595115; http://dx.doi.org/NBK54050 [bookaccession]e1208875-10 C. M. HAY ET AL.,OADS,/arxiv_data1/oa_pdf/a8/10/koni-05-08-1208875.PMC5007986.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.08.014 2211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/23/ab/main.PMC5008039.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/ab/main.PMC5008039.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/23/ab/main.PMC5008039.pdf
http://dx.doi.org/10.1016/j.burns.2015.02.009 .,OADS,/arxiv_data1/oa_pdf/23/ab/main.PMC5008039.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/ab/main.PMC5008039.pdf
"Rep. 20 (2), 49 –62 Available at: http://www.nova.edu/ ssss/QR/QR20/2/lehna4.pdf .",Non-OADS,/arxiv_data1/oa_pdf/23/ab/main.PMC5008039.pdf
http://dx.doi.org/10.1097/BCR.ob013e318233591c .,Non-OADS,/arxiv_data1/oa_pdf/23/ab/main.PMC5008039.pdf
http://dx.doi.org/10.1097/BCR.0b013e3182335903 .,Non-OADS,/arxiv_data1/oa_pdf/23/ab/main.PMC5008039.pdf
"JBCR 33 (1), 58 –64.http://dx.doi.org/10.1097/BCR.0b013e318278169a .",Non-OADS,/arxiv_data1/oa_pdf/23/ab/main.PMC5008039.pdf
http://dx.doi.org/10.1097/BCR.0b013e3182223c6f .,Non-OADS,/arxiv_data1/oa_pdf/23/ab/main.PMC5008039.pdf
"FEMA Retrieved January 30, 2016 from: https://www.usfa.fema.gov/downloads/pdf/statistics/res_bldg_ ﬁre_estimates.pdf .",OADS,/arxiv_data1/oa_pdf/23/ab/main.PMC5008039.pdf
"United States Fire Administration, d. Home ﬁre safety checklist Retrieved on 29 January 2016 from http://www.usfa.fema.gov/downloads/pdf/home_safety_checklist.pdf .",OADS,/arxiv_data1/oa_pdf/23/ab/main.PMC5008039.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Free-water imagingSchizophrenia Delusions Limbic systemDiffusion Tensor Imaging 1.,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.nicl.2016.08.004 2213-1582/© 2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1176/appi.ajp.2015.14101358 .,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.schres.2014.01.015 .,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
"36 (1), 69 –80.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
"White matter abnormalities in ﬁrst-episode schizophrenia: a combined structural MRI and D T Is t u d y .S c h i z o p h r .R e s .1 1 9( 1 –3), 52 –60.http://dx.doi.org/10.1016/j.schres.",Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.10.004 .,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/S0304-3940(01)01637-8 .,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.schres.2007.,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1093/cercor/ 12.11.1218 .,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.mehy.2006.03.,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.cortex.2008.05.002 .,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.schres.2009.01.014 .,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
"66 (1), 34 –43.http://dx.doi.org/10.1111/j.1440-1819.2011.02293 .",Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1176/appi.ajp.159.5.813 .,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1097/JCP.0b013e3181a44575 .,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.bbi.2009.11.005 .,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.3109/00048674.2010.,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
"162 (1 –3), 1 –6.http://dx.doi.org/10.1016/j.schres.2014.12.041 .",OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1176/jnp.9.3.315 .,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.08.043 .,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.neuron.,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.schres.2006.10.005 .,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
"62 (3), 717 –73 0. http://dx.doi.org/ 10.1002/mrm.22055 .",Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.2904-12.2012 .,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.schres.2014.,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
"161 (1), 70 –75.http://dx.doi.org/10.1016/j.schres.",OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/0306- 9877(78)90048-8 .,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
"9 (144), 1–13.http://dx.doi.org/10.3389/fnbeh.2015.00144 .",Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
"29 (2), 68 –74.http://dx.doi.org/10.1016/ j.tins.2005.12.005 .",OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1176/appi.ajp.159.12.1983 .,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.01.028 .,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1152/physrev.00027.2007 .,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.schres.2008.03.008 .,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1016/j.brainres.2010.04.,OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1017/ S1461145707007626 .,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
http://dx.doi.org/10.1002/nbm.,Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
"161 (1), 36 –41.http://dx.doi.org/10.1016/j.schres.2014.08.033 .",OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
"5, 93 –99.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/84/4c/main.PMC5008040.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ExerciseInternetNetworkOnline social networksSocial comparison 1.,Non-OADS,/arxiv_data1/oa_pdf/cc/3a/main.PMC5008041.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.08.008 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/3a/main.PMC5008041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/3a/main.PMC5008041.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/cc/3a/main.PMC5008041.pdf
Clinical Trial Registration—URL: http://www.clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/38/38/hyp-68-1049.PMC5008043.pdf
*A list of all Members of the CHIPS Trial Collaborative Group is given in the online-only Data Supplement.The online-only Data Supplement is available with this article at http://hyper.ahajournals.org/lookup/suppl/doi:10.1161/HYPERTENSIONAHA.,Non-OADS,/arxiv_data1/oa_pdf/38/38/hyp-68-1049.PMC5008043.pdf
"This is an open access article  under the terms of the Creative Commons Attribution Non-Commercial-NoDervis License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.The Cost Implications of Less Tight Versus Tight Control of  Hypertension in Pregnancy (CHIPS Trial) Rashid J. Ahmed, Amiram Gafni, Eileen K. Hutton, Zheng Jing Hu, Eleanor Pullenayegum   Peter von Dadelszen, Evelyne Rey, Susan Ross, Elizabeth Asztalos, Kellie E. Murphy,   Jennifer Menzies, J. Johanna Sanchez, Wessel Ganzevoort, Michael Helewa, Shoo K. Lee,   Terry Lee, Alexander G. Logan, Jean-Marie Moutquin, Joel Singer, Jim G. Thornton,   Ross Welch, Laura A. Magee, for the CHIPS Trial Collaborative Group* Hypertension is available at http://hyper.ahajournals.org DOI: 10.1161/HYPERTENSIONAHA.116.07466 Arterial Stiffness",Non-OADS,/arxiv_data1/oa_pdf/38/38/hyp-68-1049.PMC5008043.pdf
2013. http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/demo02a-eng.htm.,OADS,/arxiv_data1/oa_pdf/38/38/hyp-68-1049.PMC5008043.pdf
2014. https://secure.cihi.ca/estore/productSeries.,Non-OADS,/arxiv_data1/oa_pdf/38/38/hyp-68-1049.PMC5008043.pdf
http://www5.statcan.gc.ca/cansim/a26?lang=eng&retrLang=eng&id=3260021&paSer=&pattern=&stByVal=1&p1=1&p2=37&tabMode=dataTable&csid=.,OADS,/arxiv_data1/oa_pdf/38/38/hyp-68-1049.PMC5008043.pdf
2015. http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/38/38/hyp-68-1049.PMC5008043.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.07.008,Non-OADS,/arxiv_data1/oa_pdf/a4/e9/main.PMC5008045.pdf
The MALDI-TOF MS spectrum of “Ihuprevotella massiliensis ”strain Marseille-P2826Tis available at http://www.mediterranee-infection.com/article.php?,Non-OADS,/arxiv_data1/oa_pdf/a4/e9/main.PMC5008045.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,2 1 –23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a4/e9/main.PMC5008045.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,2 1 –23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a4/e9/main.PMC5008045.pdf
http://dx.doi.org/10.1016/j.nicl.2016.08.014 2213-1582/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/a2/b3/main.PMC5008046.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/b3/main.PMC5008046.pdf
"2.4. fMRI data pre-processing The resting-state fMRI datasets underwent a pipeline of preprocess- ing procedure, which were performed with AFNI ( http://afni.nimh.nih.",OADS,/arxiv_data1/oa_pdf/a2/b3/main.PMC5008046.pdf
"gov/afni ) and FSL ( http://www.fmrib.ox.ac.uk/fsl )p r o g r a m sw i t ha bash wrapper shell( Wang and Li, 2013, 2015 ).",Non-OADS,/arxiv_data1/oa_pdf/a2/b3/main.PMC5008046.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ADHDfMRISingle-trial variability Intraindividual variability Reaction timeAnxiety 1.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1016/j.nicl.2016.08.007 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
"The preprocessed data were then decomposed into 70 components using a high model order group ICA with the GIFT toolbox ( http://mialab.mrn.org/software/gift ), where the spatial ICA maps are generated with the infomax algorithm ( Be  ll and Sejnowski, 1995 ;s e e Eichele et al., 2008 ).",OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1002/hbm.20929 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
"5, 2. http://dx.doi.org/10.3389/fnsys.2011.00002 .",Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1037/a0032071 .402 L. Sørensen et al.,OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1016/j.neubiorev.2008.09.002 .,OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1038/npp.2009.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1080/09297040802646991 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1016/j.dcn.2013.10.003 .,OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1016/S0165-0327(03)00103-4 .,OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.3109/ 15 622975.2011.570376 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1097/YCO.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.4299-10.2011 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1007/s00406-003-0442-5 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1111/j.1469-7610.2006.01671.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1073/ pnas.0708965105 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1002/hbm.21170 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1038/npp.2008.69 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1016/j.brainres.2009.02.070 .,OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1037/0033-2909.132.4.560 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1111/j.1469-7610.2008.01926.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1111/jcpp.12217 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1097/00004583-199707000-00021 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.12.035 .,OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1002/hbm.20813 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1016/j.cpr.2013.06.001 .,OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
"9, 67 –91.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1017/S0033291713001955 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1097/ 00004583-199704000-00019 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1177/1087054705283616 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.2007.01.013 .,OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
"78 (2 –3), 60 –68.http://dx.doi.org/10.1016/j.brainresbull.2008.08.015 .",OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1016/j.neubiorev.2007.02.005 .,OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1007/s10802-009- 9316-2 .403 L. Sørensen et al.,OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1176/appi.ajp.2007.06050876 .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1007/s11682-014-9323-y .,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2924-11.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.2009.01.022 .,OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/main.PMC5008047.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/6f/main.PMC5008048.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.08.027 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/c3/6f/main.PMC5008048.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cushing's diseasePositron emission tomographyCortisol Voxel-based analysis 1.,Non-OADS,/arxiv_data1/oa_pdf/d1/cb/main.PMC5008049.pdf
http://dx.doi.org/10.1016/j.nicl.2016.08.0182213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/cb/main.PMC5008049.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/cb/main.PMC5008049.pdf
http://dx.doi.org/10.1016/j.nicl.2016.08.020 2213-1582/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
"Image processing In order to obtain measures of cortical thickness, raw data were imported into FreeSurfer version 5.0 ( http://surfer.mgh.harvard.edu ).",OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
"4, 147. http://dx.doi.org/10.3389/fnsys.2010.00147 .",Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
U. S. A. http://dx.doi.org/10.1073/ pnas.0400087101 .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1523/JNEUROSCI.,OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1080/0022250X.2001.9990249 .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1038/nrn2575 .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
"70, 1 –6.http://dx.doi.org/ 10.1103/PhysRevE.70.066111 .",Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1038/nature07239 .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
URL http://cran.r-project.org/web/packages/igraph/igraph.pdf (accessed1.1.15).,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.18637/jss.v048.i04 .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
"Cortex 14, 11 –22.http://dx.doi.org/10.1093/cercor/bhg087 .",OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1016/0378-8733(78)90021-7 .,OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1093/ brain/awp089 .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
PLoS One 3. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1016/j.nicl.2013.09.013 .,OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
"8, 1 –18.http://dx.doi.org/10.3389/fnbeh.2014.00393 .",Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/ 10.1038/mp.2013.50 .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
"41, 15 –30.http://dx.doi.org/10.1016/j.jpsychires.2005.05.005 .",OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0333-10.2010 .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
"214, 637. http://dx.doi.org/10.1038/214637b0 .",Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1016/B978- 012264841-0/50048-2 .,OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1371/journal.pone.0058429 .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
"7, 402. http://dx.doi.org/10.3389/fnhum.",Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1186/s11689- 015-9120-y .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
"Gen. Psychi- atry 49, 246. http://dx.doi.org/10.1001/archpsyc.1992.01820030078011 .",Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1093/bioinformatics/btn482 .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2013.07.064 .,OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1007/s00702-016-1548-z .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1093/cercor/bhm211 .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.3174/ajnr.A4003 .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
"14, 3 –10.http://dx.doi.org/10.1002/ddrr.2 .",Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
1–11http://dx.doi.org/10.1017/S0033291713001669 .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
"24, 32 –48.http://dx.doi.org/10.1007/s11065-014-9248-7 .",Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1523/JNEUROSCI.,OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
PLoS One 5. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.04.,OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
"http://dx.doi.org/10.1093/bioinformatics/ btp674 .Watts, D.J., Strogatz, S.H., 1998.",OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1038/30918 .,Non-OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
http://dx.doi.org/10.1016/j.schres.2012.08.021 .428 J.E.,OADS,/arxiv_data1/oa_pdf/12/d3/main.PMC5008050.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Concurrent EEG + fMRI PerceptionN100P200SchizophreniaAvolition/apathy 1.,Non-OADS,/arxiv_data1/oa_pdf/10/e8/main.PMC5008052.pdf
http://dx.doi.org/10.1016/j.nicl.2016.08.009 2213-1582/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/10/e8/main.PMC5008052.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/e8/main.PMC5008052.pdf
"Next, mean beta imageswere normalized by applying the spatial transformation matrix derived from normalization of the mean functional image (generated during motion correction) to the Montreal Neurological Institute's EPI template (http://www.bic.mni.mcgill.ca ).",OADS,/arxiv_data1/oa_pdf/10/e8/main.PMC5008052.pdf
NeuroImage http://dx.doi.org/ 10.1016/j.neuroimage.2016.04.034 .,OADS,/arxiv_data1/oa_pdf/10/e8/main.PMC5008052.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.07.013,Non-OADS,/arxiv_data1/oa_pdf/b2/e9/main.PMC5008057.pdf
massiliensis ”is available at: http://www.mediterranee-infection.com/article.php?,Non-OADS,/arxiv_data1/oa_pdf/b2/e9/main.PMC5008057.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,1 9 –20 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/b2/e9/main.PMC5008057.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/8d/main.PMC5008058.pdf
"The graft aims  to  provide  reliable,  continuous  blood  ﬂow  directly  from http://dx.doi.org/10.1016/j.ijscr.2016.08.004 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/16/8d/main.PMC5008058.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.08.0172211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/6a/55/main.PMC5008059.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/55/main.PMC5008059.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/6a/55/main.PMC5008059.pdf
http://www.cdc.gov/ healthyyouth/obesity/facts.htm .,Non-OADS,/arxiv_data1/oa_pdf/6a/55/main.PMC5008059.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/)which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source arecredited.562 DOMAGAL-GOLDMAN AND WRIGHT ET AL.",Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"Many nations have space programs, and more information about planetary missions can be found at the various agen- cies’ websites (listed alphabetically): /C15CNSA: http://www.cnsa.gov.cn/n615709/cindex.html /C15ESA: http://sci.esa.int/science-e/www/area/index.cfm?",Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
fareaid=7 /C15ISRO: www.isro.gov.in /C15JAXA: http://www.jaxa.jp/projects/sas/planetary/index_e.html /C15NASA: http://science.nasa.gov /planetary-scie nce/missions /C15RFSA: http://www.federalspace.ru/main.php?id=25 FIG.,OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"(These data comefrom the Exoplanet Orbit Database, http://exoplanets.org.",OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"Data areconﬁrmed planets with mass estimates (http://exoplanet.eu, downloaded November 19, 2015).THE ASTROBIOLOGY PRIMER 609",Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
A few exoplanets have been directly photographed (seehttp://apod.nasa.gov/apod/ap081114.html and http://apod.nasa .gov/apod/ap081117.html).,Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"Shortly after that historic announcement (http://www2.jpl.nasa.gov/snc/clinton.html), the ﬁndings were disputed by a number ofstudies that showed abiotic production of similar small, highly ordered magnetite crystals (Golden et al.",Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"There is one professional, worldwide inter-national astrobiology society: the International Society for the Study of the Origin of Life–the International Astro- biology Society (ISSOL; http://issol.org).",Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"Astrobiology-speciﬁc journals include Astrobiology , the International Journal of Astrobiology , and Origins of Life and Evolution of Biospheres Astrobiology news outlets are available to the public through organizations and websites that include NASA’s Astro-biology page (http://astrobiol ogy.nasa.gov), Astrobiology Ma- gazine (http://www.astrobio.net), Astrobiology Web (http:// astrobiology.com), the SETI Institute (http://www.seti.org), New Scientist’s astrobiology page (http://www.newscientist.com/topic/astrobiology), and the sub-Reddit community for astrobiology (http://www.reddit.com/r/astrobiology).",Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
Thisdocument is available online at https://astrobiology.nasa .gov/uploads/ﬁler_public/01/28/01283266-e401-4dcb-8e05- 3918b21edb79/nasa_astrobiology_strategy_2015_151008.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
Some European programs can be found on the EANA website (http://www.eana-net.eu).,Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
The NASA Wavelength directory (http://nasawavelength.org) lists space science education resources for a range of different audiences.,OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"Available online at http://articles.adsabs.harvard.edu/full/1999tpf..book.....B/0000001.000 .html Beinert, H. (2000) A tribute to sulfur.",Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"Available online at http://seti.berkeley.edu Berner, R.A., VandenBrooks, J.M., and Ward, P.D.",Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"Available online at https://cosparhq.cnes.fr/sites/default/ ﬁles/pppolicy.pdf Cotner, J.B. and Hall, E.K.",Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"Available online at http://www.esa.int/esaEO Esposito, L.W., Knollenberg, R.G., Marov, M.I., Toon, O.B., Turco, R.P., Colin, L., Donahue, T.M., and Moroz, V.I.",Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"Available online at http://www.eorc.jaxa.jp/en Jehlicka, J., Edwards, H.G.M., and Culka, A.",OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"Available online at http://msl-scicorner.jpl.nasa.gov/Instruments/SAM Mahaffy, P.R., Webster, C.R., Stern, J.C., Brunner, A.E., Atreya, S.K., Conrad, P.G., Domagal-Goldman, S., Eigen- brode, J.L., Flesch, G.J., Christensen, L.E., Franz, H.B., Freissinet, C., Glavin, D.P., Grotzinger, J.P., Jones, J.H., Leshin, L.A., Malespin, C., McAdam, A.C., Ming, D.W., Navarro-Gonza ´lez, R., Niles, P.B., Owen, T., Pavlov, A.A., Steele, A., Trainer, M.G., Williford, K.H., and Wray, J.J; MSL Science Team.",Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
Available online at http://planetaryprotection.nasa.gov NASA Science.,Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"Available online at http://science.nasa.gov/earth-science Nassif, T.H.",Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"Available online at http://www.seti.org/page .aspx?pid=345 Shapiro, R. (1999) Prebiotic cytosine synthesis: a critical analysis and implications for the origin of life.",Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"Available online at https://www.terc.edu/display/Products/Astrobiology%3A+An+ Integrated+Science+Approach Theobald, D.L.",Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
"Available online at http://nssdc.gsfc.nasa.gov/planetary/factsheet Williams, D.M.",Non-OADS,/arxiv_data1/oa_pdf/f4/bb/ast.2015.1460.PMC5008114.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode BMJ Quality Improvement Reports 2016; 5:210329.w4679.,Non-OADS,/arxiv_data1/oa_pdf/41/77/bmjqir-u210329-w4679corr1.PMC5008122.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode BMJ Quality Improvement Reports 2016; 5:u209539.w3933 doi:10.1136/bmjquality.u209539.w3933corr1 BMJ Quality Improvement Reports 2016; 5:u209539.w3933.,Non-OADS,/arxiv_data1/oa_pdf/c9/35/bmjqir-u209539-w3933corr1.PMC5008124.pdf
< http://www.healthtalk.org/peoples-experiences/improving-health-care/ patient-and-public-involvement-research/reasons-getting-involved-personal-benefits >.,Non-OADS,/arxiv_data1/oa_pdf/72/6f/policy-12-008.PMC5008125.pdf
< http://www.healthtalk.org/peoples-experiences/improving-health-care/ patient-and-public-involvement-research/reasons-getting-involved-personal-benefits >.,Non-OADS,/arxiv_data1/oa_pdf/5b/6f/policy-12-010.PMC5008126.pdf
< http://www.hhmi.org/biointeractive/ some-animals-are-more-equal-others-keystone-species-and-trophic-cascades >.,Non-OADS,/arxiv_data1/oa_pdf/70/66/policy-12-012.PMC5008127.pdf
< http://www.cbc.ca/radio/quirks/quirks-quarks-for-apr-23-2016-1.3548885/ the-serengeti-rules-1.3549082 >.,Non-OADS,/arxiv_data1/oa_pdf/70/66/policy-12-012.PMC5008127.pdf
<http://news.gc.ca/web/article-en.do?nid=1029069 >.,Non-OADS,/arxiv_data1/oa_pdf/5b/e8/policy-12-018.PMC5008128.pdf
< http://healthaffairs.org/blog/2015/10/21/the-daraprim-price-hike-and-a-role-for-antitrust/ >.,Non-OADS,/arxiv_data1/oa_pdf/5b/e8/policy-12-018.PMC5008128.pdf
< http://www.thestar.com/opinion/commentary/2016/04/23/eric-hoskins-quiet-campaign-for- pharmacare-hepburn.html >.,Non-OADS,/arxiv_data1/oa_pdf/5b/e8/policy-12-018.PMC5008128.pdf
< http://stats.oecd.org/ >.,Non-OADS,/arxiv_data1/oa_pdf/5b/e8/policy-12-018.PMC5008128.pdf
< http://ess.rccbc.ca/wp-content/uploads/ sites/5/2014/12/JSC-Report-Feb-1.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/4f/15/policy-12-037.PMC5008129.pdf
"For comparison with Figure 1, Appendix 2 (available at: http://www.longwoods.com/con - tent/24717 ) shows the Statistical Area Classification (SAC) groupings of Census Subdivisions  (CSDs) overlaid with LHA boundaries (Statistics Canada 2015).",OADS,/arxiv_data1/oa_pdf/7b/fa/policy-12-043.PMC5008130.pdf
< http://publications.gc.ca/ collections/collection_2013/icis-cihi/H118-86-1-2013-eng.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/7b/fa/policy-12-043.PMC5008130.pdf
< https://www.oma.org/Resources/Documents/2008RIO- FullTechnicalPaper.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/7b/fa/policy-12-043.PMC5008130.pdf
< https://secure.cihi.ca/free_products/ out_of_province_aib_201003_e.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/b5/60/policy-12-059.PMC5008132.pdf
< https://secure.cihi.ca/free_products/ HSP_Framework_Technical_Report_EN.pdf >.,OADS,/arxiv_data1/oa_pdf/b5/60/policy-12-059.PMC5008132.pdf
< http://dx.doi.org/10.3402/ijch.v72i0.21112 >.,Non-OADS,/arxiv_data1/oa_pdf/b5/60/policy-12-059.PMC5008132.pdf
< http://apps.who.int/gho/data/node.main.78?lang=en >.,OADS,/arxiv_data1/oa_pdf/b5/60/policy-12-059.PMC5008132.pdf
< https://www.nice.org.uk/guidance/qs53 >.,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/policy-12-084.PMC5008134.pdf
< http://www.health.gov.on.ca/en/pro/programs/fht/docs/fht_ inter_team.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/policy-12-084.PMC5008134.pdf
< http://www.health.gov.on.ca/en/pro/programs/fht/docs/fht_compensation.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/policy-12-084.PMC5008134.pdf
< http://www.health.gov.on.ca/en/pro/programs/fht/ >.,Non-OADS,/arxiv_data1/oa_pdf/3a/8c/policy-12-084.PMC5008134.pdf
< http://www.euro.who.int/__data/assets/ pdf_file/0003/248304/Addressing-needs-in-the-public-health-workforce-in-Europe.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/39/a2/policy-12-101.PMC5008135.pdf
<http://www.phac-aspc.gc.ca/php-psp/ccph-cesp/pdfs/cc-manual-eng090407.pdf>.,Non-OADS,/arxiv_data1/oa_pdf/39/a2/policy-12-101.PMC5008135.pdf
< http://www.health.gov.on.ca/english/ providers/program/ohip/sob/physserv/physserv_mn.html >.,Non-OADS,/arxiv_data1/oa_pdf/21/36/policy-12-116.PMC5008136.pdf
< http://www.auditor.on.ca/en/ reports_en/en11/306en11.pdf >.,OADS,/arxiv_data1/oa_pdf/21/36/policy-12-116.PMC5008136.pdf
< http://www.canadiancentreforhealtheconomics.ca/wp-content/uploads/2014/07/Rudoler-et-al.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/21/36/policy-12-116.PMC5008136.pdf
"ISBN 3-900051-07-0, URL http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/ac/c2/MEC-24-3151.PMC5008137.pdf
Mammalian brain images are from http://brainmuseum.org.,Non-OADS,/arxiv_data1/oa_pdf/5c/ef/GLIA-63-1303.PMC5008138.pdf
Available at http://www.diabetes.org/diabetes-basics/statistics/ Last accessed 18 June 2014.,Non-OADS,/arxiv_data1/oa_pdf/63/11/DME-32-1051.PMC5008143.pdf
"All image analysis was performed with ImageJ, either in its standard ver-sion (http://rsbweb.nih.gov/ij/; RRID: nif-0000-30467) or in the Fiji distribution (http://fiji.sc/Fiji; RRID: SciRes_000137).",OADS,/arxiv_data1/oa_pdf/57/ce/CNE-524-456.PMC5008145.pdf
"2002; http://genome.ucsc.edu/), IGV is optimized to provide high-performance data visualization as a stand-alone software application (IGV , http://www.",OADS,/arxiv_data1/oa_pdf/db/32/EPH-100-1429.PMC5008151.pdf
"Genotype-Tissue Expression project (GTEx; http://www.gtexportal.org/; GTEx, 2013) is a resource that can be used to visualize human gene expression and regulation for multiple tissues from a database collected and analysed within the GTEx project.",OADS,/arxiv_data1/oa_pdf/db/32/EPH-100-1429.PMC5008151.pdf
Visualizing various tracks using UCSC Genome Browser reveals the location of four alternatively spliced exons of mouse Cacna1b based on mouse genome version Dec. 2011 (GRCm38/mm10 ;http://genome.ucsc.edu/cgi-bin/hgGateway; Kent et al.,OADS,/arxiv_data1/oa_pdf/db/32/EPH-100-1429.PMC5008151.pdf
"Brainspan is a complementary site that, although not speciﬁcally designed to identify alternative splicing, shows a heat map of gene expression levels in different regions of the human nervous system across development (http://www.brainspan.org/; BrainSpan, 2011).",OADS,/arxiv_data1/oa_pdf/db/32/EPH-100-1429.PMC5008151.pdf
Available from: http://developinghumanbrain.org Copley RR (2004).,Non-OADS,/arxiv_data1/oa_pdf/db/32/EPH-100-1429.PMC5008151.pdf
"Retrieved from http://www.emotionalavailabili-ty.com Bowlby, J.",Non-OADS,/arxiv_data1/oa_pdf/23/ab/CDEV-86-1321.PMC5008154.pdf
"All model outputs were reduced to a subset of only reef locations obtained from the coral reef distribution layer from UNEP-WCMC (http://www.unep-wcmc.org), generatedusing the validated Millennium Coral reef Mapping Project (MCRMP) data (Andr /C19efou €etet al., 2006).",OADS,/arxiv_data1/oa_pdf/f9/ea/GCB-21-3389.PMC5008158.pdf
"All interpolation was performed using Climate Data Opera- tors, a software package available from: https://code.z-maw.de/projects/cdo/.",OADS,/arxiv_data1/oa_pdf/f9/ea/GCB-21-3389.PMC5008158.pdf
"All model output adjustment, projections, data visualization, and analysis were conducted using the NCAR Command Language (NCL; http://www.ncl.ucar.edu/).",OADS,/arxiv_data1/oa_pdf/f9/ea/GCB-21-3389.PMC5008158.pdf
"We are also grateful to Mary Haley andother developers of the NCAR Command Language (Version 6.2.0) of Boulder, CO (http://dx.doi.org/10.5065/D6WD3XH5).",Non-OADS,/arxiv_data1/oa_pdf/f9/ea/GCB-21-3389.PMC5008158.pdf
AMARES/MRUI(http://carbon.uab.es/mrui) software analysis was used to quan- tify phosphorylated compounds.,OADS,/arxiv_data1/oa_pdf/4f/14/ANA-78-21.PMC5008165.pdf
"NIH-CPSI (http://backinmotionpt.com/wp-content/uploads/2010/03/mens_pfcpsi-.pdf)Nine-item questionnaire (total score 0 –43) measuring: Pain (four questions evaluating pain location, frequency and severity, 0 –21) Voiding (two questions evaluating voiding and storagesymptoms, 0 –10) Impact on QoL (three questions, 0 –12) IPSS (http://www.urospec.com/uro/Forms/ipss.pdf)Eight-item questionnaire measuring: Urinary symptoms (seven questions evaluating incomplete bladder emptying,frequency, intermittency,urgency, weak stream, strainingand nocturia, 0 –35) Impact on QoL (one question, 0–6) UPOINT [50] Aims to stratify patients into speciﬁc symptom-led phenotypes.",Non-OADS,/arxiv_data1/oa_pdf/ee/12/BJU-116-509.PMC5008168.pdf
"Measures urinary symptoms, psychosocial dysfunction,organ-speci ﬁcﬁndings, infection, neurological/systemicroutes, and tenderness ofmuscles [50] Has been used toinform phenotypically directed multimodal treatment in CP/CPPS [51] IIEF-5 or SHIM (http://surgery.arizona.edu/sites/surgery.",Non-OADS,/arxiv_data1/oa_pdf/ee/12/BJU-116-509.PMC5008168.pdf
"Validated questionnaires Patient Health Questionnaire-2 (PHQ-2, http://www.commonwealthfund.org/ usr_doc/PHQ2.pdf) –a two-item questionnaire to assess the frequency of depressed mood over the past 2 weeks Patient Health Questionnaire-9 (PHQ-9, http://phqscreeners.com/pdfs/02_PHQ-9/ English.pdf) –a nine-item questionnaire to assess the frequency of depressed mood over the past 2 weeks Generalised Anxiety Disorder-7 (GAD-7, http://phqscreeners.com/pdfs/03_GAD-7/English.pdf) –a seven-item questionnaire to assess the severity of generalised anxiety disorder over the past 2 weeks.",Non-OADS,/arxiv_data1/oa_pdf/ee/12/BJU-116-509.PMC5008168.pdf
§ Box 1can be found in the full version of the guideline: http://prostatecanceruk.org/media/2403685/prostate-cancer-uk- chronic-prostatitis-guideline-full-sep-2014.pdf NICE CG173: www.nice.org.uk/guidance/cg173/resources/ guidance-neuropathic-pain-pharmacological-management-pdf NICE CG90: www.nice.org.uk/guidance/cg90/resources/guidance- depression-in-adults-pdf NICE CG91: http://www.nice.org.uk/guidanca/cg91/resourcest/ guidancedepression-in-adults-with-a-chronic-physical-health- problem-pdf NICE CG97: http://www.nice.org.uk/guidanca/cg91/resourcest/ guidancedepression-in-adults-with-a-chronic-physical-health- problem-pdf  BSSM guidelines: www bssm.org.uk/downloads/BSSM ED Management Guidelines 2013.pdfa BSSM  = British Society for Sexual Medicine; CP/CPPS  = chronic prostatitis/ chronic pelvic pain syndrome; GAD-7  = Generalised Anxiety Disorder 7: LUTS  = lower urinary tract symptoms; MDT = multidisciplinary team; NICE = National Institute for Health and Care Excellence; NSAIDs  = non-steroidal anti-inflammatory drugs; PHQ-9  = Patient Health Questionnaire-9.,Non-OADS,/arxiv_data1/oa_pdf/ee/12/BJU-116-509.PMC5008168.pdf
Fulland ‘quick reference ’versions of the original guidelines are available from the Prostate Cancer UK website (http://prostatecanceruk.org/prostatitisguideline).,Non-OADS,/arxiv_data1/oa_pdf/ee/12/BJU-116-509.PMC5008168.pdf
The quick referenceversion is also available at http://www.bjuinternational.com/?,Non-OADS,/arxiv_data1/oa_pdf/ee/12/BJU-116-509.PMC5008168.pdf
"Available at: http://www.cebm.net/index.aspx?o=5653.Accessed June 2014 6 Hsu CC ,Sandford BA .",Non-OADS,/arxiv_data1/oa_pdf/ee/12/BJU-116-509.PMC5008168.pdf
Available at: http://pareonline.net/ getvn.asp?v=12&n=10.,Non-OADS,/arxiv_data1/oa_pdf/ee/12/BJU-116-509.PMC5008168.pdf
"Availableat: http://uroweb.org/wp-content/uploads/18_Urological-infections_LR.pdf.Accessed March 2015 10 Hetrick DC ,Ciol MA ,Rothman I ,Turner JA , Frest M ,Berger RE .",OADS,/arxiv_data1/oa_pdf/ee/12/BJU-116-509.PMC5008168.pdf
Available at: http://healthguides.mapofmedicine.com/choices/pdf/ prostatitis1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/12/BJU-116-509.PMC5008168.pdf
Available at: http://healthguides.mapofmedicine.com/choices/pdf/prostatitis2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/12/BJU-116-509.PMC5008168.pdf
Available at: http://www.uroweb.org/gls/pdf/24_Chronic_Pelvic_Pain_LR%20II.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/12/BJU-116-509.PMC5008168.pdf
Available at: http://www.nice.org.uk/guidance/cg97/resources/cg97-lower-urinary-tract-symptoms-fullguideline3.,Non-OADS,/arxiv_data1/oa_pdf/ee/12/BJU-116-509.PMC5008168.pdf
Available at: http://www.nice.org.uk/guidance/cg173/ resources/guidance-neuropathic-pain-pharmacological-management-pdf.Accessed July 2014 112 Prostate Cancer UK .,Non-OADS,/arxiv_data1/oa_pdf/ee/12/BJU-116-509.PMC5008168.pdf
Available at: http://prostatecanceruk.org/media/41628/2782-understanding-psa-test.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/12/BJU-116-509.PMC5008168.pdf
"The activation SPMs, interaction SPMs, and PPI maps were projected (enclosing voxel projection) onto ﬂattened left and right hemispheres of the human PALS B12 atlas [Van Essen, 2005, http://sumsdb.wustl.edu:8081/sums/ directory.do?id=636032] using the Caret software package [Van Essen et al., 2001, http://brainvis.wustl.edu/caret].Occipital activation sites were identiﬁed by comparison with the maximum probability atlas of retinotopic regions [Abdollahi et al., 2014].",OADS,/arxiv_data1/oa_pdf/05/aa/HBM-36-3845.PMC5008173.pdf
URL http://viceroy.eeb.uconn.edu/estimates.Table 1.,Non-OADS,/arxiv_data1/oa_pdf/23/72/EMI4-7-404.PMC5008181.pdf
URL https://www.marum.de/ Binaries/Binary12275/Fahrtbericht_M76_1-3a_b.pdf.,OADS,/arxiv_data1/oa_pdf/23/72/EMI4-7-404.PMC5008181.pdf
The used geochemi- cal data of the samples can be retrieved from PANGAEA –Data Publisher for Earth & Environmental Science (http://www.pangaea.de).Table S6.,OADS,/arxiv_data1/oa_pdf/23/72/EMI4-7-404.PMC5008181.pdf
"B ,51, 298 –313, doi:10.1034/j.1600-0889.1999.00013.x.Acknowledgments Funding for the Multi-scale Synthesis and Terrestrial Model Intercomparison Project (MsTMIP; http://nacp.ornl.gov/MsTMIP.shtml) was provided throughNASA ROSES grant NNX10AG01A.",OADS,/arxiv_data1/oa_pdf/f3/ec/GBC-29-775.PMC5008182.pdf
"Data management support for preparing, documenting, and distributing modeldriver and output data were performedby the Modeling and Synthesis Thematic Data Center at Oak Ridge National Laboratory (http://nacp.ornl.gov), withfunding through NASA ROSES grantNNH10AN68I.",OADS,/arxiv_data1/oa_pdf/f3/ec/GBC-29-775.PMC5008182.pdf
Finalized MsTMIP data products will be archived at the ORNL DAAC (http://daac.ornl.gov).,OADS,/arxiv_data1/oa_pdf/f3/ec/GBC-29-775.PMC5008182.pdf
[Availbble at http://daac.ornl.gov.],Non-OADS,/arxiv_data1/oa_pdf/f3/ec/GBC-29-775.PMC5008182.pdf
"Distributed Active Archive Center, Oak Ridg e, Tenn. [Available at http://daac.ornl.gov.]",OADS,/arxiv_data1/oa_pdf/f3/ec/GBC-29-775.PMC5008182.pdf
Available at: http://www.sfgate.com/bayarea/ article/BAY-AREA-Woman-whose-inmate-dad-donated-kidney-2609092.php.,Non-OADS,/arxiv_data1/oa_pdf/4c/93/BIOE-30-119.PMC5008185.pdf
2015 January 26 Avail- able at: http://www.independent.co.uk/news/world/americas/parents-of-twins-with-alagille-syndrome-in-public-plea-for-liver-donor-after-discovering-father-is-a-match–but-can-only-donate-to-one-child-10003178.html [cited 2015 May 22]10A simple utilitarian approach might bring us to such a conclusion.,Non-OADS,/arxiv_data1/oa_pdf/4c/93/BIOE-30-119.PMC5008185.pdf
Available at: http://www.organdonation.nhs.uk/newsroom/news_releases/article.asp?releaseId =359 [cited 2015 January 25] 28United Kingdom Guidelines for Living Donor Kidney Transplanta- tion.,Non-OADS,/arxiv_data1/oa_pdf/4c/93/BIOE-30-119.PMC5008185.pdf
National Institute for Health and Care Excellence 2010 Availableat: https://www.nice.org.uk/proxy/?sourceurl =http://www.nice.org.uk/ newsroom/features/measuringeffectivenessandcosteffectivenesstheqaly.jsp [cited 2015 May 22] 49G.,Non-OADS,/arxiv_data1/oa_pdf/4c/93/BIOE-30-119.PMC5008185.pdf
British Transplantation Society Congress 2014 AbstractBook Available at: http://www.bts.org.uk/Documents/Congress2014/BTS2014_AbstractBook.pdf [cited 2015 May 22]Phillippa Bailey and Richard Huxtable 8 © 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/93/BIOE-30-119.PMC5008185.pdf
16 Dec Available at: http://www.nytimes.com/2009/12/20/magazine/20organ-t.html?pagewanted =all&_r =0 [cited 2015 May 22] 64H.,Non-OADS,/arxiv_data1/oa_pdf/4c/93/BIOE-30-119.PMC5008185.pdf
Available at http://www.fda.gov/down- loads/MedicalDevices/DeviceRegulationandGuidance/Guidance- Documents/UCM259305.pdf Last accessed 20 February 2013.,Non-OADS,/arxiv_data1/oa_pdf/6c/70/DME-33-235.PMC5008188.pdf
Available at: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/69/19/BJU-116-397.PMC5008189.pdf
"Available at: http://www.qub.ac.uk/research-centres/nicr/FileStore/ PDF/Incidence/Filetoupload,382846,en.pdf.",OADS,/arxiv_data1/oa_pdf/69/19/BJU-116-397.PMC5008189.pdf
Available at: http://www.nice.org.uk/CG175.,Non-OADS,/arxiv_data1/oa_pdf/69/19/BJU-116-397.PMC5008189.pdf
Available at: http://decisionaid.ohri.ca/ docs/develop/User_Manuals/UM_Regret_Scale.pdf.,Non-OADS,/arxiv_data1/oa_pdf/69/19/BJU-116-397.PMC5008189.pdf
Available at: http://www.gov.uk/government/uploads/system/uploads/attachment_data/ ﬁle/215528/dh_128868.pdf.,OADS,/arxiv_data1/oa_pdf/69/19/BJU-116-397.PMC5008189.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/  Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/61/b5/mtm20163.PMC5008202.pdf
"This work was sponsored by Eli Lilly and C o m p a n y .A d d i t i o n a ld e t a i l so ft h i ss t u d y ,e n t i t l e d‘ AS t u d yo f LY2189265 Compared to Sitagliptin in Patients with Type 2 DiabetesMellitusonMetformin’,canbefoundatClinicalTrialRegistry:http://clinicaltrials.gov(NCT00734474).",Non-OADS,/arxiv_data1/oa_pdf/68/39/DOM-17-849.PMC5008205.pdf
2009.Available from URL: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugs AdvisoryCommittee/UCM148659.pdf.Accessed12January2015.,Non-OADS,/arxiv_data1/oa_pdf/68/39/DOM-17-849.PMC5008205.pdf
Available from URL: http://www.missingdata.org.uk.,Non-OADS,/arxiv_data1/oa_pdf/68/39/DOM-17-849.PMC5008205.pdf
(http://www.cdc.gov/nchs/ndi.htm).,OADS,/arxiv_data1/oa_pdf/86/21/AJIM-58-905.PMC5008208.pdf
"Wash-ington, DC: NIOSH (http://www.cdc.gov/niosh/ltas/).",OADS,/arxiv_data1/oa_pdf/86/21/AJIM-58-905.PMC5008208.pdf
(http://www.osha.gov/pls/ oshaweb/owadisp.show_document?p_id=18599&p_table=federal_- register).,OADS,/arxiv_data1/oa_pdf/86/21/AJIM-58-905.PMC5008208.pdf
An Atlas of MS. http://www.atlasofms.org/ (accessed 19/09/ 2013).,Non-OADS,/arxiv_data1/oa_pdf/db/33/ENE-22-990.PMC5008210.pdf
http://www.popdata.bc.ca/data (accessed 19/03/2015).,OADS,/arxiv_data1/oa_pdf/db/33/ENE-22-990.PMC5008210.pdf
http://www.popdata.bc.ca/data (accessed 19/03/ 2015).,OADS,/arxiv_data1/oa_pdf/db/33/ENE-22-990.PMC5008210.pdf
http://www.popdata.bc.ca/data (accessed 19/03/ 2015).,OADS,/arxiv_data1/oa_pdf/db/33/ENE-22-990.PMC5008210.pdf
http://www.popdata.bc.ca/data (accessed19/03/2015).,OADS,/arxiv_data1/oa_pdf/db/33/ENE-22-990.PMC5008210.pdf
The Matlab-code to compute thebrain Modes is available at: http://www.slneuroimagin-glab.com/mt-tools.,OADS,/arxiv_data1/oa_pdf/42/a3/HBM-36-3404.PMC5008218.pdf
(Available from: http://www.crn.nihr.ac.uk/children/pcpie/young-persons- advisory-group/.,Non-OADS,/arxiv_data1/oa_pdf/56/dc/JRSM-6-206.PMC5008219.pdf
(Available from: http://www.invo.org.uk/ ﬁnd-out-more/what-is-public-invol vement-in-research-2/.),Non-OADS,/arxiv_data1/oa_pdf/56/dc/JRSM-6-206.PMC5008219.pdf
Journal of Health Services Research and Policy 17(4): 248 –251 available from: http://hsr.sagepub.com/content/17/4/248.abstract.,Non-OADS,/arxiv_data1/oa_pdf/56/dc/JRSM-6-206.PMC5008219.pdf
"and Walker, S. (2014) lem4: Linear mixed-eﬀects model using Eigen and S4, Avail-able from: http://cran.r-project.org/pack- age=lme4.",OADS,/arxiv_data1/oa_pdf/db/14/INA-26-391.PMC5008221.pdf
"Mott, L., Fore, D., Curtis, J. and Solomon, G. (1997) Our Children At Risk: The Five Worst Environmental Threats to Their Health, Available from: http://www.nrdc.org/.Mullen, N.A., Liu, C., Zhang, Y., Wang, S. and Nazaroﬀ, W.W. (2011) Ultraﬁne par-ticle concentrations and exposures in four high-rise Beijing apartments, Atmos.",Non-OADS,/arxiv_data1/oa_pdf/db/14/INA-26-391.PMC5008221.pdf
"R Core Team (2014) R: A language and environment for statistical computing, Available from: http://www.r-pro-ject.org/.",Non-OADS,/arxiv_data1/oa_pdf/db/14/INA-26-391.PMC5008221.pdf
Available from: http://www.euro.who.int/__data/assets/pdf_ﬁle/0004/162535/ e96541.pdf WHO (2013) Review of evidence on health aspects of air pollution –REVIHAAP Project.,OADS,/arxiv_data1/oa_pdf/db/14/INA-26-391.PMC5008221.pdf
Available from: http://www.eu ro.who.int/__data/assets/pdf_ﬁle/0004/ 193108/REVIHAAP-Final-technical-report-ﬁnal-version.pdf 402Rivas et al.,OADS,/arxiv_data1/oa_pdf/db/14/INA-26-391.PMC5008221.pdf
"To view a copy of this license, visit http://creativecom- mons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/08/c0/mtm20168.PMC5008224.pdf
